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Abstract
Serum cholinesterase is an enzyme similar 10 acety lcholinesterase but of
unknown function. Activity varies wide ly between individuals and numerou s
variants are known. Numerous studies have related the activify of serum
cholinesterase to serum lipid concentrations but it is not known whether the
enzyme plays a part in lipoprote in metabolism nor, il it does. whethe r this is
related to its catalytic activity or to some other feature of the protein. II was
therefore decided to compare the relationships of its concentration and activity to
the concen tration s of serum lipids and lipoproteins.
Cholineste rase was purified from human serum, and antise rum was raised
in a rabbit. The antiserum was used 10 measure the concen tration of the enzyme
by rad ial immunodiffusion in sera from 117 blood donors and 282 patients for
whom serum lipid profiles had bee n requested.
In the donor group the correlation between acti\<Uy and concentrat ion of the
enzyme was 0.95 and there was lillie difference between the correlat ions 01 the
two measures of cholin esterase with lipids. In the patient group the correlation
between serum cholineste rase activity and concentratio n was only 0 .88 and all
the lipid indices correlated bette r with the concentration of cholinesterase than
with activity. This was probably because of variable loss of activity during
transport and sto rage, and because of enzyme inhibition by drugs.
For further analys is the patients were preferred because they had lasted
before blood sampling and had a greater range of lipid concentrations.
Oorrele tions with cholines terase concentration were in the order 'total LDL' (LDL
+ VLDL) > VLDL > triacylglycerols > cholesterol. The correlation coefficien ts were
similar, 0.51 with 'total LDL' as against 0.41 with cholesterol, but the shapes of
the plot s were markedly different. The plot of cholinesterase against cholester ol
showed very weak relationship. The pial against trlacylqlycerots showe d a welt-
defined triangular shape, At towe r triacy lglycerol concentrations a wide range of
cholinesterase concentrations was found but with high triacylglycerol
concentrations the enzyme concentration was always high. The possible nature
of the relationship is discussed.
In 1M preparatory stages, impurities occurring in affinity-purified
cholinesterase were investigated by western blotting; and in concentration
measurement, reproducible variation in precipitin ring patterns between
individuals was observed.
Key words : Serum cholinesterase concentration; serum lipids; immunological
variation of serumcholinesterase.
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Chapter 1
INTRODUC TION
1.1 Objectives
There have been many re ports of raised serum cholinesterase ac tivity in
hyperlip idaemia. Serum cholinesterase activity is rout inely measured on all
samples sent to The C harles A . Janeway Hospital for serum lipid profiles and
these m easurements had confirme d this associat ion. The function or functions o f
cholinesterase in the serum are unknown. Th ere are many variants of the
enzyme, some of ibese havin g different substrate affinities. T he basis of the
relationship between serum cholinesterase activity and serum lipids o r
lipoproteins is not known, whe ther pr imary or secondary, or whether this is
cependeru on the enzym ic activity or some other feature 01the cholinesterase
protein.
Th e first objective 01 this project was to pu rify cho linesterase from human
serum, to use the purified enzyme to ra ise polyclonal antibodies in a rab bit, and
to develop competence in a method of measurin g cholinesterase concent ration in
human serum samples using the rabbit antiseru m. The second objective was to
establis h normal ranges for concentration and specific activity of t he enzyme and
then to eslimate these parame ters in patients' serum samples in w h ich the
cholinesterase acuvltles hada lready been measured. The first purpose of this
was to investig ate the nature of the re lationship between serum cholinesteras e
and se rum lip id levels, partic ularly to see whether the ra ised activ ity in
hyperlip idaemia was in deed due 10raised concentratio n of the e nzyme, as was
presumed by most autho rs, and to see whelher the concent ration of the enzyme
correla ted better or worse with lip id leve ls than did activ ity. The second purpose
was to look ou t for sam ples wit h unusual specific activity, such as migh t be the
result o f inhibition, know n to be caused by various drugs and toxins, o r due to
genetic variants.
These objectives were largely met, though the estimation of spec ificacti vity,
based on two measurements (ccncenteuon and activity) and therefore having
compounded measurement error, was not considered accurate enough for
quenuteuve purposes, but served for qualitative comparison of spec ific act ivity
and Its variation in patients and controls. In addition, an exploration was made of
impurities in the purified cholinesterase and immunological variation in serum
cholinesterase between lndtvtduais was observed.
1.2 History and nomenclature
In 1914, the physiologist Henry Dale, having found that lho physiological
effects of acetylcholine are very short-lived and that acetylcholine is rea dily
hydrolysed to choline and acetic acid, suggested the presence of an esterase in
the blood. He did not appear at that time to have considered that the enzyme
might be present in the tissues. In 1926, Loewi and Navratil estab lished the
existence of an acetylcnoline-spflttinq enzyme by showing that the breakdown of
acetylcholine by aqueous extracts of frog heart could be prevented by heating
the extract or exposing it to ultraviolet light, or by the addition of physostigmino.
Several esterases in animal tissues were found to be incapable of hydrolysing
acetylcholine, but in 1932 Stedman et al. found an enzyme in norse serum thai
specifically hydrolysed choline esters, though it hydrolysed butyrylchol ine raster
than acetylcholine. They proposed the term cholinesterase for this enzyme.
Stedman and Stedman (1935) went on to show that blood cells also contain
a cholinesterase, and in 1940 Alles and Hawes showed that the cholinesterase in
human red ceue is different from that in human serum. The aClivity of theser um
enzyme rises steadily with increasing concentrations of acetylcholine whereas
the red cell enzyme shows substrate inhibition with high conce ntrations of
acetylcholine. They also showed that acetyl-p-methvlchcnne is hydrolysed at
about the same rale as acetylcholine by the enzyme in red cells, but hardly al alt
by the serum enzyme. Mendel et a/. (1943) found in contrast Ihat the
cholinesterases in horse serum and dog pancreas would hydrolyse
benzoyictoune whereas those in human red cells and dog brain would not.
Nachm ansohn and Rothenber g (1945 ) went on to show that in hum an blood ,
relative tothe rateof acetylcho linehy dro lysis, benzoylcholine hydrolysi s is ab::ul
4% in red cells bul about 60% in serum, and that fo r bUlyrylcholine the figur es
are about S% and 27()OA!respectively. Benzoy lcholine and bu tyrylthioc holine are
now pr obably the mos t comm ons used subs trates in specific assays of serum
cholinesterase (Whitta ker, 1985 ).
Mendel an d Rud ney (1943) found Ihat th e enzymes tha t they purified fro m
horse serum and dog pancreas wou ld catalyse the hydrolys is of some non-
choline esters as well as choli ne este rs , where as the enzyme frombra in and re d
cells from seve ral species wa s specif ic for chol ine esters. They also noted th at
thefor merhave only slight act ivity at low concentrations of ace tylcholine whereas
Ihe latter exh ib it maximum activ ityat low acety lcholine concen trations , Because
of the se lind ing~ , they proposed the name 'pseudocho linesterase' for the form er,
reservi ng the name 'ch olinesterase' or 'true cholinestera se' for the latte r.
Augustinsson (1948 ), reviewed the a lready volumino us literature, and
reporte d extensivewo rk of his ownon the chcn nesferasee In a range o f tissues in
a range of species, including invertebr ates, usin g a ran ge of s ubstrates. He wa s
agains t the use of the term 'pseudocholinesterase ' and c ited sev eral o ther
autho rs who had called for its abando nment. He poin ted out that both enzymes
hydrol yse cho line esters at hig her ra tes than ncn-choflne es ters, and genera lly
split acetylCholine at a higher ra te than other c holine e sters, w hereas un specifi ed
esterases sp lit aU sorts of este rs at th e same rate or even at higher rates than
acetylc holine or other choline esters. He also mentioned that both enzymes are
inhibited by very small amoun ts of phy sostig mine whereas oth er esterases a re
no!. He therefore consi dered them bo th 10 be choline esierases , and started by
roferring to them as 'specific cholinesterase' for, the one most active on
acety lcholine at low concentrations, and 'nc n-specnlc choli nesterase ' lor the
other. He found that both enzymes a re presen t in a variety o f tissues, and thai
their sp ecificiti es vary fromtissue to tissue with in a given spec ies, as we ll as in a
given tissue from apectes to species. He therefore came to regard the
chounesterasee as a family of enzymes with widely divergent properties, and
divi ded them into two groups, Group I corresponding to the 'specif ic' and Group II
to the 'non-specific' cholineslerases. His data convinced him 01the identity of the
enzymes in erythrocytes and brain, and he noted thai in the ery throcyte il had
been demonstrate d to be membrane-bound and presumed that Ihis wou ld also
be true in the nervous system.
In only the nexl yea r (1949), Augustinsson and Nachmansohn pro posed
tha t those in Group I, which had been shown to have well-defined belt-shaped
acetylcholine concentration optima, should be re named 'acetyl-cholines terase',
and that those in Group II might be called 'cholinesterase'. They pointed out that
the name of the former wou ld assoclare this type of enzyme with its physio logical
subs trate, at least In nerve and m uscle tissue, whe re a function of acetyrcncloe
appeared fairly well established, and that as the physiological function of the
latter was unknown, call ing them cholinesterases was at least temporarily
appropriate .
Subsequent work on structure and tissue localisation of these enzymes,
rev iewed by Massoulie and Bon (1982), Brimijoin and Rakonczay (198 6) and
Chatormet and Loc kridge (1989) has shown mat they occur in two homo logous
sets 01 mo lecular forms. Each enzyme may exis t as a monomer, dimer or
tetramer. In additio n, one, twoor three tetramers may be attached bydis utphide
bon ds to the same end of a 'couaqen-nke ' tail, consisting of three peplides in a
trip le helical arrangement. Eachmonomer has a singleactive serine residue. Bon
at al. (1979) proposed that these six molecular forms should be desiqnated as
G1• G2 and G4 for the non-tailed or 'globular' forms and A4, As and A\2 for the
tailed or 'asymmetrical' for ms, where the subscript in each case represe nts the
number of catalytic subunits. These forms have been found thro ughout
vertebrates andeven in Drosophila acetylcholinesterase. The picture is however
mo re complicated than this. Theglobular forms of acetylcholinesterasemay each
exis t in hydrophilic and amphiphilic forms. The amphiphilic nature can be
conferred by ei the r of two hydrophobic a nchors which attach the protein to cell
membranes. One is a small glycolipid containing mya-inosilol, glucosamine and
ethanolamine in amide linkage to the C-te rminus of the catalytic subunit (Roberls
at af., 19 87) The other is a 20 kDa componenl which contains fatly acids but no
inositol and no e thanolamine or glucosami ne wit h free amino-acid groups . II is
asymmetrically linked to two catalyllc subunits by disulphide bonds. Similar
membrane- bound forms of the 'ncn-epecrnc cholines terase' are thought to exist
because detergent·soluble globular forms of the enzyme have been found in
venobra te tissues . Additional complication Is added by the fact thai the proteins
are glycosylated. There is evidence that th e glycosylation of acetylcholine varies
from tissue to tissue and in the course of development and differentiation, but it is
not know n whether the same applies to the 'non-speclnc cholinesterase', Anot her
complication is th ai in some species (the electric ray, Torpedo and Ihe chicken,
and there fore probably also other species) there appear to be other assoc iated
peplides (see Massoulie andBon , 1982).
The various forms of the enzymes are found in different locations. The tail
proteins attach the enzymes, probably by Ionic interactions, to extracell ular
basement lamina where as the hydrophob ic components enable the globular
forms to be attach ed to cell membranes. For example, the bulk of asym metric
acetylcholinesterase is found in the synap tic cle ft, attached to the basement
lamina, the G4 form of acetylcholinesterase is also found in brain and Is attached
10 cell membra nes by the 20 kDa anchor, while the red ce ll acetylcholinesterase ,
G2 1nhuman s and calli e, but G 1 in the ra t, is also amphiphilic but has the small
glycolipid anchor. Theprincipal oholinesterase fou nd in human serum is the 'non-
specific cholinesterase'. About 94% is the G4 form (Atack et aI" 19B7) , The
multiple forms of the remainder will be discussed tater. Evidence for the
presence of ece tylcnollneeterase in human serum was found by Rubinstein 6t af.
(1970) and confirmed by Sorensen et al. (1986), but its concentration is lower by
a factor of more than400 (Brimijoin and Hammond , 1988).
The name 'acetylcho linesterase' rap id ly became generally adopted afte r its
proposal in 1949, but to this day the other enzyme is referred to by different
authors as 'cholinesterase', 'pseudocholine sterase', 'serum cholinesterase',
'plasma cho linesterase', 'non-specfflc cholinesterase' and, in those spec ies
(including our own) in which il hydrolyses butyry lcholine tho most quickl y,
'butyrylchollnesterase' and in other species , in which prcplcnytchoune is
hydrolysed more quickly, 'prcplcnylchounesterase'. The Enzyme Commission
(Bielka et ai" 1979) has given the latter enzyme the systematic name
'acylchonne acylhydrolase' (Ee 3.1,1,8) and adopted 'cholinesterase' as the
trivial name . However , as the term cholinesterase has not only been used in the
past lor acetylchol inesterase but is commonly used as a general term 10 cover
both enzymes, this seems a little unfortunate . Though the 'ncn-specfuc' enzyme
occurs in the plasma in vivo, the term 'serum cholinesterase' is used much more
than 'plasma cholinesterase'. In this work the term 'serum cholinesterase' w ilt be
used except when referring to the enzyme in other tissues, when
'butyrylchol inesterase' will be used.
1.3 Human serum cholinesterase
Lockridge at al. (1979) showed that tetramenc human serum cholinesterase
exists as a dimer of dimers of apparently identical subunits. The members of
each pair are joined by a single disulphide bond, Afte r reduction and alkylatio n of
the inter-ch ain disulphide bonds the enzyme was found still to be a tetrarner and
still fully acti ve. It was therefore concluded that the disulphide bonds were not
necessary for either the tetramenc structur e or for activity, and that the four
subunits we re held together by non-covalent bonds. Heat-inactivation studies
showed, however, that the inter-cham disulphide bonds increase stability. The
easy reduction lind alkylation of these bonds suggested that they are near the
surface of the molecule. This was reinforce d when Lockridge and La Du (198 2)
showed that limited proteolysis could rem ove a small peptide containing the
disulphide bond, and thesubunits still stayed together.
The complete amino-acid sequence has since been determined (Lockridge
et ai" 1987a) and confirmed from the sequences of over lapping cDNA clones
from fetal brain and live r (Prody at al., 1987) and cDNA clones from neonatal
brain (McTiernan at al., 1987). The protein contains 574 amino-ac ids per subunit.
The vast majority of the polyclonal antisera and monoclonal antibodies raised
against acetylcho linesterase had no measur able affinity for the other
cholinesterase and none of the antibodies against the taner reacted with Ihe
former (Weifz et al., 1984; Brimijoin and Aakonczay, 1986; Sorensen et al.,
1986). This led 10 the suspicion that, despite the homology I)f the quaternary
snucfuree of the two kinds of chc'nestereses, the amino-acid sequences and
protein folding might be significantly different. It was the refore a surprise to find
that the amino-acid sequence of human serum chol inesterase is 53.8% identical
to that of the acetylcho linesterase of the electric ray (fish) Torpedo californica
(Schaumacher e t al., 1986). Torpedo acetylcholinesteras e has almost the same
number of amino-acids too, 575, and distancesof Ihe active site serines from the
amino-termini are 198 in human serum cholinesterase and 200 in Torpedo
acetylcho linesterase. Human serum cholinesterase is 38% identical to
Drosophifa acetylcholinesterase. It shows no signi ficant homology with the serine
proteasea but shows similarities 10 a rabbit liver microsomal esterase, to
esterase-a of Drosophila, to bovine thyroglobulin (Chalonnot and Lockridge,
1989) and to lipase of the fungus Geofrichum candidum (eteoes et al., 1990).
From the established amino-acid composi tion and the percentages of
protein and carbohydrate in the enzyme reported by Haupt et al. (1966),
Lockridge atal. (1987a) calculated thesubunit mo lecular weight of human serum
cholinesterase as about 85.5 kD. giving about 342 kD for the tetramer. This is in
good agreement with the figure of 348kD determined by Hauptat al..
During sequencing, glycosylatild asparagine showed up as a blank, since
the carbohydrate chain prevented ex traction of the phenylthiohydantoin
derivative Into Ihe sequencing solvents. Oul of the 40 asparagine residues in Ihe
peptide, 9 were distinguished in this way. Every one of these was in the
sequence Asn-X·(Ser or Thr), where X can be any amino-acid except proline.
This sequence is kno wn to be common to all N-glycosidically-linked carbohydrate
chains (Bause , E., 1983). A tenth asparagine residue which also fitted into this
sub-sequence was eliminated as a possible carbohydrate-bearer because it is
next to one of the asparagines that does have a carbohydrate chain (Asn-Asn-
Ser-Thr - the f irst has no chain) and carbohydrate chains have never been found
to occur on adjacent asparagines. Lockridge at al. (1987a) cite the data of Haupt
at af. (1966) as supporting their conclusion of nine carbohydrate chains and as
suggesting tha t the chains are of the complex type, ending in sialic acid. The
possibility tha t other carbohydrate chains might be present as O-linked
oligosaccharides was not examined.
Lockridge at al. (1987b) determined the positions of the disulphide bonds.
Each subunit has eight 'halt-cystlnss'. Six of these form three intra-chain
dlsulpnlde bridges, ons . four residues from the carboxyl terminus - forms the
Inter-chain bond , and one could not be alky lated. Comparison with Torpedo
acetylcholinesterase showed that they have the sa me number of disulphide
bonds, with the same number of amino-acids in each loop and very similar
'hydropathy indices' (sic, devised by Kyte and Doolittle, 1982) suggesting that
their folding is very similar. However, the explanation of the difference in
antigenicity of the choioeeterasee of a single species could well lie in the
carbohydrate chains. Torpedo acetylcholinesterase has only lour asparagine
residues that have the possibility of being glyco sylated and only two of them are
in the same places as glycosylated residues in human serum cholinesterase.
1.4 Clinical signif icance
In the ve ry paper In which the existence of serum cholinesterase was fir st
demonstrated (Stedman et al ,. 1932) it was noted thatthe activity in the serum
from different horses varied considerably. By 1948 Augustinsson was able to
report that investigat ions of human serum cholinesterase activity had been
carried out with a great number of patients with various diseases, some showing
an elevation and some a depression of mean activity , but that the data did not
seem to have any diagnostic value because, in humans also, the enzyme's
activity varies markedly between normal healthy individuals. This is, with notable
exceptions, still true today; Whittaker, 1986, gives tables of conditions associated
wilh increased and (more) with decreased serum cholinesterase activity.
Much evidence has been collected that indicates that serum cholinesterase
is synthesized in the liver (Kaufman, 1954). Recently, this has been proved by
the finding that in a person who was a heterozygote for a genetic variant
('atypical', see next sectVn) serum cholinesterase, the variant was etlmtnated
and replaced with the 'normal' variant when the person had a liver transplant
(KhOUry at al., 1987). Serial measurements of the enzyme in an individual can
therefore be used 10 monitor liver function in liver disease and after porto-caval
shunting or liver-transplantation (Whittaker, 1986), but there are other indices of
liver function. The two principal areas of clinical interest in serum cholinesterase
are in succinylcholine sensitivity and organophosphate poisoning.
Succinylcholine (suxamethonium) is a usually-ehon-actlnq muscle- relaxant
used in general anaesthesia for surgery and electro- convulsive therapy. Its
introduction into clinical practice led to the realization that normal healthy
individuals differ in their inherited abilities 10 metabolize different drvqs - opening
a field which has since become known as 'pharmacogenetics' • and to the
discovery of the first of many genetic variants of serum cholinesterase. Its
physiological effects were first investigated in 1906 (Hunt and Taveau), and in
1941 Glick showed that il was hydrolysed (slowly) by horse serum
chonnesierase, but it was not untiJ 1949 that its potent neuromuscular blocl\ing
activity was described by Bovat at al.. These authors pointed out that II might be
valuable in clinical applications because it was hydrolysed rapidly by serum
cholinesterase and therefore gave only transient effects.
By 1952 il had been commercially available for long enough for Bourne et
al. and Evans er al. to be able to report on its effects in hundreds of patients. The
former group found that in the majority of patients the paralysis laatec from 2·4
I.
minutes, the latter 2-6. Both groups noted that in a few of their patients the
durati on of action of the drug was prolonged, quoted several other reports of the
same finding thai year (the longest being three hours), investigated the serum
cholinesterase activity, and found that it was much lower in those with prolonged
paralysis. The latter group demonstrated an inverse relationship between the
serum choli nesterase activi ty and the period of apnoea . They also suggested thai
the explanation for the action of succinylcholine lies in a difference between
acetyl cholineste rase and serum cho linesteras e such that the lormer is subjecl lo
competit ive inhib ilio n by ii , but hardly hydrolyses it. while the latter usually rapidly
removes it. Both groups suggested the nee d for caution in the use of the drug in
patients likely 10have low cholinesterase activity such as those with liver disease
or malnutrition, or poisoning with anticholinesterase compound s such as certain
insecticides and war gase s. They counselled avoid ing ii , or giving a reduced
dose, and only where faci lit ies existed for prolonged artificial respira tion.
The followIng year it occurred to Forbat at al. (1953 ) to investigate the
relatives of a patient who had exhibited prolonged apnoea with tho drug. The
on ly available one was a healthy brother and he too had a very low serum
cho linesterase. Subse quen t studies (see next section) ted to the esta blishment of
inherited varia tion in serum cholinesterase as the explanati on for this clin ical
phenomenon and \0 the finding tha t the posesston of a variant enzyme is more
important Ihan the cholinesterase activity, as usually measured , in determining
du ration of apnoea .
The other main area of cli nical interest in serum cholinesterase is in
poisoning by an tichotines terases . This is reviewed by Whittake r (1986). Many
compou nds inhibit cholinestera ses . These include drugs used in the treatment of
such disorders as myaest henia gravis, glaucoma, urinary retention and para lytic
ileus, and to reverse the effects of non-depolarising (competiti ve) muscle relaxant
drugs such as tuboc urarine (George et al., 1990). However , the inhibitors which
most frequen tly cause toxic ily are the systemic insec ticides (and nerve gases).
Mos t of these are eithe r carbamates • which cause reversible inhibition and only
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short-lasting effects (Vandekar et af., 1971) • or organophosphates, which cause
irreversible inhibition and therefore much longer-lasting effects. The
pharmacological effects of these compounds are due to the inhibition of
acetylcholinesterase but most of them inhibit serum cholinesterase 10 a greater
extent. The measurement 01 serum cholinesterase can therefore be useful. In
these cases , not only for diagnosing intoxicalion, but for monitoring workers at
- risk of exposure to such compounds for changes which occur before symptoms
develop, as well as in determining when an individual might return to work. As
has already been stated, serum cholinesterase activity is very variable between
individuals. It is therefore often not possib le 10 diagnose toxic exposure with a
single post -exposure measurement if a baseline pre-exposu re measurement has
not been made. Coye at al. (1987) cite numbers of cases of agricultural workers
exposed 10 the organophosphates mevlnpbos, phosphamidon and diazinon who
complained of symptoms but were sent back to work because of serum
cl-:v!ir.esterase levels with in the normal range. They showe d thet diagnosis can
still be made by removing the workers from exposure and making serial
measurements. Serum cho linesterase activity is then seen to rise until event ually
stabilising again.
1.5 Genetics and molecular biology
The first report of low serum cholines terase in siblings, ascertained by ihe
finding of prolonged apnoea with succ inylcholine in one of them (Forbat at at,
1953), wa s followed by fu rther reports of family studies. Lehman (the chemical
pathologist author of Evans et aI., 1952 and Forbat at al, 1953) and Ayan (1956)
used a single dividing line between normal and low serum cholinesterase ac tivity,
which led them to believe that some patients had norma l levels and that the
inheritance of low levels was recessive. AUoll and Thompson (1956) suggested
that, in a family they reported, hete rozygo tes had intermed iate levels . The data of
Lehman and Ryan were also compatible with this idea .
In Iha meantime, anothe r line of enquiry was being pursued, namely that
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different individuals might have qualitatively different enzymes rather than just
different amounts. Foldes et at. (1954) investigated the hydrolysis of
acetylcho line, benzoylcholi ne, succinylcholine and procaine by the serum of 16
human subjects and found 'no parallelism ' between the rates. From this they
concluded Ihat either there is more Ihan one enzyme in tt re serum capable of
hydrolysing acetylcholine or Ihal marked qualitative differences exist between
individuals . Following this up, Stayner (1955) pointed out Ihal determination 01
the rate of hydrolysis of succinylcholine is complicated by the teet that it is a
dicholine. He therefore decided to investigate the affinity of the serum
chol inesterase of different individuals for succiny lcholine by determining the
amount of succinylcholine required to cause 50% inhibition (Iso) of the ability of
the enzyme to hydrolyse acetylcholine . He found that the lso was fairly uniform in
8 patients responding normally to succmylchcune but increased in 2 who had
prolonged apnoea.
Around the same time, Kalow had a similar idea, Heralded by a number 01
abstracts and letters, e.g. Kalow and Lindsay (1956), Katow, Genest and Staron
(1956), Kalow (1956), he published in detail in 1957 the results of a large study in
three papers describing his method of detec ting the 'atypical' serum
cholinesterase (Kalow and Genest), the relationship between dose of
succ inylcholine and duration of apnoea (Kalow and Gunn) and the distribution
and inheritance of atypical forms of the enzyme (Kalow and Staron) and was
apparentl y unaware of the work of Foldes at al. or Stovner. His method differed in
that instead of determining the amount of inhibito r necessary to cause a fixed
percentage of inhibition, he used a fixed concentration of inhibitor and
determine d the percentage inhibition, The substrate he chose was
benzoylc hollne and the inhibitor was dibucain e (also known as ctnchocalne ,
Nupercaine and Percalne) , each used at 10·5M. The percentage inhibition was
termed the 'dibucaine number', This method was subsequently adopted as a
standard test. Investigation of nearly 1700 sera indicated that dibucaine numbers
could be divided into three groups. Those above 70 • usually around 79 • were
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consi dered typ ical, between 70 and 40 intermediate, and below 20 atypical. None
was found between 40 and 20 . Karow and Genest (1957) tcund , as Stayner had
done, thai the inhibition was independent of activity, except that activity was
always low in Ihose with very low dibucaine numbers. They also found that
dibuca ine numbe r remained constant over lime in individuals.
Ka low and Gunn (1957) ga ve different doses of succinylcho line 10the same
individuals on different occasions when they received a series of
electroconvulsive treatments. They found a linear relationship between tne
logarithm of apnoea-time and the logarithm of dose with the same slope in all
individuals but different intercepts. Individuals with intermediate dibucaine
numbers were found to have serum cholinesterase activities within the normal
range more often than to have normal responses to succinylcholine. Those with
very low dibucaine numbers had much longer apnoea than those with normal or
intermediate numbers, and their serum did not appear to hydrolyse
succinylcholine, though it did hydrolyse other choline esters.
Kalow and Staron (1957) studied not only a large population, made up of
students, labourers, unaelected general hospital patients, and mental hopital
patients, but the nuclear families of five students with intermediate dibucaine
numbers and two extended pedigrees of patients found because of prolonged
apnoea wilh succinylcholine. The dibucaine numbers were found to fall into three
distinct groups explainable by the existence of two codominant alleles, inherited
in Mendelian fashion. The frequency of the atypical allele in the mental hospital
patients was higher than in the others, so in case there was some association
with mental disorder, the population frequency was estimated from the healthy
subjects only. This gave an incidence of atypical homozygotes of about 1 in
5,100 and of heterozygoles of about 1 in 36. Though the mean esterase activities
were different in the different groups, there was very extensive overlap so that
activity cannot be used to distinguish genotypes.
The investigators determined the experimental error of measuring dibucaine
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numbers and found that the variatio n in results of people in the high , usual or
typica l group cou ld just about be explained by experimen tal error . However , the
numbers in the intermediate group varied too widely to be so explained.
Furthermore their mean was not midway between those of the olher two groups
and their distribution was skewed , with a tail to the left . Examinati on of the family
data led to the conclusion of the probable existence within the 'typical' group of
several alleles, giving different intermediates with the atypical allele. Amongst
these they were able to predict what later became known as 'The Silent Gene'
(allele would be bette r now), which contributes nOlhing 10the activit y but does not
affect the dibucaine number created by the other allele of its bearer either. Thus
in combination with a typical allele the activity will be below average but the
dibucaine number normal, but when passed on to a child receiving an atypical
allele from the other parent the dibucaine number win be low rather than
intermediate. SUbsequent work has revealed Ihat there is more than one 'silent'
allele and that there are indeed other alleles, but before giving further information
on these it is worth mentioning the discovery of a second locus affecting serum
cholinesterase.
Investigating several reports that starch-gel electrophoresis of serum
reveale d a series of bands which displayed serum cholinesterase activity, Harris
a/ et. (1962) examined human sera by two-dlmenstonat electrophoresis wilh
paper in the first dimension and starch gel in lhe second. They found four bands
that were present in an individuals and named them C1,C2, C3 and C4, the last
being nearest to the origin in the starch-gel dimension and much more intonse
than the others. A further (diagonal) band overlapping the C4 band could often be
seen in trace amounts in adult serum and was r - -h more prominent in neonatal
sera, and two other bands which they called 'storage bands', 8 1 and 82,
migrat ing faster than C4 in paper but more slowly lhan it in starch qel, appeared
only after storage of lhe sera for len or mora days. Yet other bands have been
identified by other workers who have used different nomenclature. Harris et sl:
found that some individuals had an extra band which they called Cs' Like S1 and
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S2 this band moved slighlly more slowly in starch gel than C4 but unlike them it
moved more slowly in paper. Family studies (Harris at al. 1962, 1963a)
suggested that the exira band was inherited and that individuals carrying il were
heterozygous for a gene determining it. Masson (1979) showed that bands Cj ,
C3 and C4 correspond 10 the serum cholinesterase monomer, dimer and
tetramer . and Lockridge and La Du (1982) showed that another band, detected
between C3 and C4 (CHE.4 of LaMotta st al., 1965; possibly equivalent to band c
of Bernsohn at st. 1961), was the trimer. Masson (1989) has shown that the C2
band represents the monomer linked 10 albumin by a disulphide bond, but the
nature of Cs has still not been established.
Harris at al. (1962, 1963a) designated individuals with and without the extra
band Cs+ and Cs- ' The band could not be detected in all individuals who would
have 10 be heterozygotes but the expression of the band was found to be quite
variable, leaving the possibility of its presence at concent rations below the level
of de tection in obligate heterozygotes who were apparent ly Cs- ' The mean
cholinesterase activity was found to be about 30% higher in Cs+ individuals than
in those who were Cs- , sugge sting that the Cs component might be an ex tra
component with no direct homologue in Cs- individuals (Harris at at, 1963a).
Subsequent work (Harris et al., 1963b) showed independent assortment 01
Cs+/Cs- and typical{atypical serum cho linesterase in families in which both
genes were segregating , indicating that the two are not allelic , The loci were
designated E1 and E2 (in order of discovery) by Molulsky (1964). In his system,
variants at the first locus are specified by superscripts - e.g. E1u and E, a for the
usual and atypical alleles respectively . and the presence or absence of the Cs
band is specified as E2+ or E2- . Later , 'An International System for Gene
Nomenc lature' (Shows et at , 1979) proposed the naming of the loci as CH El
ano CHE2 with variants specified thus: CHE(U, CHE1'A , CHE2'C5+ ,
CHE2"C5- . The latter system was never universally adopted and has now been
superceded (see below).
By exposing duplicate electrophores is gals to substrate with and without the
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inh ibitor RO 2·0683 (dlmelhylcarbamate of (2·hydroxy-2-phenyl·benzyl)-trimethyl
ammonium bromide), Harris at al. (1963b) demonstrated that in individuals with
the atypica l allele who were also Cs+, the Cs component is inhibited by dibucaine
just as much as is C4, indicating that the presence and properties of tho C5
component are determined by genes al (al least) two loci. Scott and Powers
(1974) purified the Cs component and investigated its properties with various
substrates and inhibitors, and managed to form a hybrid between it and
neuraminidase-treated C4' They came 10the conc lusion thatthe Iwo loci produce
similar enzymes that differ in charge rather than in size and differ slightly in
nearly all of the properties they examined and that the Cs component is a hybrid
between polypeptides produced by the two loci. This seems rather unlikely lor
two reasons.
Firstly, since the gene at Ihe second locus could not be expected to have
the same mutation as thai of the first locus when the tetter happened to code for
the atypical variant, this solut ion could not be expected to result in a hybrid
enzyme that was inhibited to the same extent as the tetramer produced from
alleles at the first locus only. Secondly, if two active enzyme proteins were being
produced, and since the enzyme is a dimer of dlmers. cae would expect not one
extra tetramer band, moving more slowly than the tetramer produced by the first
locus alone, but at Ihe very least, two, one corresponding to a tetramer
composed of a dimer produced by each locus and one corresponding to a
tetramer of the polypeptide from the second locus, and there should be an extra
dimer band and an extra monomer band. If heterodimers could form and could
lead to the formation of tenamers composed of three polypeptides from ana
locus and one from the other , then there should be two extra dlmer bands and
four extra tetramer bands in Cs+ individuals.
Scott and Powers (1974) explained the higher cholinesterase activity in Cs'"
individuals by their second enzyme hypothesis. Altland at al. (1971) showed that
the mean serum concentration of immunoprecipitable active cholineste rase
protein of Cs+ individuals was very significantly greater than the population
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mean. Simpson (1966) found that posessio n of the Cs+ heterozygote genotype
also seemed to increase the activity of the atypical form of cholinesterase. She
did not propose a mechanism either for this or for the appearance of the Cs band
but a possible alternative 10Ihe hypothesis of Scott and Powers would be thai
the second locus produces a non-enzyme protein that associates only with the
tenamertc enzyme (or some other fixed number of sucunns , monomer or dimer)
and increases ita plasma half.life, as well as reducing its electrophore tic mobility.
Tsim et af. (1988a) lmrnunopurit'ed an A12 form of cholinesterase from
chicken muscle using a monoclonal antibody previously shown to react
specif ically with acetylcholinesterase and not with butyrylcholinesterase. They
found that this enzyme showed the active site characteristics, substrate
spec ificity and subunit properties of both acetylcho linesterase and
butyrylcho linesterase t.,ld concluded that each catalytic tetramer consisted of two
acetylcholinesterase and two butyrytchouneeteraee subunits linked by disulphide
bonds to the collagen-like tail. They also reported (Tsim et al., 1988b) that while
this is tho dominant cholinesterase form in the muscle of one-day-old chickens, it
and an asymme trical form containing only butyrylcholineste rase as the cata lytic
torm give way during developmen t to homogeneous acetylcholines terase. This
work does show that hybrid cholinesterases can exist as well as promoti ng new
speculation as to the rete of butvrylchollnes ierase. It may be that this hybrid form
can appear in human serum, probably wi thout the tail. Jones and Evans (1983)
nole d an extra cholinesterase band - running more slowly but close to the C4
band . in human felal serum on polyacry lamide gel electrophoresis . They said
that it had nat previously been described but did not refer 10 the fetal band of
Harris er al. (1962). Jones and Evans found that thei r fetal band hydrolysed bo th
acety l and butyrytthlocnotlne but did not investigate whether it had the
cha racteristics of both enzymes . However, evidence to follow suggests that Cs Is
not a two-enzyme hybrid.
The CHE1 locus was shown to be linked to the transferrin locus (Robson 81
al., 1966) and the transferrin gene was later shown to be on chromosome 3
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(Lavareda de Sousa and Lucette. 1985). Lovrien at al. (1987) found tentative
linka ge of the CH E2 locus to the «-haptoqtobln gene, which was already known
to be on chromosome 16. Maraztta at al. (1989) combining their own and other
published data obtained a lad score of 2.51 (not statistically significant) for this
linkage al a recombinalion dislance of 0.32 but this was increased fa a score of
3.2 (just significant) when informat ion from three other markers on chromosome
16 was include d, and 10 4.1 with information from a further marker. Soreq at al.
(1987) carried oul in situ hybridization of chromosome spreads with cloned
bufyrytc houneeterase eDNA and reporte d hybridization 10chromosom e 3 and the
long arm of chromosome 16 and later (Zakut et al. (1989) thal lhere were three
sltee of hybridiza tion, two of them on chromosome 3. This work appeared 10
confirm the linkage results and the theory of Scott and Powers (1974) that CHE2
codes for a peptid e of similar sequence to thai coded by CHE1. However, Eiberg
at st. (1989 ) found a higher lad score with a reeutctlon-rraqmenr length
po lymorp hism in the v-crystaltin gene Cluster, which is on chromosom e 2. This
was not based on a large amount of evidence. Information from 832 families and
a large number of genetic markers was searched. but the families ware not all
tested for all markers. The linkage found was based on just one family in which
there we re 15 children and no crossovers. The authors noted an apparent very
weak linkage to a chromosome 8 marker with information from 27 families . They
pointed out that apparent deviations from Mendelian distribu tion had been
encountered in previous studies as well as their own and put forward their finding
of linkage to the v-crystalin gene cluster as a use fui 1001 10 investigate whether
these dev iations were trivial or reflect some real deviation such as heter ogeneity
or distortio n of segrega tion.
Workers in the laboratory of La Du and lockridge have subseque ntly
isolated genomic clones for the human butyrylcholinesterase gene (Arpagau s at
al., 1990). There was very good agreement between tha sizes of hybr idizing
fragments observed in Southern blots of total genomic DNA and a restriction map
derived from the cloned DNA, strongl y suggesting thai Ihere is only one gene.
This supported evidence from polymerase-chain-reaction amplification of a
fragment of the gene containing the atypical mutation (McGuire et st.; 1989)
prepared from genomic DNA of homozygous atypical individuals. Sequencing
gels never showed any band heterogeneity, as would have been expected if
there was more tnan one gene present, since the other gene could not be
expected to have the same mutation. In the same laboratory, the DNA of three
individuals expressing high-intensity Cs bands was examined (Masson at al.
(1990). Southern blots with probes for each of the four exons of the identified
gene and seven restriction enzymes did not show any different bands from those
of Cs- individuals.
It now seems fairly certain then that there is only one gene encoding the
catalytic subunits of human buiyrylchoftnesteraee and on this basis the Human
Gene Nomenclature ccmmtttee has renamed the E1 or CHEl locus 'BCHE',
while the other is still called CHE2 at present (Masson at al., 1990). Scott and
Powers (1974) explained the absenceof their proposed second enzyme in about
90% of most poputauonaby citing the precedenl of intestinal lactase which is
similarly absent in about 90% of the adults in most populations. Soreq at al.
(1987) suggested that 'the CHE2 gene might have turned into a pseudogene in
the majority of individuals'. The results from the laboratory of La Du and
Lockridge are as much against the existence of a pseudogene as a functional
one; and butyrytchclinesterase.like gene would have to be different enough that
none of the probes would hybridize with it at the stringency used. The possibility
of a non-enzyme protein would not require the postulation of a non-functional
gene. It would only require that the majority of people produce a form of the
protein (perhaps with a different charge, less hydrophobicity, or no free -SH
group) thai would not associatewith serum cholinesterase. Masson et al. (1990)
checked the Cs+ phenotype of their three subjects several limes over six months
to eliminate false positives and it is interesting thai in one of them the extra band
disappeared and reappeared again two months later. II would seem then that
physiological changes may aHect the association of the proteins. Masson et al.
suggested that another possibility for the function of the CHE2 gene was that it
produces an enzyme thai connote the assembly of butyrylcholinesterase subunits
with another protein, but that possibility would. like the second
butyrylcholinesterase enzyme hypothesis. require an explanation of non-function
in the majority of people.
Returning to the atypical vartant, Katow and Davies (1958) tnvesuqated the
difference between it and the usual variant with a series of inhibitors. They came
to the conclusion thet the esteraslc sites of the two variants might be identical
and that the difference was at 'the anionic site' (which accommodates the
quarternary-ammonium choline part of choline ester molecules being hydrolysed)
where one of two neqanve charges was missing in the atypical variant. (More
details of this are giYen in the discussion.) This has subsequently been proved
right by McGuire at al. (1989) who found that the only consistent difference of the
atypical from the usual DNA sequence in 14 heterozygous and 6 homozygous
atypical subjects was a single base change that results in the substitution or a
neutral amino-acid (glycine) for an acidic one (aspartic acid).
The hypothesis of the existence of a sitent allele was prayed right when the
first case of complete absence of serum cholinesterase activity was published
(Liddell at al.• 1962; Hart and Mitchell. 1962). Serum from this indlvldual did not
affect the dibucaine numbers of sera from normal and atypical homozygotes
when mixed with them in vitro and family data at this stage suggested that the
silent gene was allelic to the usual and atypical alleles. Further work by Simpson
and Kalow (1964) strengthened this impression though the possibility 01 a
suppressor gene closely linked to the structural gene could not be ruled out.
Absence of enzyme actiyity could be due to absence of production of the protein
or to production of a truncated protein or a full length protein with no catalytic
activity. In addition, very low activity could be due to an abnormal enzyme or very
low production of the usual enzyme. There have been many reports of
heterogeneity of the silent phenotype, based on activity measurements,
Immunological techniques and electrophoresis and more different types have
been distinguished Ihan named.
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Goedde and Altland (1968) showed that in two cases there was no activity
and no immunologically -delectable serum cholinesterase protein while in three
others there was a lillie 01 each, but differen t amounts. AflIand and Goedde
(1970) found nine different electrophoresis patterns amongst cases with a little
acuvtty as well as relative differences between amount of enzyme protein and
amount of activity, if any. They pointed out thai since the the phenotype is rare
individuals showing it are more likely 10 be helerozygoles for different 'silent'
alleles than homozygotes . Scali (1973) proposed the names '0 type' and 'Ttype'
for complete absence of activity and trace activity (usually 2·4% of normal) in
different families at Eskimos and came 10 the concl usion that they were allelic.
These subsequenlly became known as E~ and E\ , and Scott and Wright (1976)
then proposed the name E~ (more correctly E~) for the allele found in another
family with activity under 10% in whom the C4 band moved faster than the usual
variant on electrophoresis. Whittaker (1990) has proposed the name E1 for the
allele of another variant that has much more immunologica lly detectable enzyme
protein than other types but no detectable activity with butyrylthiocholine iodide
as substrate and very little with benzoylchoune, while show ing that yet other
types appear to exist.
Nogueira at al. (1990) have now published the DNA sequence of one silent
allele. It has a change of sequence from GGT to GGAG at codon 117, an
unusual combination of a transversion and an extra base. The frame shift
changes the amino-acids coded from that point onwar ds, but more importantly
results in the reading of a stop-codon after ami no-acid 128 so that a very
truncated protein with no esteralic site is produced . In the same paper the
authors report partial sequencing of the DNA of another Individual wi th no
immunologically detectable protein. The abnormality had not been found but
there was no abnormality at codon 117.
A series of other variants have been described which have the same
inhibition charac teristics as the usual variant but lower ac tivity. Like Ihe 'silent'
variants the existe nce of these was first deduced from anomalous resul ts in
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families in which the usual and atypical alleles were segregating as their
heterczyqctes with the usual allele could not be distinguished from usual
homozvqotee. The first described was the J variant (Garry er al., 1976). The
authors calculated that the allele caused 66% reduction of usual enzyme
molecules and (Rubinstein at st., 1976) showed that heferozygotes for this
variant and the usual or atypical one had less enzyme protein Ihan individuals
homozygous for the usual or atypical or their heterozygote, which all had about
the same amount of protein. In the latter paper they concluded lhat there was
indeed reduction in the number of circulating usual enzyme molecules. They
allowed that they had not excluded the possibility that there could be decreased
numbers of a variant molecule but considered this unlikely. Actually, inspection of
their plots of concentration against activity clearly shows that the ETE\ genotype
gives a specific activity between between that of E~E~ and E~ Ef, suggesting that
E~ allele does indeed produce a variant enzyme .
In the same way, Rubinstein at al. (1978) identified the K variant and
concluded that the E~ allele causes a 33% reduction in circulating usual enzyme
molecules. From analysis of 795 caucasian serum samples, Evans and Wardell
(1984) found the E\ allele to be rare but estimated the frequency of the E~ allele
to be 0.115 giving the frequency of heterozygotes as about 20% of the population
and homozygotes about 1 in 76. Mcguire at sl: (1989) noted a DNA
polymorphism present in usual and atypical alleles resulting in the substitution of
threonine for alanine at amino-acid position 539 and after examining 40
individuals they estimated the frequency (Bartels at al., 1989) of alleles coding
threonine to be 0.125 and suggested that this could be the K variant. If this
proves to be true it will show that a formerly-designated 'quantitative' variant is
qualitatively different. Perhaps this change reduces the plasma half-life of the
molecule as it is less easy to see how it ccutd reduce synthesis.
Another allele detected by unusual resul ts in families in which the usual and
atypical alleles were segregating is E~ (Whill aker and Britten, 1987). The variant
has less activity with benzoylcholtne than does the atypical one. Immunological
studies have not been carried out.
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The know n diffe rential inhibitors of the usual and atypical variants were all
ter.lary-ammcnhm compounds unlll Harris and Whi ttaker (19B1) found that
sodium fluoride also differentially inhibited them, and (Harr is and Whittaker,
1961, 1962) thai in some individuals inhibition by dibucaine and fluoride was
discrepant, revealing new phenotypes. Further work (Whittaker, 1967)
strengthened the evid ence for a fluoride resistant variant that was coded by
another allele altha CHEl locus .
Another variant was found (Simpson and Elliot, 1981) through a proband
with prolonged apnoea with succinylcholine who had an unusually high dibucaine
number for a usual-atypical heterozygote . luckily the individual belonged to a
large Newfoundland famil y ava ilable lor testing. She proved to be a heterozygote
for the atyp ical allele an allele coding a new variant , 'cholinesterase
Newfoundland '. Thoug h hav ing a low activity with succiny lcholine, like the
atypical variant, the Newfoundland variant has a high percenta ge inhibition with
dibucaine wher eas th e atypical variant has a low percentage inhibition. Thi s
difference in dibucaine numbers was found 10 have no over lap with the usual
variant when succinylcholine was used as sub strate.
Harris an d Whitt aker (1963) found thai , at much higher concentrations than
sodium fluoride, sodium chlor ide also differentially inhibi ts the usual and atypica l
variants but inhibits the atypical variant mor e, the opposite to inhibit ion wi th
sodium fluoride and dibucaine . Further work (Whittaker , 1968c) revealed some
individuals in whom chlor ide inhibition was discrepant with inhibition by dibucain e
and fluoride, suqqestln q yet more phenotypes. The discrepan t cases included
individuals who were sensitive to succinylchol ine but ap peared to be of the usual
phenotype when tested with dibucaine and fluor ide (Whitt aklO,; , 1968d).
Various investigato rs observed Ihat cholinesterases could be activated by
alcohols al low conce ntrations but were inhibited by highe r concentration s.
Whittaker (196Sa) found that the usual and atyp ical variants of serum
cholinesterase were differentially affected, the atypical varian t being activa ted
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less and inactiv ated at lower alcohol concentrations. She found thai the greatest
differentiation between them was given by 1% n-txna nol and proposed that
alcohols could be used as another method of dilingu ishi ng between the variants.
She went on (Whittaker, 1968b) 10 define the alcohol number as the ratio of
benaoylcnoune activities in the presence and absence of 1~'Q n-butanol under
standard conditions multiplied by 100, and found that there were some
individuals with whom the alcohol number was discrepant with the phenotype
suggested by dibucaine and fluoride inhibition, revealing yet more new
phenotypes .
Family data 10 confirm the phenotypes revealed by sodium chloride and n·
butanol as due 10inherited variants has yet to be publis hed. There have been
several other reports of dltterent phenotypes without family studies. In the very
near future it is likely that DNA sequencing will not only reveal the diHerences
responsible for all the rest of the known inherited variants but show whether there
is genetic basis for phenotypes for which fami ly studies have not bean dono as
well as discovering previously unrecognized polymorphism. The existence of so
many variants allelic with the usual variant and no others shown to be allelic with
the Cs+ and Cs- varia nts is suggestive independen tly of the evidence given
earlier that the gene at the 'CHE2' or 'E2' locus does not code for a second
butyrylcholinesterase.
Goto at ai, (19SS) have reported a family in which a silent serum
cholinesterase allele producing no immunologically detectable protein and the
Cs+ gene are segregating. So far there is no family member who is both a
homozygote for the silent allele and an obligate carrier of Cs+ but such a case
could prove that the second locus does not produce an active enzyme.
Cs is not the only inherited variant with increased activity or an extra band
on electrophoresis. Neiliich (1966) reported an American family of unspecified
ethnic origin in which the proband and three relatives had very high plasma
cholinesterase activi ty (three of them 3·4 times the male mean) and an extra
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band between the C4 and storage bands. He investigated the enzyme in vivoby
injecting the proband and controls with diisopropyl fluorophosphate (DFP) and
concluded that the proband had a normal number of enzyme molecules but that
some of them were much more active Ihan usual. Yoshida and Molulsky (1969)
reinvesligaled the same family and named the variant E Cynthiana after ils place
of origin. They concluded from in vitro DFP inactivation and from reduction of
activity by immunoprecipilation Ihat the enzyme was of normal speci fic activity
and present ii' increased numbers of mo lecules. They found thai it migrated
more srowly than the Cs protein on electrophoresis and from varying starch gel
concentration deduced tha t this was not due to difference in charge but higher
molecular weigl'll. Their explanation of this was tha t the extra band was due 10a
structurally diferent enzyme which associated in more than four subunits together
and had an increased rate of synthesis.
Delbruck and Henkel (1979) reported two German families in which a total
of 11 members had plasma cholines terase activities up to four times normal and
an extra band on electrophoresis but they did not compare the latter with a Cs+
serum. They found that the enzyme had the same inhibition with dibucaine,
fluoride, succinylcholine and DFP, and the same pH optimum and heat
inactivation as the usual enzyme, and rocket elect rophoresis indicated that it was
present in much increased concentration. This evidence suggeste d Ihat these
families also had the Cynth iana variant. DelbrOck and Henkel also tried
electrofocussi ng and found six bands in the region pH 4.4 to 4.9 and suggested
tha t a difference in charge might be responsible for higher aggregatio n.
Yamamoto et al. (1986, 1987)reporled a Japanese family with members
serum cholinesterase activities abou t twice normal. Again the characteristics
wore the same as the usua l enzyme except that the pH optimum seemed to be
slightly lower. On electrophores is two extra bands were found, one between the
C4 band and the origin and the other between the dimer and trimer bands. This
tatter band disappeared in the presence of heparin and the auihore no ted that the
invest igators of the Cynthiana variant had used heparinised plasma. Yamamoto
26
at al. noted that assoc iat io n betw een hepar in and other serum pro teins had been
reported and specu lated tha i the taster extra band disappeared because heparin
b ound to it and slowe d it down to the same rate as anothe r band. In the lighl of
the knowledge th at the C2 band represen ts the assoc iation of the cholineste rase
m onomer with albumin and that the Cs band is also almost ce rtainly due \0
association of the enzyme with another protein il the possibility that the
Cynthiana variant is due to association of the enzyme wi th yet another protein
and that this protein prolongs the hall-life of the enzyme seems more likely than
the hypothesis of Yoshida and Motulsky of increased sy ruteers and increased
aggregation of the enzyme . Though Yamamoto 01al. did not realize it, their
discovery of another extra band strenglhens this possibility considerably since a
band between the dimer and trimer bands could hardly be caused by increased
aggregation.
Warran at af. (1987) reported a Saudi family with members with serum
cholinesterase activities 3-5 limes the reference mean. The proband also had a
Slow-moving extra band on electrophoresis and it showed the same inhibition as
the C4 band. Serum was used but staining was not enough to show the bands
faster than C4. There was no comparison with a known Cs+ serum and
e lectrophoresis of the serum of the other family members was not done, bullhis
could well be another case of Cynthiana as may a single case of high
cho linesterase and an exira band slower than the Cs band reported by Klein at
al. (1967). All of the families were compatible with autosomal 'dominant'
transmission; no homozygotes occurred. As none of the families appeared to be
segregating for any of the known serum cholinesterase variants it was not
possible 10 test whether the non-Cg extra band variant{s) were allelic with lhem
o r not. This would have in dicated whether the extra bands were indeed due to a
protein coded by another locus or due 10abnormality of cholineste rase (pe rhaps
causing it to associate with a normal form of another protein) .
There may be othe r variants with high serum c holinesterase activity.
O hkawa at af. (1989) reported a Japanese family in which six members tested
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had an extra ba nd of the same mobility as Cs bu t four of whom had activities 3-5
times the reference mea n, the ot her two having activities in the up per half of the
norma ! range. The high results were much higher than expecte d for cases of
Cs+. Raised serum cholinesterase ac tivity is assoc iated with hyperlipidaemia
(see Section 1.7, p. 3 1) but the proband had normal serum cholesterol and
triacylgl ycerol concentrations and ultrasound examinations for fatty liver were
negative in all family members. Krause et al. (1988) clai med a new variant with
increased specific activity in an Africansr mother and son on the basis thai
activity was raised but serum ch ol ineste rase protein was not, as jUdged by rocket
electrop horesis . Howeve r, the activities , said to be abou t twice normal, did not
appear to be far above the upp er limit of the normal range as jUdged from the
activi ty of ano ther fam ily memb er said to be no rmal (the labora to ry's range was
not given) and the pro tein concentrattons were a lillie higher tha n controls . The
mothe r had a C s band and the son did not. The dibucaine and f luoride numbers
were normal. T he halt- life at 52°C was increased. It may well be th at this was not
a new variant but Cs' Simpson (1972) showed that though po lyacrylamid e gel
electrophoresis detected 33% more cases than the starch gel use d by Harris at
al. (1962) it sti ll failed to detec l the ex ira band in 50% of obligate carriers who
were typed Cs- by sta rch gel e lect rophores is.
Th ere ha ve bee n many other reports of other serum cholinest erase
electropho resis bands without increased activity, some present in all sera , some
appearing in disease and some found In some Individuals In population scree ns.
The au thcr detecting the most b ands in normal serum w as Juul (1968) who found
twelve using a three-layer polyacrylamide gel and desta ining electrcphcretlcally .
Of these the ban d wit h the mo st activi ty (80%) was the seventh, counting from
Ihe front. If true , and assum ing that this represented the tetramer , this leave s two
bands not accoun ted for by the mo nome r dlmer trimer and C2 compo und.
Bernsoh n st a/. (1961) did detec t one such band using starch gel. These bands
could represen t twoo f the sm a ller molecules associated wilh so me other serum
protein, or one of th em associated w ith two other proteins . On the same
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assumptions, Juul found five bands moving more slowly than the tetramar. He
pointed out that that bands coul d represent polymers, degradation produc ts, or
modification of the enzyme by the separation procedure as well as association
with other proteins. LaMotta at a/. (1968) detected two bands in purified
cholinesterase moving more slowly than the band (their CHE5 of LaMolla el al,.
1965) which we now know to be the tetramer. They found thai when they isolated
and concentrated the materia l from these bands the mobility became the same
as the tetramer band so they concluded that they could not be higher polymers
but conformational isomers.
Gaffney (1970) suggested that the bands might represent hydrophobic
associat ion of the chcltnesterase with other proteins after loss at some of the
sialic acid residues from the cholineste rase. This was alter finding that alter
treating serum cholinesterase with neuraminidase all the bands were replaced by
a single band of low mobility . His preparation of the enzyme did not contain any
C2. Masson (1990) has shown that C2 is not affected in this way and suggests
that the albumin subunit protects me desialated cholinesterase subunit from self-
aggrega tion by masking a hydrophobic area exposed by the remova l of sialic
acid residues . From this it is not hard to imagine that other blood proteins might
well associate with serum cholinesterase to give rise to discrete electrophoretic
bands. Loss of sialic acid residues could then be the explanation for the
appearance of the storage bands. However, if this is so, the sialic acids involved
must be los! from a different area from that which the putative protein responsible
for the C5 band abbuts because Simpson (1972) found that while there were two
storage bands in C5- individuals , C5+ individuals showed four.
Ogita (1975) investigated the blood of a patient with a leiomyoma who had
very little serum cholineste rase activity. He showed that when the blood was
incubated with purified C4, sialic acid was released and that a series at less
mobile electrophoretic forms were produced. He also showed that tho extent to
which this occured varied with the patient's condition , and postulated - but did not
demcnetrete • that the band of Cs mobility found in the serum 01 four of the
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patient's relanves was formed by their production of lower levels of the same
'neuramlnldase -uke' enzyme. Augustinsson and Ekedahl (1962) had shown that
stripping sialic acid residues from serum cholinesterase does not reduce Its
ca talytic activity, so Ogila had to postulate thai the patient was also producing a
proteolytic enzyme ecuve against cholinesterase.
Ogila called his idea of band production 'the epigenic modification
hypothes is', He suggested that the gene respons ible for the neuram inidase- like
enzyme has a 'no rmal' allele NU and an allele NR that may be activated by
changed physiolog ical conditions and thus raise the neuraminidase activity
beyond the normal range. As a resu lt, the 'C4 component' wou ld lose neuraminic
ac ids and be transformed into Cs-Iike components of slower mobilit y. With
further Increases the Cs or the C7a,b and additional slow components wou ld be
formed. The 'C4 componenl' is of course the cholinesterase tetramer and the
Ogita did not cover the expected effects upon the entities responsible fo r the
faste r bands . He did not propose that his hypothesis accounted for all cases at
Cs+ but suggested that there might be hete rogeneity, his hypothesis accounting
for families in which some obligate carriers d id not show the band.
The Cs band that Ogita referred to was described by Ashton and Simpson
(1966) from starch gel electropho resis in a single individual foun d in a large
survey of families from Brazil. The man also had another fai nter slowe r
chornesterase band that was no t given a name. None of his four children
showed either band. Bands C7a and C7b were described by Van Ras and Druet
(1966 ) tram two-dimensiona l paper/starch get electropho resis in two healt hy
African sub jects out of 734 surveyed . These investigators also found a band
whic h they calted Cs in four other healthy individuals in the same survey . All of
these bands were distinct from the fetal and storage bands. Other slow-moving
bands have been described in surveys of Cree 'Indians ' and Eskimos (Simpson,
1972), in glaucoma patients (Juut, 1968; Juul and Leopold, 1968) an d in
myeloma patients (Gallango and Arends, 1969). Using three-layer
po lyacrylamide disc gel electrophoresis , Brock (1989) has surveyed plasma
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samples of 193 healthy Danish volunteers and found the Cs band at lhe
re markably high frequencies of 40 .2% in men and 29.6% In women. He also
reported three other exira bands, which he called Cl ', C6 and C7. in 24, 53 and
9 of the voluntee rs respectively and concluded tha t all lour exira bands occurred
independently and that none of the m (inclu ding Cs) had any influence on the lolal
plasma cholinestease activity . Masson et al. (1990 ) say that so fa r Masson has
eli minated albumin and degradation products of acetylcho linesterase,
butyrylcho linesterase and collagenous tal l as candidates for the non-e nzyme
component of Cs- When this protein has been identified and il is understood how
it associates with the enzyme, understanding of the formation of the many oiher
unexplained bands with cholineste rase act ivitymay notbe far behind .
Molecular biology techniques have bean used to investigate the struc tureof
the butyrylcholinesterase gene and its expression in development. in tumours
an d in organophosphate poisoning, but the work is not directly relevant to the
findi ngs presented here.
1.6 A note on function
Acetylcholinesterase has a very low substrate concentration optimum.
Bu tyrylcho linesterase in contrast has a low activity towards acetylcholine at such
a low concentrat ion. but is not inhibited by much higher concentrations of
acety lcholine (Augustinsso n and Nachmansohn, 1949). It is nol diff icult to
imagine therefore that the two enzymes might be complementary in the nervous
system and muscles, butyrylchol inesterase taking ove r the hydrolysis of
acetylcholine from acetylcholinesterase at higher substrate concentrations , and
work on canine tracheal smooth muscle (Adler and Filbert . 1990) suggests that
this may well be true. This however does not axptatn lhe presence of
butyrylcho linesterase in the serum (or of acetylcholinesterase in the red cell
membrane) where it presumably has some other function. This wo rk inves tigates
the relationship of the enzyme to serum lipids.
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1.7 Association of serum cholinesterase with plasma
lipoproteins
1.7.1Clinicalstudies
Manyobservationshavebeen made suggestingassociation between serum
cholinesteraseand foodintake, levelsof serumljpidsor lipoproteins, or wilh rate
of lipidlur novat.
In1950, Waterlow, nolingthat lowserumcholinesterase had beenfound in
undernourished subjects (McCance, Widdowson and Hutchison, 1948).
measured cholinesterase in plasmaandin liverbiopsies beforeand after fouror
live weeks of {eeding a high-milk dielto two malnourishedAfrican infants. In the
liver , thecholinesterase increased morethanother enzymes, andin theplasma it
increased more than did the lotal protein. In 1954 Berrya/ al. noted that the
same authors (Hutchison, McCance and Widdowson, 1951) had found, in their
studiesof undernulritiOrl and feeding, that al lhe endof rehabililalionwhen men
became'fat', lheaverage serum cholinesterase washigherihen 'normal'. Acting
upon this, Berryat al. measuredthe bodyfal (by skin·fold thickness) and plasma
chojreeteraseof 345menandfound asignificant positive correlation.
Serum cholinesterase wasfound10be raised in hyperthyroidism, diabetes
mellitusand hypertension by Anlopol etal. in1937(though theythought thatthe
enzymewas acetylcholinesterase), decreased in hypothyroidism (Thompsonand
Whittaker. 1965) and increasedin nephrotic syndrome(Kunkel and Ward, 1947).
Thesefindingshavesubsequently beenconfirmed byotherworkers.
All of these Ilndings have been linked by the association of
butyrylcholinesterase with lipid metabolism, In1963, Clitherowet al.pointedout
that Ihepenultimate product offatty aciddegeoorationand theprimaryproductof
lipogenesis of fatty acids having even numbers of carbon atoms is butyryl-
coenzyme A.Theypostulatedthat '~is, and toa lesserextentthe acyl-coenzyme
A derbanvee of cerlain otherhigher fatty acids, might become involved in the
choline ester synthetic pathway. The predicted products, particularly
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butyrylchoJine, have a powerful nicotinic action and ifnot rapidly destroyed would
pro bably have undesirable and to xic effects. The authors suggested that the
hy d rolysis of these choline esters , almost al lhe site of formation . might be the
principa l b iological function of butyrylcholinesterase . In sup port of th is hypo thesis
they noted that a seasonal va riation had been fou nd in horse serum
cholinesterase and pointed outtha t this close ly para llels the well-kn own seasonal
vari ationin fal metebc jsm, The firs t tunan case o f homozygosis fo r silent serum
cholinesterase had been re poned th e prev io us yea r (UddelJ ata/., 19 62; Hart and
Mi tchel. 1962) but Clilherow al a/ . did not meouc n this, and the fact thai such
Ind iv iduals do not appear to suffer from the toxicity they predicted had obvio usly
not come to their notice. Venkatakris hnan (1990) has now shown thai inhibition
of propion y lcholinestarase activity with tetraisopropylpyrophospho ramide esc-
OM PA) in ra ts does notcause accu mulatio n 01choline esters in liver or serum, or
Inc rease th eir excretion in the ur ine. This doe s not howeve r mean that
butyrylcholineslerase could not hav e any ro le in lipid metabolism.
The most comprehensive series of clinica l studies 01 the associa tion
between serum ch olinesterase and lipid metabolism has been carried out by
Cucuianu and colle agues {1968, 1973 (3 papers), 1975, 1976, 19 78 , 198 5 (two
papers». In thefirs t study (Cucuian u etal., 1968) they looked at subjects divided
Into four categories def ined by norm al bOdy weight vs. obestty and
nor molipidae mic vs. hyperlipidae mic. TI le)' found that both obesity and
hyperlipidaemia we re associated w ith increased serum cholinesterase, obese
subjects ha ving higher cholinesterase than normal weight subjects for a given
level of lipid . The serum lipid ind ices used were cholesterol an d triglycerides
(now known as triacy lglycero ls). Th ey found that bolh were positively correlated
with serum cholinesterase and loo k this as support lor the hypotheee propo sed
by Clltherow ot af. (1963). They al so invest igated a few subject s with thyroid
imbalance and noted that these with hyperthyroidism had high serum
cho linesterase with low cholestero l and that those with hypothyro id ism had low
cho linesterase with high cho lesterol. They noted that increased m obiliza tion of
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lipids was known to occur in hyperthyroidism but that high serum cholesterol is
uncommon in this condition, and suggested thai !his is probably a res ult of
increased eliminatiOnof et1Oleslet~ and oxidatla1 of 6pids. From this !hey
lXH'lduded thai serum c/lOIinesleraseshouldratherbecceeated withlncreased
int'AJx of uneslerif!9dfatty acidsandtheir uptake by the liver than with acbJal
le'w'Elts of ~poprOleins. They mentioned that neonates nave low serum
chOlinesteraseand low levelsof cholesterol, phospholipids and lriacytglycerols
buthigh concentrations01free fatty acids, and speculated that the mechanisms
leading 10 maturationof lipogenesis and synthesis of serum cholinesterase are
somehow linked. However the increase of serum chOlinesterase as an
expression01a nonspecifICandrather general stimulation 01protein synthesisIn
theliver 01obese andhyperlipidaemic subjects couldI'lOI be ruled out, and soma
ollhair taterwork wasdirected towards this question,
In 1973 Cucuianu and coleagues showed that treatment of 20
hypertipidaemicpatients withcIofibrale loweredIhe mean serum cholesterol by
23% and ltiacylglycerols by 31% but did not reduce the raised serum
cholinesterase signi!icanlly (Haraguset a/.• 1973). whereas the lreatmenl of
leukaemic patents withc-escerecnase. whictl lmpairsnecetc proleinsyntheSis.
caused a decrease in both lip:>protein cholesterol and serum choIineSlerase
(Cucuianu et al.• 1973a). These papers weredted by Cuc:uiano (1988) who
quoted a referencesaying that clofibrate seems mainly 10 enhance Ihe removal
of VLDl·triacylglyceroi and does notgreatly c\epress therate of VLOl synlhesis.
The inferencefrom this would be that serumcbonresieresesynthesis is relaled
toVlDl synthesisrather than to theserumconcentration of VLDl Clofibrate Is
oneof a classof drugs whiChinduceproliferation 01percxisomes in hepatccytes
anda marked increasein peroxisomal enzymes involved in lipid metabolism (lor
refssea Furukawaatal., 1985). However. Brownand Goldstein (1990) say met
thesilas of action ot Iha fibric acids(which include clofibrate) are onlypartially
established and remain controversial. Thoughthe primary effectof these drugs
is to increase the acUl/it}' of fipoprotein lipase, whichin tum promotescatabolism
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of the trtac ylqlycerot-nch lipoproteins, VLDL an d IDL, the drugs may also
dec rease he patic synthesis and secre tion of VlDL.
In 1975 Cuc uianu at al. published th e results of a more extensive study,
including fa r more subjects Ihan in 19S8 an d invo lving lipoprote in electropho resis
to investigate the relationship of serum cholinesterase to duterent types of
hyperlipoproteinaemi a, and the measure men t of ceruloplasmin to see whether
changes connected with hypernpcprctetn aemfa involve non-speci fically other
enzymes secreted by the liver into the p lasma. This added the informatio n that
serum cholinesterase was much higher in subjects with ondogenous
hypemiac ylqly cerola emta • type IV and 'm ixed hype rlipaemia' (roughly type lib ) •
than in tho se with pure hypercholesterol aemia (type Ha). It also showe d that
many normoJipid aemic overwe ight subjects ha d higher levels of se rum
triacyfgfycerol and prebeta fract ion of lipo protein than normal weight controls.
Similarly, type lIa subjects who we re overweight had higher se rum
triacylglyc e rols and cholinesterase than typ e Ita subjects who were of normal
weight. Se rum chol inester ase activity was found to correlate best with pr ebete
lipoprotein (l.e.VLOL), closely followe d by triacylglycerols, with a poorer
correlatio n with se rum cho lesterol and very weak one with 'relative body we ight'
(not defined) , and a slight positive correlation with beta lipop rotein (l.e . LOL) was
not signi fic ant. The interpretat ion was that se rum cholinesterase activity is
correlated with preb eta lipoprotein and tha t the lesser correlation with cholesterol
occurs be ca use a fairly large proportion o f serum cholesterol is carried in the
prebeta fraction. The serum cholineste rase was not sign ifican tly higher in the
lean type lIa subjec ts than in the controls . The authors cited evidence tha t the
main defe c t in this disorder is in catabo lis m of beta lipoproteins. They also noted
from the lit er ature that de layed production and turnover 01lipoproteins had been
found In hypo thyroidism whereas in endo genous hyper triacylg lycero laemic and
obese normolipidaemic subjec ts increased turnover of choleste rol and free fatty
acids had been fo und as had increased turnove r of serum lipop roteins in pa tients
with the nep hrcuc syndrome. All of this pointe d to the associat ion of se rum
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cholinesterase wi th lipoprotein synthesis . They mentioned that the plot of serum
cholinesterase activity against serum triacylglycerol concentration flattened with
increasing triacylg lycerol, a few patients with very high lriacylglycerols having
normal serum cholinesterase activities, and interpreted this as being due to
defective or saturated mechanisms for remova l of triacy lgly,o;erols. The serum
ceruloplasmin di ffered very littlE> betwee n the gr oups studied, showing Ihat the
changes in cholineste rase could not be exp lained by entirely non-specific
increase in pro tein synthesis by the liver, though they did note that serum levels
of factor XIII and of tecithin.choteetero! acyltransfe rase had been found 10 be
raised in obese and hyperlriacyJgJycerolaemic suolec ts. The work on factor XIII
was thei r own (Cucuianu at af., 1973b). In that pape r they also divided the
hyperlipidaemic patien ts into different types and measu red serum cnollnes terase
(lhough the numbers were smaller than repor ted in 1975). Inspection of thei r
results shows th at the pattern of factor XIII elevation in the different groups
closely mirrored that of serum chollnesterase. They also measured plasma
fibrinogen and though no t discussed, the results show that it too was raised in all
hyperlipidaemic groups but that the pattern was different, the highest leve l
occuring in type tla, followed by lib and the lcweetn type IV, Both factor Xlii and
fibrinogen were significantly lowered by treatmen t with clof ibrate 1.5 g/day with a
low-carbohydra te diet for 45-60 days in nine hyp ertriacylglycerolaemic patients
whereas cholinesterase was not
The pape r by Haragus at al. (1973) • reporting reduction of Vl Dl by
clofibrate ueatmen t wi thout influence on raised serum cholinesterase • is in
Roumanian. The Engl ish summary does not me ntion the concomitant use of a
diet and neither does Cucuanc (1988) in quoting it. Haragus at a/. (1973) and
Cucuianu elst.. 1973b (just discussed above) w ere wr itten in the same year and
have two authors in common but the number o f patients and length of treatment
are different. Fro m this the assumption made he re is that the patients of Haragus
er al. (1973) were tre ated with clofibrate alo ne. However, returning to the
patients of Cucuianu a t al., 1973b, one might have expected that VLDL synthesis
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might be reduced by the diet and hence that ser wn cholinesterase might fall too ,
if its synthesis is related to thai of VLDL, though net as much as it would if il we re
affected by increas ing VLDL clearance. My r1ek at al. (1978) included seru m
cholinesterase amongs t many other measurements on Itle blood of 190 patien ts
with cardiov ascular diseases before and after a a-s-week rehabilitation
programme of weight-reduction and improvemen t o f physical fitness, witho ut
lipid-lowering drugs , and they did find a highly signifICant fall in serum
cholinesteras e along with falls in cholesterol, trlacylg lycerols and phospholipids .
Cucuianu et a l. (1976) compared act ivities of serum v-glutamyltrans·
peptidase (yGT) and cholinesterase in controls and dillerenl types of hypertrpo-
proteinaemia . Subjects with liver dis ease and other conditions in which yGT w as
known to be rai sed were excluded. Like the chcuneetorasc, yGT was found to be
raised in hyp erllpop rotelnaemias, bu t again the pattern was different. Unlike
serum choline sterase , yGT activity did not co rrelate with serum cholesterol, and
was not raised in type lib hyperlipopro teinaem ia. The yGT was much the highe st
in type V, in wh ich the serum cholinesterase was low er than it was in type IV.
Plotting bot h enzymes against triacylg lyce rol showed that while th e
cho linesterase activ ity reached a plateau, the yGT ac tivity cont inued 10rise wi th
increasing tri acylglycerol and correspondingly , a slx ' weGk course of clofibra te
plus diet (type unspeci fied), which lowered the triacy lg lycerols of ten patients w ith
hypertriacylg lycerolaemia by 72%, brought about a 47% fall in )6T but, as
before , no ch ange in the serum chOlinesterase activity .
Cucuian u at a f. (1978) compared the activ ities of lecithin:cho leste ro l
acy ltransferase (Le AT) and serum ch o linester ase In the types of
hyperlipoprote inaom ia , in obese SUbjects wit hout hypertipidaemia. in patien ts
with hepatocellular d iseases and in ones with chctes taats. The changes in the
two enzymes be twee n differen t groups were very sim ilar and their activities we re
more strongl y correla ted wtth one anothe r than with either cho lesterol o r
triacylglycero ls. Correla tions with lipoproteins were not given. The authors p ut
forward the possibill ty of a functiona l relationsh ip bet ween increased lipoprotein
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turnover. induction of liver enzymes and thrombotic tendency and went on to
publish (Cueuianu at et., 1985a) a study including measurement of plasma
fibronecl in and factor VIII-related antigen (VUlA:Ag) along with cholinesterase,
fibrinogen and factor Xill in hyper1ipoproleinaemias. cirrhosis. nephrotic
syndrome and controls.
Fibronectin showed a similar pattern of elevation in the groups to
cholinesterase except that it was lower in hyper tipoproleina emia type IV man In
type lib. It was sl ightly better correlated with cholestero l than with triacyJglycerols
but was better correla ted with serum cholinesterase than with either cholesterol
or triacylglycerols, or with fibrinogen, Vlll A:Ag or factor xm. Factor XIII was better
correla ted with lr iacylglycerols than with cholesterol. but only a little better. It too
correlated better with cholinesterase than with the lipids or any other protein, and
better than did flbronectin. The correlations of VIIlA:Ag with lipids and
chounesterase were not given but the results show that it was equally elevated in
hyperlipoproteinaem ias type lIa and lib and slightly less so in type IV (and
grossly elevated in cirrhosis and low in nephrotic syndrome, I.e . directly opposite
to changes in cholinesterase) .
The same year, Cucuianu et al. (1985b) published yet another study
comparing lhEllevels of clo lli ng factors and serum cncunesrerese . Not having the
specifICplasma (from beagle dogs genetically defICient in factor VII) required to
measure human rector VII, they used a measurement roughly corresponding to
the combined act ivities of factors VII and X in controls and hyperlip idaemic,
cirrho tic, major surgery post-oceratlve , end chctestetc patients. The clotting
index was found to be raised in the types of hyoerlipidae mJain a similar pattern
to that of cholinesterase (except that in type lib the clotting index was closer to its
value in Hathan to that In type IV). However, unlike cnctnesterase, it did not go
down significantly in ccet-ccereuve or chcles tatio patients. The correlation of the
clotting index with cholinesterase improved when these groups of patien ts were
excluded (0.578 to 0.716) and 'remained significant' when the cirrhotic pate nts
were excluded (actually fell to 0.475). What the authors failed 10 point out was
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thai these exclusfcne made virtually no difference 10 the co rrelation of Ihe clolling
index to serum trlacylglycerol (0.637, 0.661 and 0.645 respectively, all 6
correlations p < 0.001), i.e. that the clotting index is much more closely related 10
the absolu te level of triacylglycercllhan is cholinesterase .
These studies show that though many proteins secreted by (he liver are
elevated in hyperlipidaemias the patterns are different. Thus the particular
relationship of cholinesterase cannot be taken merely to be part of a general
trend. In particu lar , serum cholinesterase activity seems to be associat ed with an
increased rate of synthesis of VLDL or its release into the bloodstream and not at
all with its catabolism. In this regard it is significant that the protein studied that
most closely approximated the relationship of cholinesterase to serum lipids and
lipoproteins was LCAl, since the chclestervl ester in VLDL is derived mainly, if
not entirely, from the action of LCAl in the plasma. Several papers important to
the establishment of the tatter theory were pcbtished in 1978 (reviewed by
Frohlich et al., 1982), the same year that Cucuianu at al. published their study on
comparison of Le Al and serum cholinesterase levels, so Cucuianu at al. could
not have been aware of the full implication of their findings at the time. It is
surprising, however, that when Schouten at al. (1987) challenged association of
serum cholinesterase activity and lipoprotein metabolism as fortuitous, Cucuiano
(1988) In defence of his theory that 'raised serum cholinesterase activity and high
levels of lipoproteins (mainly VLOL) represent different effects of a common
cause acting upon the hepatocyte and leading 10an accelerated rate of synthesis
and turnover of lipoproteins' did not mention this point. He said that the
association of increased serum cholinesterase activity and accelerated
lipoprotein turnover could be due to specific induction, unspecific stimulation or
hyperreactive hepatocytes. His evidence discussed above suggests that it may
be fairly specific.
Schouten at af. (1987) it might be noted, had based their challenge on their
finding that reduction of LDL-cholesterol with 'MK·733' in 11 Mterozygotes for
LDL-raceptor deficiency did not cause a fall in serum cholinesterase activity.
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'MK·733' blocks cholesterol synthesis by compet itive inhibit ion of 3·hydroxy·3-
melhytglulary l-CoA reductase. The wo rk of Cucuianu and colleagues had shown
not only thai cholinesterase seemed 10correlate with VLDL synthesis rather than
absolute level, but that its apparent correlatio n with cho lesterol was only through
the association of raised cholesterol with raised triacylglycerols and thai
cholinesterase is not raised in lean subjects with pure hypercholes!erolaemia
(type lla] . Schouten et al. (1988) admitted thai their data on palients with types
lIa, lib and IV hyperlipoproteinaemia agreed with those of Ouculanu at al. (1975) .
The group publishing the next-largest number of papers on this topic from
clinical studies have been Kutty and colleagues . They have also reported in vitro
studies and much animal work which will be discussed in the following sections.
Way, Hutton and Kutty (1975) reported a study of 16 children with nephrotic
syndrome. Serum choli nesterase, dextran-precipitable lipoproteins (LDL +
VLDL), triacylglycerols and cho lesterol were arl found to be raised compared with
values in controls. In 7 of the patients further measurements were made after
recovery, as judged by serum albumin concentration as well as 'the clinical
picture'. In all caeee the serum cholines terase returned to within normal limits
along with falls in the beta-lipoprotein to normal or below-no rmal levels. These
findings were interpreted as evidence for the theory, developed from tn vitro
studies (Section 1.7.2, p. 46), that serum cholinesterase stabilises LOL, Slowing
its metabolism and hence increasing its half-life and plasma COncent ration. II was
further proposed that pre-beta lipoproteins might be increased by a 'log-jam
effect', explaining the observed increase in triacylglycero ls.
Kutly at st. (1975) reported the investigation of a patie nt accidenta lly
poisoned by the organophospha te, Parathion. The serum cholinesterase , LDL
and cholesterol were measured on admission and two-hour ly to 12 hrs and then
at 24, 48 and 96 hre. The LDL fell to a trough at 6-3 hrs and then rose through
the rest of the pence. The serum cholestero l reached a minimum at 10 hrs before
making a similar recovery . The serum cholinesteras e activity was zero on
admission. By two hours it was part ially restored fo llowing a dose of the
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cholinesterase reactiva tor pralld oxlme chlo ride on admiss ion. It then fell again 10
12 hrs before also reco vering. It was felt lhallhe coincident fall of cholinesterase
activity and LDL could not be due to liver damag e as reco very was 100 rapid and,
taken along with the finding that serum cholinesterase and beta -lipopro tein levels
were both depressed in guinea-pigs at one hour after dosage with tho
organo phosphate phosp hollne iodide, these resu lts we re taken 10 indicate that
cholinesterase has a function in the synthes is of LD L from VLDL.
Kutty at el: (1981a) proposed the use of a comp lemen tary risk factor (CAF),
serum cholinesterase actlvity/HDL-choleslerol. to improve prediction of risk 01
cardiovascular disease based upon the established risk factor (ERF), total
cholesterol/HOL-cholesterol. They investigated all the correlations between CAF,
ERF, 'total LOL' (LOL + VLDL), serum triacylglycerol and cholesterol in 290
adults. C AF was more highly correlated with ERF Ihan with the other lipid
indices. It has a much smaller ccefflctent of variation than ERF which might
suggest that it would be less useful, but it behaved differently. ERF correlated
best with 'total LOL', tnen with triscylglycerols, and only slightly less well with
total cholesterol. CRF correlated better with triacylglycerols than with 'tctat LOL'
and much better with either than with total cholesterol. Except for tha finding that
ERF correlated better with trlacylglycerol than with total cholesterol, which might
not have been guessed, these results are what would be expected Irom the fact
that total cholesterol is the numerator of ERF and from the relationships of
cholinesterase with lipid indices found by Cucuianu and colleagues discussed
above. They thus support Cucuianu's findings. Jain, Kutly a/ af. (1983)
compared CRF with ERF in hyperlipoproteinaemic patients and controls. ERF
was highest in type lib hyperltpcprctelnaemla, followed by Ha, and much less
elevated in type IV, whereas CRF was almost identically and impressively
elevated in Types lib and IV, but only just higher than controls in type lIa. The
investigators concluded that the use of EAF or CRF alone could predict \~ risk
of lschaemtc heart disease in 45% of {he cases whereas the combination
improved the predictive value to 65%. The relationships of the levels of serum
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cholinesterase in the different groups and controls in this study were similar to
those found in the Cucuianu series of papers except thai the mean activity was
rather higher in type lib than in type IV, whereas Cvcula nu et al. consistently
found it slightly higher in type IV.
KUlIy sf al. (1987) measured the cholinesterase , 'total LDL', cholestero l and
triacylglycerols in the serum of 66 patients with confirmed ischaemic heart
disease and B3 controls. 34 at the patients had serum cholines terase ecnvu'es
greater than the 95th percentile of the controls and all of them had activities
grea ter than the control mean. 50% of the patients were hype rchote eteroleemic
and 80% of them were hypert riacylglycerolaem ic. Serum cholineste rase was
positively co rrelated almost equally with 'total LDL' and triacylglycerols, and only
a little less with cholesterol. More interesting however was the finding that 18% of
the iechaemtc heart disease patients with significantl y raised serum
cho linestera se had normal lipid levels. The authors suggested that this could be
explained by their theory (mentioned above) that cholinesterase stabilises LDL
and suggested that the clearance of LDL could be sufficiently impede d by
elevated cholinesterase, even in normolipidaemic individuals, to engender
atherosclerotic plaque formation . They proposed the posibili ty that people at high
risk of developing atherosclerosis might fall into two catego ries : those with
hyperlipidae mia (and raised serum cholineste rase) in whom susceptibility is
mulntactor tany determined and dietary excess is a major risk teeter, and others
with inherited hypercho linesterasaemia who might be at even greater risk even
though diet and blood lipids are wen controlled. A subsequent investigat ion found
that the Cs variant, which has aproximate ly 30% higher activ ity than the usua l
variant (see Section 1.5, p. 14) was not more common in hyperlipidaem ic
subjects than in controls (R.H. Payne, personal communication ).
A few cmer authors have published on clinical studies of cholinesterase in
hyperlipidaemia. The paper of Myrtek at al. (1978) · refe rred to earlier in
connection with cholinesterase reduction with cret . showed correlations between
serum cholinesterase and lipids but differed from all other reports in finding a
greater correlation of cholinesterase with cholesterol Ihan w ith triacylglycero1. A
slight positive correlation with phospholipids before rehabilitation was net
significanl but when figures from before and after the rehabilitation programme
were combined the correlation increased and became significanl at the 0.001
level, but was still less than that with cholesterol. A table of baseline correlations
is given between 23 measurements, including lipids, proteins, electrolytes, blood
cells, catechclamlnes. uric acid, maximal oxygen consumption, and weight.
Amongst the enzymes, glutamate·oxaloacelate transaminase (GOT) and.
weakly, glutamate-pyruvate transaminase (GPT) correlated with triacylglycerols
and phospholipids, but neither correlated with cholinesterase. Apart from lipids.
the only strong correlations of cholinesterase were with weight, blood sugar, and
serum creatinine. Perhaps the later might be related to cholinesterase through
common essoctatton with hypertensive renal damage. When results before and
after rehabilitation were combined, correlations of cholinesterase with GOT and
GPT appeared because those enzymes also decreased with weight loss and
increase of maximal oxygen consumption.
The largest single study • of 1023 individuals . has been published by
Schriewer at al. (1985). Most of these subjects (824) proved to have normal
serum lipid levels but like Cucuianu at al. and Kulty at al., Schriewer at al. did
find serum cholinesterase activity to be raised in hypertriacylglycerolaemia and
mixed hyperlipoproteinaemia (higher in the latter) compared to ncrmcupoaenc
subjects and intermediate levels in individuals with pure hyperchotesterotaemta.
They also divided the subjects into three categories with regard to HDL-
cholesterol, with more similar numbers in the groups, and found an inverse
relationship with serum cholinesterase. However, on regression analysis they
found that the inverse relationship of cholinesterase with HDl-cholesterol
disappeared when triacylglycerol was taken inlo account but that there was a
positive correlation of cholinesterase with triacylglycerol which did not disappear
when HDl- cholesterol was taken into account and therefore decided that the
primary association was with triacylglycerol or VlDL metabolism. They also
"
scored their subects on a nine·point coronary risk scale based on serum
lriacylg!ycerol, relative body weight, smoking and diastolic blood pressure, and
founda clearcorretanon of serumcholinesterase with this index. They remarked
thai the question of whether raisedserumcholinesterase is itself a coronaryrisk
factor could only be decided by a prospective study, but said that if Ihe serum
cholinesterase is very high it would be worth looking for the presence of other
rlsk tactors.
Reuter and Geus (1987a,b) publishedresults on 206 individuals dividedinto
four grcups by serum lipids (normolipidaemic, cholesterol raised, Iriacylglycerol
raised or both raised) and divided into two groups by weight (normal or
increased). In all four serum lipid groups, cholinesterase was higher in
overweight subjects.and in both weight groups cholinesterase was higher in
hypercnoesterotaemc subjects than in the respectlve ncrmollpicaemlcs. but
significantly raised in hypertriacylglycerolaemicsubjects, and more so in those
with mixed hypertipldaemia. Lipidconcentrations were not given and there was
no indication of measurement 01 lipoproteins, but the authors considered that
raised cholinesterase acuvity is caused by increased VLOLsecretion and, citing
their earlier work (Geus, 1980; Geus and Reuter, 1982 • not seen), suggested
the followingpossiblemechanisms: nonspecific inductionof protein synthesis;
simultaneous synthesis 01cholinesterase and 'VLOL·apoprotein'; induction of
cholinesteraseby intermediates of triacylglycerol metabolism.
Lehtonen et al. (1986) measured or calculated total cholesterol LOL-
cholesterol, vt nt-chcesterol. HDL, HDL·cholesterol, lriacylglycerols, ApoA·I,
ApoB and serum cholinesterase in 83 patients with 3·vesse! coronary artery
disease and controls (matched for age, sex, weight and smoking). They
examined every factor and various combinations as discriminators.
Cholinesterase was foundnot to be a gooddiscriminator on its own, but ApoA.
l/cholinesteraseand HDL/cholinesterase (nearly the reciprocalof 'CAF' 01Kulty
a/ al., 1981a) detected 77.1% and 71.1% of the patients respect!vely. For
comparison, the best single-index discriminators were Hp t -cnoleeterol (74.1%)
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and ApoA-1 (73.9%) and one other good two-index discriminator was HDL/total
cholesterol (nearly the reciprocal of 'EAF', 73.6%).
Magarian and Dietz (1987) measured cholinesterase and triacylglycerols,
total cholesterol , VLDL·cho lesterot, Lp t -choiesterot and Hp t-cnolestero t in
hypertensive patients in a cross-over study of therapy with u-blocke r, p-blocker
or placebo. They found that cholinesterase correlated negatively with HDL·
cholesterol and positively with all the rest. The correlations were as good or
better than those found in other studies , but the authors failed to recognise the
check and balance thai produced these results. The correlations were doubtless
decreased because p-btockers sign ificantly decrease HDL-choJeste rol and
significantly increase the other lipid indices (Magarian at et.; 1987) while
competitively inhib iting serum choli nesterase (Whittaker at et., 1981) . However
they were increased by internal controlling because the 117 measurements
cons isted of 6 or more measurements on each of the 16 patien ts (2 whilst on
each drug and 2 or more in the intervening period on placebo).
AI the beginning of this section it was mentioned that diabetes mellitus is
associated with raised serum cholinesterase . Hyperlipoproteinaemia is known \0
be common in diabetes. Eight of the hyperlipidaemic patien ts included in the
study of Cucuianu at af. (1968) were diabetic but he never studied diabetics as a
separate group. Most of the work on association of serum cholinesterase and
lipids in diabetes has been done in animals and will be discussed below.
Venka takrishnan (1990) reports measurements of serum chollnesteraae ,
triacy lglycerols, choleste rol, 'total LOL' (LDL + VLDL) , Hut-cboiesterot and LDL-
choleste rol in type I and in Type II diabetic patients. She found significan t positive
corretanons between cholinesterase and triacylglycerol in both types; correlat ions
with other lipid indices were not signif icant.
Finally, in the early stages of alcoholism fat accumulates in the liver and
hyperlipidaemia may also be found. Lieber (1989) has reviewed work on this.
Ethanol displaces fat as a source of energy for the liver. This block in fat
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oxidation favours fal accu mulatio n. In addi tion , the altered redox state seco ndary
10 the oxidation of ethanol promotes lipogenesis, for instance. through an
increase 01 (I -glycerophosphate and enha nced formation 01 acy lg lycerols . The
depressed oxid ative capacity of the mitochon dria inju red by chronic alcohol
feeding also conlribules to the developm ent of the ratty Jiver. The accum ula tion of
fal in the liver acts as a stimulus for the secretion of lipoproteins into the
bloods tream and the de velopment of hype rlipidaem ia. Hyperlipidaemia may also
be cau sed by lhe pro lifera tion of lhe endoplasm ic reticulum after chro nic ethano l
consu mption and the associated increase of en zymes involved in the assembly
of triacylglycerols and lipoproteins. The propensity to enhance lipoprotein
synthesis is offset. at least in part, by a decrease in m'crotubutes and the
Impairment of the secretory capacity 01 the liver. The level of blood lipids
depends upon the balance between these processes. At at the early stage of
alcohol abuse, when liver damage is small, hyperlipidaemia will prevail, whereas
theopposite occurs wilh severe liver injury.
Cucu;anu et al (1976) included 37 alcoholics in their study. Only 8 of them
had hyporlipidaemia (7 type IV and 1 type V) and none of them had raised
cholinesterase. Vincent 8t al. (1982) found the mean serum cholinesterase In
chronic alcoholics to be nearly three times the normal. They also sludied SUbjects
brought into hospital in a state of alcoholic Intoxication ancl found the mean to be
raised in them too, but not so much. They quoted other authors with similar
results. They also quoted several groups who had studied the effects of alcohols
on serum cholinesterase activity in vitro. They confirmed previous findings with
ethanol, showing that with benzoylcholine as substrate, serum cholinesterase
activity increased with increasing concentration 01ethanol in the medium up to a
maximum between 6 and 7% alcohol, thereafter declining and becoming
progressively inhibited beyond 12% alcohol, whereas with acetylcholine as
substrate the activity was Inhibited from the lowest concentration of alcohol. They
made it clear thai Iheir findings of raised serum cholinesterase in chronic
alcoholic and intoxicated patients could not be due 10 the effect of alcohol
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present in the blood at the lime of sampling because they used acetylcholine as
the substrate . They also measured serum yGT and found that during 'dry ing-oul'
patients' ;OT fell very dramatically from very high levels while the serum
cholines terase changed very little. They mentioned however thai the level rell
progressively during the pathologica l progress ion of alcoholic cirrhosis and eou!d
then be used as an indicator of prognosis. They concluded (translation) 'The
activating effect of alcohol on serum cholinesterase appears connected in
alcoholics to an action secondary to enzymatic induction on the liver and hepa tic
biosyn thesis of serum cholinesterase and corresponds , it seems , 10a process of
steatos is (fatty liver) and hypertrtacylglycerclaemta' , citing Cucuianu at al. (1976).
They did not however measure the serum lipid levels themselves.
The patients of Cucuianu et al. (1976) had all been known to have been
consu ming large quantities of alcohol for at least five years. Most of them had
enlarged livers . Only 10 had raised alanine aminotransferase (same enzyme as
GPT). The liver is usually enlarged with fatly infiltration but tends to shrink in
cirrhosis. Alanine aminotransferase activ ity is usually mildly elevated in acute
alcoholic hepatitis but can be normal in cirrhosis . Cirrhosis might therefore have
been the cause of the non-elevatton of the cholinesterase in some of the cases,
but is otherwise myste rious. It was noted that the nutritional condition of the
alcoholic subjects was not as good as that of the control subjects or of the non-
alcoho lic hypertipidaemic subjec ts, but this might also have applied to the
patients of Vincent et al. (t982).
1.7.2 In vitro stud ies
l awrence and Melnick (196 1) applied 11 histochemical enzyme stains to
human serum following immunoelectrophoresis and found localization 01 all of
them in the beta-lipoprot ein precipitin line. They then separated beta- lipop rotein
from serum and plasma samples by ultracentrifugation, measured the acuvntes of
12 enzymes in the beta-lipoprotein fraction. Following ultrasonication the activity
of 10 01 the enzymes, including serum cholinesterase, increased conside rably.
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Freezing and thawing, addition of dinitropnenol. ether extraction and bubbling
oxygen through the preparation had the same effect 10varying degrees. The
authors interpreted their findings as demonstrating that beta-lipoproteins form
physical complexes withvariousproteins therebycarrying them in inactive stales.
A.H. Payne (personalcommunication)has tried 10replicate t~ ultrasonication
experiment withoutsuccess. Dubbs (1966) has been quoted as providing support
for this theory with respect 10 cholinesterase but his wor1( did not actually do so.
He subjected serum to unrascncaton and then electrophoresis and 'ound
siriking increase in the cholinesterase C3 band and lesser increases in the C,
and ~ bands • and eventual disappearance 01 all bands. From what is now
known of the structure of serumcholinesterase (see Section1.3, p. 6) this merely
indicated fragmentation ct the tetramer lntc dimer and monomer before further
denaturation.
Kutty and Jacob (1972) incubated human serum samples with different
concentrationsof isoniazid, which proved, as theyhoped, to be a cholinesterase
inhibitor. They found a linear relalionship betweenpercentage inhibitionof serum
cholinesterase and fait in lDl concentration while the lotal serum protein
coocentration remained constantand lhey suggested thallhe Ianin lDl miglt be
caused by the inhibition01the cholinesterase. Kuttyand Acharya (1972) reported
similar experiments using single concentrations of isoniazid or eserine. Both
cholinesterase inhibitors apparently cawed beta lipoprotein ooncentrations 10
fall. Ultrasonicatiol'l of serwn lor 25 minutes caused an increase in pre-bela
lipoprotein anddecreasein betalipoprotein, as estimated by dextran precipitation
and cellulose acetate electrophoresis (and an increase in cholinesterase C~.
Incubation 01LOLwith 'isolated' rabbil or human serum cholinesterasefor six
hours at pH 6.5 'appeared 10stabilize the lipoproteins as assessed by agar-gel
electrophoresis'. K.M. Kutty (personal communication) has kindly provided the
details of this experiment not given in the abstract. The chofinesterases were
isolated by eluting them from starch gel after electrophoresis. On the agar gel
LOl without additions was compared with LDl incubated with either of the
preparations of cholinesterase and with LDL incubated with the solution used to
elute the enzymes. The lane loaded with the LDL incubated with the elutant
solution showed only about 20% of the amount of LDL as in the lane of the
unincubated LDL, whereas in the lanes ccntalntnq enzyme about 80% of the l DL
remained.
Kutty sf al. (1973) incubated isolated human serum beta-lipoprotein with
phospholipase 0 2. Electrophoresis then showed replacement of the beta-
lipoprotein band of the untreated lipoprotein preparation with a band of prebeta
mobility and the appearance of a strong cholinesterase band where little had
been evident in the untreated material. Thus in this series of experiments Kulty
and colleagues had not only shown that addition of cholinesterase to LDL
appeared to stabilize the LDL but that inhibition, destruction or 'release' of
cholinesterase (by phospholipase OJ from LDL seemed to cause a reversion of
LDL to a particle with pre-beta mobility. They formed the theory (Kutty at 011.,
1973) that cholinesterase was associated with the LDL particle, but chemically
rather than physleauy, as Lawrence and Molnick (1961) had proposed. They
suggested that cholinesterase might bind by its active site to the
phosphorylcholine moiety of lecithin on the surface of l Dl, stabilising the lDL
and inactivating the cholinesterase and that the action of lipoprotein lipase on the
trlacylglycerols of VLOL produces a pre-LDL (which one might now Identify as
IOL) and that the binding of cholinesterase to this formed 'true' LDL.
Kutty st a/. (1977) prepared beta-lipoprotein from the serum of 33 patients
by heparin-calcium-chloride precipitation. Alter washing the precipitates in 1'Yo
triton X-100 in saline they measured the cholinesterase activity and found that it
was approximately proportional to the concentration of beta-lipoprotein in the
samples from which it had been prepared. As previous users of this method of
preparation of bete-llpcprcteln (BUCkley et al., 1968; Eaton and Kipnis, 1969) had
examined their products for contamination with albumin (by qet-, paper- or
immuno-electrophoresis) and found little or none, Kulty al al. took the finding of
cholinesterase in the lipoprotein to indicate a structural association between the
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two . II shouid be noted however that enzymatic staining is much more sensitive
Ihan protein staining and is also more sensit ive Ihan visually examined unsta ined
lmmunopreclprtatlon, as results 10be presented here have show n.
KUlty and colleagues (ehu at al.• 1978) then measu red cholinesterase,
cholesterol and triacylglycerols in sera sent for lipid screening and in LDL
precip itated from those sera. The cholinesterase was inc reased in bolh sera and
LDL fractions in type ua hyperupcprotetnaemta , and more so in types lib and IV
(slightly more in IV) compared with the normolipidaemic patients. However, in
type lIa the elevation reached statistical significance in Ihe LDL fraction but not in
the whole sera and they look this as support for their theory . They also div ided
the data into four groups by LDL concent ration and found the pattern of rise in
triacylg!ycerols, cholesterol and cholinesterase with LDL to be very similar in the
precipitated LDL to that in the whole sera. They proposed that there are two
pools of cholinesterase activity in the serum , one free and the other bound to
LDL. No significant difference was found in mean cholinesterase activity between
whole sera and supernatants from the precipitation of LOL. The mean was just
less in the supernatan ts. Actually, if chol inesterase is bound inactive in LDL one
might expect the result to be lower in the whole serum since it is diluted by LOL,
bu t this difference migh t not be detectable. The activity in the precipitated LOL
was less than one tenth of that in serum. Cho leste rol , triacylgtycerols and
cholinesterase were also compared in serum and LDL tractions of obese
subjects with and without hyperlip idaemia . In the LOL, as in whole ser um,
cholinesterase was higher in hyperl ipidaemia. The overall conclusion was that
chol inesterase mighl playa rOle in beth lipoprotein synthesis and structure .
In an abstract , Puhakainen, AyM nen and Pentula repo rted measurement of
cholineste rase In serum, HDL and ·VHDL'. They found most activity in the 'VHOL'
and noted that patients with low HDL concentrations tended to have high total
serum cholinesterase activity and vice versa. Ryhanen et al. (1982) enla rged on
this . They pooled serum from 80 healthy normcllpldaemtc adults and measu red
cho linesterase , cholestero l and Iriacylglycerols in the whole serum and in VLDI .,
50
LOL, HDL and VHOL fractions . No cholinesterase was detected in the VLOL. The
activity in the HDL (expressed as lUlL) was an order of magnitude greater than
that In the lOL, and in the VHDL it was another order of magnitude greate r and
about three times the activity of whole serum. The fractions were then washe d
and the measur ements made again. The cholestero l concentration of all fractions
was increased by the washing. The cholinesterase activity in the HDL was
halved, and reduced slightly in the VHD L, but in the LDL it apparently increased
slightly. The latter finding wa s supported by the finding on elec trophoresis of one
of the minor cholinesterase bands that was not detected in the unwashed
fraction. This was interpreted net as showing that cholinesterase was truly an
integral part of LDL and consequenuy increased in concentration by was hing as
was cholesterol, but as indicating the removal ot inhibitory subs tances.
Inspection of the results reveets that albumin was detected in all the frac tlons . in
the same rank c ruet but no t the same propo rtions as the cholines terase • and
that it too was no t all removed by the washing, though it never actually increased.
Citing their abstract, these workers came to the conc lusion that LDL increases
serum cholines terase activity and that HDL inhibits it
1.7.3 Animal studies
Much of the animal work on serum cholinesterase and lipids has been done
in rats, so it is worth noting that sex and specific differences in induced changes
in cholinestera se activity have been found . Harrison and Brown (1951) reviewed
some such find ings and reported a study of rats fasted for six days. 3erum
cholinesterase chouneeterase activity at the start was almost six times higher in
virgin females than in males. During the fast the activity fell continuously in the
females but rema ined constant in males while the serum albumin and total
protein decreased gradually in both sexes, slightly more in females. Body and
liver weights fell cont inuously in both sexes but per gram of liver the
cholinesterase remained cons tant in males, while in females it fell sharply for two
days and Ihen levelled .
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It has long been known that accumu lation of fat in the liver occurs when the
diel is inadequate wi th respect (0 its conten t of 'l ipotrophic factors': choline,
betaine and methionine (see references in Pawklne and Nishikawara, 1951). Th is
type of fatty liver can occur in starvation and during the feeding of high-fat diet s.
Choline can be synthesized using labile methyl groups donated by methio ni ne,
and one theory for the mechanism of lally liver is thai lack of choline impairs
synthesis of phospholipids (Mayes, 1990) . Fatly live r also occurs in alcoholism ,
as was mentioned abo ve.
Hawkins and Nish ikawara (1951) measured serum cholinesterase ac tivity in
rats led a hypoupct rophtc die t with or withou t supplements of lipot rophic factor s,
They expected that a nimals shOwing fatty liver would have a lowered serum
cholinesterase since the enzy me is synthesi zed in the liver . However, in ma la
adult and weanl ing rats , serum and liver cholineste rase was significantly raise d in
animals fed a hypolipotrophic diet compa red with those on diets suptemented
with any of the lipotroph ic factors, Female rats on the hypolipotrophic oiet had
significa ntly lower se rum cho linesterase than those given a supplement of
choline chloride , The authors concluded from this that the hypo lipotro phic d iet
was no t diiec lly respo nsible for the elevation observe d in males, Osada et al.
(' 989) fed rats a high-fat diel and compared them with others on a contro l diet, or
returne d to the contro l diet for a period afte r the hig h-fat diet or on ei ther d iet
supplemente d with lipotrophic factors. The mean serum cholinesterase was
lowered in two groups given the high.fal diet alone compared with all the other
groups. All the anima ls were male. The serum lipid levels were unfortunately not
measured in these studies .
Kutty and Jacob (t972) induced hyperlip lrfaemla in rabb its by intravenous
injection of the lipopo lysaccharide of E. co li. (The mechanism by which this
occurs is unknown.) Twenty-four hours after injection the mean concentra tions of
total serum lipid and 'total LOl', and the cholines terase activity, were all raise d.
The tactcrs by which they were raised were about 4, 11 and 2 respec tively. Kutty
at al. (1973) extended this study. They invest igate d similar ly treated rabbil s
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before inject io n and at 24, 48 and 72 hrs. Serum cholesterol, triacylg lycerols and
'total LOL ' we re all ma rkedly increased at 24 hrs. be fore falling 10 intermediate
levels by 48 hrs., which were maintained at 72. Quantitative measure men ts of
the individual lipoproteins had not been developed. but their relalive
conce ntrations were observed by inspectin g elect ron micrographs of the sera
and counting the particles of different sizes, and by examining the bands on
elec iropnorests . Both o f these methods showed a mass ive increase of Vl DL by
24 hrs. which was partially rep laced by LDL by 48 hrs. and almost entirely so by
72 (the HDL lalling and then rising again in the meantime). The serum
cholinesterase activity was not measured, but it was examined by
electrophoresis to look at the bands, whose meaning had not been established at
the lima. The results showed a large increase in enzyme activity by 24 hro., a
lower level at 48, and an activity back to control or below by 72. These results
very nicely bear out the predominant impression from the clinical studies that
increase in cholinesterase activity is related to the appearance 01 Vl DL in the
serum and is not directly related to absolute levels of cholesterol, triacytglycerols
or LDL The investigators were however more interested in the possibility of tho
chemical association of cholinesterase with the LDL particle, one of Ihe in vitro
studies described above having been reported in the same paper.
Kutty at al. (1977) investigated the possible role of cholinesterase in
lipoprotein synthesis in rats by measuring the incorporation of 3H.lysine into
lipoprotein frac tions with or without treatment with the cholinesterase inhibitor
neostigmine. The neostigmine, which reduced the serum cholinesterase activity
by about 50% caused a fall In labelled beta lipoprotein 01 about 75%, a Slight
increase in labelled pre-beta lipoprotein and about a 50% increase in labelled
alpha lipoprotein. Serum glutamate-pyruvate transaminase activity and
cholesterol esterjcholeeterol ratio were unaffected. The results were taken as
support for the hypothesis of stabilization of LDL by cholinesterase. However,
since lipases are esteraees. it is also possible that the neostigmine might have
lnhibitad lipoprotein lipase which converts VLDL to IDL. The increase in labelled
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HDL is more of an enigma. II cou ld be due to a reductio n in HDL cleara nce, due
to some other eff ect of ne ostigm ine. but it could just be a result of the rec iprocal
relationship observed to occur between LOL and HDl which is not properly
understood.
Similar results were obtained by RyM nen et al. (1984) in a study of
poisoning by the organo phosphate dichlorvos in rabb its . They found Ihat serum
chol inesterase activity fe ll to a minimum at 4 hrs. afte r ueann e nt. returnin g 10
normal by 72 hrs. yGT and LeAr were affected in the same way , though the
changes in the latter were not statistically significant. LOL showed a very
dramatic paralle l fall and rise, and HOL moved in (he opposite direct ion though
(he changes were much smalle r. VLDL was unaffecte d. C holes terol fell and rose
slighUy with LDL. Triacylg lycerol s and ester ified falty aci ds rose slightly to peaks
at 8-24 hrs. In a previou s pape r (Nousiainen and Pyhanen, 1984) it had been
reported that (in male rat s) disu lphiram also inh ibited ser um cho linesterase but
caused a rise in cholestero l and a fall in Iriacylg lycerol s . The lipoproteins were
not measured . Ayhanen el sl . (1984) claimed that this disagree d with Kutty's
hypothesis and suggested tha i or ganophosphates migh t cause a fall in LDL by
inducing LDL receptors, or by inhibiting HMG·CoA·reductase (the rate- limiting
enzyme in cho lesterol synthesis) by phosphorylating it. Since the VLDL
concentration was unaffec ted, the iener explanation at least seems unlikely.
Kutly at al. (1981b) found that in genetically obese mice (objobl ,
heterozygotes (obI. ) with obes ity induced by injection of gold thiog rucose . and
genetica lly diabetic mice (db/db) cholinesterase act ivity in serum and liver was
2-2.5 limes what it was in hetero zygous contro ls. All these categories of mice are
known to have very high blood glucose (l.e . the obese mice are also diabelic)
and the investigators found that they all had higher ca lorie-in takes than the
controls. ob/+ mice led a high-carbo hydrate diet also had raised liver and serum
cholines terase but not as high as the other groups . Their calorie-intake and
blood glucose were also found to be raised but to a lesser exten t than the other
abnormal groups . Diabeti c mice starved for 24 hrs showed a 4QOAJ reduc tion in
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cholinesterase activity in the liver but no reduction in the p lasma . poss ibly due to
long halt-life of serum c holinesterase, though there co uld have been continued
secre tion of enzyme alrea dy synthesized.
Kut ty at al. (1983) w ent on to observe increas es in food-in tak e, weight. and
serum cholines terase in growing weanling mice . Comparison of obese (ob/ob)
and lean (ob/+) mice showed that all three variables were higher in the obese
mice from abou t 28 days onwards and stead ily separated . However, from the first
blood sampling at 24 days until 35 days, whi le food intake and weight were
increasing serum cholinesterase activity fell and thereafte r rose . Testing mice
only 21 days old showed thai the cholinesterase was initially low but that its
activity transiently rose sharply on weaning from a mothers milk (high fat) to a
lebcretc ry mouse -food (high carbohydrate) clot, so the type, not just lhe amount
of rood mattered. Diabetic (db/db) mice restricted 10the same amount of food as
the average taken by non-diabetic mice showed a similar rise in serum
cholines terase activity to theirs from 32 days, though at a higher level. but
diabetic mice allowed food ad lib. showed a much Sleeper increase. Serum lipids
are known to be raised in diabete s and frequently in obesity, bu t lhey were nol
measured in these studies.
Kutty at al. (1984) then studied Zucker fat rats. These animals are obese,
hyperphagic and hypertriac ylglyce rolaemic with hyperlnsulinaemia and normal
blood sugar. Homozygous fal rats were compared with hom ozygous lean
controls and correlations were calculated with the two groups comb ined. Serum
cholinesterase activity co rrelated better with serum triacylglycerols than with
insulin or cholesterol, but less well than with load intake, weight or liver
cholinesterase act ivity. However , the numbers were smal l (27 total). There was
apparently a negative correlation between se rum cholinestera se and blood
glucose in these animals . In this study and that on the adult mice (Kutty er al.,
1981b) the prcpic nytcho linesterase activity was also measured in adipose tissue.
It apparently fell when rises occu rred in serum and liver, but it was men realized
(mentioned in the discussi on of the 1984 paper) that this was because of the
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increase in tat content of the cells and that per cell the adipose tissue
cholinesterase also increased .
In tho same laboratory, Venkalakrisnan (1990) has studied serum
cholinesterase and lipids in diabetic animals. Induction of diabe tes with
srrectozctccin and alloxan in rats was used as a model for type I diabetes.
Serum cholinesterase, lriacy lglycero ls, glycerol and 'lo la! LDL' all increased with
the development of diabetes, returne d 10normal whe n the hype rglyc aemia was
controlled with insulin, and rose again when the insulin was slopped. Total
cholesterol and HDL always moved in the opposite direction to the oth er indices
except that choleste ro l did go up when diabetes was induced with alloxan rather
than eneptczctocln . VLDL was not measured quanlitalively but electrophoresis
indicated that fluctuations in it corresponded to the changes in serum
triacylglycerol levels.
Gold thloqlucoee-freated mice were used as a model fo r Iype II diabetes.
These animals show in sulin resistance with hyperinsulinaemia and
hyperglycaemia. Like the type I model rats Ihey showed rises in serum
cholinesterase, Iriacylglycerol s, glycerol and 'total LDL' , but in these animals the
total cholesterol and HDL-cholesterol also increased. These studies thus show
that serum cholinesterase activity is not direclly related to total cholesterol,
bearing out Ihe suspic ion ex pressed by Cucuianu at a/. (1975). Furthermore
elevation of rerum cholinesterase occ urs in Zucker fat rats along with high insulin
and glucose levels that are normal bu t correlate negatively w ith cholinesterase,
while in type I diabetic rate elevation of serum cholinesterase occurs with low
insulin and high glucose, and in type II diabetic mice with high insulin and high
glucose, indicating clearly that cholinesterase is not directly related 10either
glucose or insulin levels. Jt should also be noted that in con trast to the Zucker
rats and type II diabetic mice tbe induction of type I diabe tes in rats caused
weight loss indicating that the commonly observed association of serum
cholinesterase elevation with obesity is nota last rule.
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Uver propionylcholinesterase act ivity was increased in both the type I and
type II diabetic models though not significantly in the former. The activity in
adipose tissue was significantly but on ly slightly increased in the former bul nol in
the latter, but as in KUlty et al. (1981b and 1984) Ihese were weI-weight
estim ates and enzyme activ ity per cell or pe r gram of protein was no t eslimaled
but likely 10 be very elevated .
lso-OMPA, wh ich inhi bits serum and liver propionylcholineslerase. caused
decreases in serum glycerol , triacylglycerol and 'lOlal LOL' levels in normal and
diabetic rats , and diabetic m ice. and withdrawal of iso-OMPA resulted in their
increase. Changes in cho lesterol were less clear. In the type I diabetic model
rats it went down along with Iriacylgtyce rols but in the type II diabetic mice it went
up slightly. Iso·OMPA is supposed 10 be a specific inhibitor of cholines terase but
it also caused significant decr ease in serum glucose in the diabetic rats and
lesser decreases in the control rats and diabetic mice , so the results should nol
be taken to prove that cho linesterase plays an active r61e in lipid metabolism.
Howe ver, tne fall in glycerol was taken as suggesting that se rum choure srorasc
might play a rale in adipose tissue lipolysis.
Intravenous hep arin injectio n is known to release lipo protein lipase from
blood vessel walls leading to rapid hydrolysis of plasm a triacy lgtycerots.
Admi nistration of heparin to cta benc rats caused B5% reductio n in lriacy lglyceruls
wilhin 30 minutes but mere was no change in serum cholinesterase . This was
taken as ind icating that the increase in serum cholinesterase in diabetic rats 'is
ret due 10 the serum level of lriglycer ides'. The clinical studies descr ibed above
put a slightly different slant on this . They suggested not that the two are not
related but that serum cholinesterase activity · and possibly synthesis - correlates
with the rate of synthesis of triacylglycero)s (or Vl OL) rather than with the
absotute level. In the diabeti c rats the two go up togethe r and the fact that
cholinesterase does not tall when Ihe rate 01 removal 01 triacylglycerols is
increased does not detract from this .
"
Twoother animalstudiesare relevant here. BUller at al. (1988) investigated
the effects of the peroxisome-proliferating hypolipidaemic agents najenopln and
clofibrate on Ihe activities of serum eeteresee in mice and rats of different
genotypes and ages. They found that though serum aryfeslerase activity fell,
serumcholinesterase activityslgnificanlly increased in all groupsof bolh species.
Theynotedhowever thai these drugscausehepatomegallyand suggested that
the increased serum cholinesterase might just be ,he result of increased liver
mass. Udomeraf. (1989) looked for a correlation between serum cholinesterase
and LDl in Watanabe Heritable Hyperlipidaemic rabbits. They found that in
contrast toa lhree-rcldvariation of lDl , serumcholinesterase activitieslay within
a narrow range, and there was no correlation betweenthe two. Theseanimals
have hyperlcidaemle due 10 an tn t -receptor defect. The result is therefore
8>caclly what onewould expectif cholinesterase activity is correlatedwith VLDL
synthesisandnot with absolute levels or removal rale of LDLand illustrates il
very well. The authors however completely missed (his interpretation. They
worked on the hypothesis 01 Kutty at al. (1978) 01 two pools of serum
cholinesterase, onebound to LDL andthe other free, and concluded that serum
cholinesterase may be regulated so as to maintain comptexauonwith LDL within
physiologically acceptablelimits.
Finally, Kuttyet al. (1979) investigated the possibleinvolvement of serum
cholinesterase in lipid metabolism by studying atherosclerosis. They induced
atherosclerosis in rabblts by feeding them cholesterol and compared frozen
sectionsof their aortaewith controls. Cholinesterase activity was found in the
intima only in the aortae from the atherosclerotic rabbits and the spots of
chomesterase staininqwerereported to correspond 10the sitesof lipidstaining
in adjacent sections. The substrale used for cholinesterase staining was
acetyllhiocholine so this experiment did not prove that the enzyme responsible
was one alsofound in serum. (Augustinsson, 1961, found the cholinesterase
activity in rabbit serumto be greater, and about equal, with acetylcholineand
proplonykholoe thanwith butyrylcholineas substrate. Simeon et ai.,1988,found
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evidence of three choli nesterases in rabbit serum , two hydrolysin g both
acetylcholine and butyrylchoHne and o ne hydrol ysing, of those two s u bstrates ,
only buty rylcholine.) In the sam e paper , KUlty er al. reported measurement of
cholesterol ester synthesis and proprorwlchonnesterase activit y in cu ltured rat
f ibrobla sts exposed 10 ser um fro m the rabbits. In cells grown in hyperli pidaem ic
rabbit serum both were increase d com pared w ith contro ls, the choles te rol ester
synthesis about eleven times , the cho linesterase activity about tw ice. The
cholinest erase activity did not see m to be der ived from the se rum because the
activity in cells grown in no rmal rabb it serum with addition al horse serum
cholines terase was not increased signif icantly . Additio n of ne ostigmin e to the
hyperlipidaemic serum reduce d both measurements, lhe cholesteryl ester
synthes is to about seven times control and the cholineste rase activity 10 a level
not significantly above control. The auth ors co ncluded that cholineste rase was
syruheslzed by the fibroblasts in the presence of nype rctolee teroiaemfc serum
and that by removing cho line ester s as Clitherow et al. (1963) had proposed (see
1.7.1, p . 31) it maintained idea l conditio ns for fatty acid metabolis m.
1.8 Measurement
Serum chol inesterase is usually measured through lts choline esterase
activity . For several reas ons this is not a direct measure of the concen tration of
enzyme protein. Firstly, there are numerous genetic variants. some of them
common and most probably at least so me of the se have diHerent speci fic activit y
with respect to the most commo nly used subs trate in measuremen t,
butyrylthiocholine (see Section 1.5. p. 11 ).
Secondly, various drugs an d toxins inhibit the enzyme. Th ese inclu de not
only compounds used spec ifically as cholinesteras e inh ibitors such as
neostigmine (used in the treatme nt of myaesthenia gr avis). ecihopate iodide
eyedrops (for glaucoma , McGa vi, 1965 ) and organophosphate insecticid es, bUI
other drugs to which more peo ple are exposed . Prop ranolol (WhiUaker of et.,
1981, and therefore probably other beta-blockers). chlorpromazine and its
sutphodoe (Erdos et aI" 1958, and therefore probably other phenolhiazines),
phenelzine andother monoamine oxdase inhibitor entdeoressants (Bodley el
ai" 1969). the antiemetic, metcclopramae {Kabamela l" 1988: Kao andTurner,
1989) and the chemically similar but less used anHarrhythmic, procainamide
(Kabam at ai" 1987). and the anti-cancer drugs cyclophosphamide.
mechlorethamine(nitrogen mustard) andtriethylene nitrophospl'l::lramide ('Thi(l·
tepa', Zsigmond and Robins, 1972) all cause clinically evident reductionof serum
chol inesteraseactivltybyprolonging theaction ofsuccinylcholineand haveeither
been shown toinhibit serum crolines lerase in vitro or arelikely 10 do because of
their structures. (Otherdrugs known to reduceserum cholinesterase activity •
contraceptive pills (Robertson, 1967) andthe gluco-steroids oexamet hesone and
pre dnlsone (Bradamanl9 at al., 198 9) probably do so by reducing synthesis of
Ihe enzyme.)
Thirdly, one has toconsiderthe possib ilityof actvaton of lhe enzyme. The
insulin·dependent inc/ease in I:poprotein lipase activity in adipocytes has been
has been shown to bedue to acuvejen of pre·exisling prolein ra the!'than 10
increased synthesis (Seme nko~ich el al. (1989) and serum cholinesterase has
been shown tobe activated in vitro by alcohols(Whill aker, 1968a),
In the work for this thesis serum cholinesterase concentration was
measured to determinewhether the raised activity fotrld in bypertipdeemla is
due toincreasedconcentrationof enzymeor not, and incase some high.specific-
activityvariantsmight be found, There were reasons for belie~ing that the high
activityfound in hyperlipidaemia was incleed dueto increased ccncenueucn of
enzymeapart from therela lionships between cholinesterase ectvlty and lipids
discussed in thepreceding sections.
Kunkel and Ward (1947) inhibited serum cholinesterase irreversibly by
injectingdiisopropyl f1uorophosphate intofive human subjects and observing the
return of enzyme activity whichcould only come from synthesisof newprotein.
Two of the subjects had liver cirrhosis and lowserumcholinesterase activ ities,
two had nephrot ic syndrome and high acevuies. and 000 was a con trol. In all
c ases the activities returned from zero back to 8().1QOO~ ol lhe ir origina l levels in
32 days and the curves of percentage of orig inal leve l per da y of regeneration
w ere ve ry similar , The serum lip id leve ls were not measured, so one ca nnot say
that they did not behav e in exactly the same manner as the enzyme and o ne
c amot say for certain that the high activities in nephrctc syndrome were no t
caused by activa tion by one of the lipi ds. but the aut horS' conclusio n that the
levels reflected the rates 01syn thesis s till seemed likely .
Further. Altla nd e t af. (1971 ) measured se rum cholinesterase concentration
in 269 blood do nors and found a corre lation of 0.87 with activity. The y did not
measure serum lipidsand did not study subjects with above-normal activi ties. bu t
one might reasonably expect that so me of their subjects would have bee n
hyperlip idaemic , so the fact that they d id not find any individuals with markedly
h igher specific activities suggests that lipids do not activate the enzyme .
However, it seems that not everyone is convinced of this. RyhAnen et a l. (1982 )
concluded that LDl cho f&slerol ecreases seru m cholinesterase activ ily wh ile
HOL cho lestero l inhibits It. Meas ureme nt of crcnoesterase concentration can
sette this ques tion. Fu rthermore. it w as felt that the examination of whetho r
t riacylglycerols or VLDL correla te bette r with the actiVityor the concen tration 01
ch oflnesterase could add ress the que stion of whethe r the en zyme is active ly
involved in their metabot ismor merely cos ynlhe sized.
In the work presented here ctcunes terase was pur ifledlrom human serum.
an tibodies were raised against it, and the antiserum was used to measure the
concentration o f cholinesterase in hu man se rum samples. Impurities in the
antigen solution and immunological va riation in the cb omesterase we re found
incidenta lly.
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Chapter 2
MATERIALS AND METHODS (1)
2.1Purification of human serum cholinesterase
2.1.1 Introduction
Da s and Liddell (1970) purified human serum cholinesterase by ion-
exchange chromatography on OEAE-cellulose at pH 4.0, tollowed by
eleclrofoc using in a pH gradient, followed by gel filtration. The first step is
effective because serum cholinesterase is one of very few serum proteins Ihat
are negati vely charged at pH 4. It the refore remai ns in the column w hils l Ihe
majority of proteins, being less acidic, pass straight through. DIU and Liddell
eluted the choli nesterase with an exponential g rad ient of sodium chloride from 0
10 0.2 M in the buffe r, 0 .02 M sodi um acetate.
Muensch et al. (1976) used the same firsl step, but modified it by
introducing the sodium chloride in a line ar gradien t, which they claimed resulted
in hi gher purificat ion. They also added mM EDTA
(elhylened iamine lelraace late) and 1 mM me rcaploethanol to the bu ffer to
improve stabil ity of the enzyme. They replac ed the ether two step s with
prepara tive po lyacrylam ide disc gel elec trophoresis .
Loc kridge and La Du (1978) used the same first step , with the mod if ica tions
of Muens ch at al., and followed it with affin ity ch romatography on procelnamice-
Sepharose 46 at pH 6.9. Subsequently (Lockridge at al.• 1979) they om itted Ihe
mercaptoemanot from fhe buffers, because they found that the enzyme was
more stable in its absence, and they ope rated the affinity column at pH 7.0 . Later
(Lockridge at at., 1987a) they added a third stage , consisting of ion-exchan ge
chromatography again, this time at pH 7 .0 , but the reason for this was no t given.
In this work . the methOdof Lockridge and co -workers was used with several
modifica tions. First. the remova l of chol inesterase from the ion-exchange colum n
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was different. In the absence of an apparatus to produce a linear gradient,
choline s terase , with othe r very acidic proteins, from batches of up 10 500 ml o f
human serum was eluted with 1 M sod ium chlOride alter washing a ll other
proteins out of the column with buffer. Then cho linesterase-containing fractions
from all batches were pooled and put back onto !he column, and the serum
cholinesterase eluted with 0.06 M sodium cnlcnde. lhe concentration found 10
remove it by Lock ridge and col leagues. Second. cncune was used to enno the
choline sterase from the affinity column , ins tead of sodium chlor ide . Third , affini ty
chromatography was follo wed. net by fur ther ion-exchange chromatography, bu t
by gel fil tration. This easily separated the cholineslerase from the single other
remain ing protein detected on eect ropbcrests . which was of much lower
molecu lar weight than cholinesterase.
2.1.2 Detection of cholin esterase and ot her proteins durin g
purif ication
2.1.2.1 Polyac rylamide gel electro phoresis (PAGE)
Se rum and effluent and eluates from columns were examined and
compar ed by PAGE (T • 6.43%; C - 2.6%. biS) in a vertical slab-gel apparalus
(Hoefer Scientific Instruments Vertical Slab Gel Unit. SE 600 series) w ith gel
crces-eectce 3 • 142 mm , run at constant power 0115 Watts. The detai ls were
asfoUows:
Acrylam ide sol ution (amounts for 500 ml )
Acrylamide 73.05 9
N,N·4methyI9ne·bis·acrylamide (bis) 1.95 g
Buffers (Ashto n and Braden, 1961)
Gel buffe r . 5 (amounts tor 1 L)
citric acid 7.2 9
Iris ba se 27.9 9
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boricacid 5.99
UOH 0.69
bromophenol blue trace
Vessel buffer (amountslor1 L)
boricacid 11.8 9
UOH 1.29
Making the gel:
Pullogelher gelapparatus.
Pour30 ml acrylamide solution into a 50or 100mt measuringcylinder.
Add14ml 5 • gel buffer.
Add1drop of TEMED(N,N,N',N'.tetramethyk:lhylenediamine).
Makevolumeup 104Sml with5 • gel buffer. Mix.
Weigh out 40 mg of ammonium persulphal9 and disolve in 25 ml deionized
water.
Addthe ammoniumpereulphate solutionto theacrylamidelbuffer.
Mixand pourimmediately into thegel former throughafunnel.
2.1.2.2 Stains
2.1.2.2.1Serum cholinesterase stains
2.1.2.2.1.1 . Specific sta in
The us ual method of detection of cholinesterase used ampl' 1';; S·
butyryJlhiocholine iodide as substrate in a solution also containing copper
sulphate, sodiumcitrate,and potassiumferricyanide. asdescribed by Karnovsky
and Roots (1964).In thepresence of cholinesterase, thiocholine is released, and
this is precipitated as colourlesscupric thiocholine. The thiocholinereduces the
ferricyanide 10ferrocyanide,andthe leuer combines withthe copperionsto form
..
the insoluble copper ferrocyanide. The citrate cheletee the coppor ions in
solution, pr eventin g the fo rmation of copper ferr icyan ide. The recipe is:
Stock solutions
Solution A:
Perlitre:
maleic aci d 11.61 9
NaOH 6.0 9
AdjuSI10 pH 6.0 ifnecessary.
Solution B:
Sodium c itrate
copper sulphate
0.B7 9 in 30 ml water
0.37 9 in 50 ml water
Disolve sepa rately and mix.
Prepare freshly
Solution C: 8 mg potass ium ferricyanide in 10 ml water
Solution 0 : 30 mg butyryltblocnoune iodide in 40 mt of solution A
Mix in order: solution 0
solutionB (8 mil
solutionC
Then pour ove r ge l.
2.1.2.2.1.2 Non-specific slain (a-naphlhyl propionale)
Sometimes, for thepurposeof illustration,chcttneaterase wasdemonstrated
with a non-s pecific esterase staining method, in which the substrale is ({-nap h lhyl
propionate . In the presence of cholinesterase, o-n aphtho! is released , and this
forms a complex w ith the diazonium dye, Fast Red TR Salt (a-chtoro-c-tonndtne
diazotate) . Th is m e thod gives a darker slain , which does not fade. The recipe is:
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Disolve 10 mg u-naphthyl propionate in 1 ml ethanol.
Disolve 10 mg Fast Red in 100 ml water .
Mix and leave 10 stand.
Filler just before use (because u-naphthyl propionate breaks down
sponta neously to c-napnmo! and thai reacts with the Fast Red).
2.1.2.2.2 Protein stains
2.1.2.2.2.1 Amldo Blac k
Other proteins were usually stained with 0,01% Amido Black in 5% acetic
acid, and if necessary 10 discern faint bands, or lor illustration, the gel was
destained with sev era l washe s with 10% acetic acid.
2.1.2.2.2.2 Coomas sie Blue
Whe n greale r sensitivity was requi red, protein was stained with Coomassie
Brilliant Blue R. The recipe is:
Sla in
methanol 42 ml
Coomassie Brilliant Blue A 100 mg
Mix we ll. Then add
wate r
glacial acetic acid
Mix well and filte r,
42ml
16m l
Pour over gel, cover , place in oven at 50°C for sever al hours.
Wash
z-propeno! 10%
acetic acid 12.5%
in water.
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Change wash several times unti l background is clear.
2.1.3 Preparatio n of the Aff inity Column
The affinity ligand, procatnamioe. was coupled \0 the gel. CH Sephercse 48
(c -emlnchexyt-eepherose 48, Pharmacia Fine Che micals , Inc.) with the coup ling
agent , EDC (1-(3-dimethylaminopropyl)-3-elhyl-carbod iimide hydroch loride ). 1
gram of the gel was used . The manu facturer states that the amount of coupled
spacer groups in CH Sepharose 48 is 10 - 14jlM/ml of ewolen ge l. and 1 9 of dry
gel expands 10 abou t 4 ml when we t. Therefore the maximum amount of spacer
groups is about 60 j.lM. The molecular mass of procainamide hydrochloride is.
271.8, so 60 j.lM is abou l16 mg. This wou ld be the minimu m amount required 10
occupy all available pcsitrcne on tho gel. 100 mg was used, giving approximate ly
a six-fold excess . The car bodiimide should be in ten to a hundred-f old excess so
about 600-6000 j.lM was required . The molecular weigh t of EDC is 191.7, so the
required amount was in the range of 115 mg 10 1,15 g. 1 9 was used.
The gel was allowe d to expand in 0.5 M sod ium chlor ide, and then washed
on a sintered glass fi lle r with the rest of 200 ml of 0.5 M sodium chloride , and
then with 50 ml of water. It was then rinsed into a beaker containing tho
procainamide disolved in a small amount of wa ter. Then the EDC, also disolved
in a little water, was added . The pH was adjus ted to about 4.6 with hydrochlor ic
acid. The total volume was adjuste d 10 about 50 ml so that the EDC would be at
about the recomm ended concent ratlon of 0 .1 M. The reaction mixture was stirred
for about 25 minut es while the pH was monito red to see that it remained in the
range 4.5-6.0; it drifted up slightly 10 4.7. Then it was left on a recip roca ting
shaker for abou t 24 hours.
After this, the gel was washed with five washes each of alkaline buffer (D.l
M sodium btcarbonate, 0 l) M sodium ch loride, pH 8.3) and acid buffer (D.l M
sodium acetate, pH 4.D) alternately, about 40 ml each time . It was then pacue d in
a column and equ ilibrated with 0.02 M potassiu m dihydrogen phos phate, pH 7.D,
containing 1 mM EDTA (hereafter referred 10 as affinity co lumn butter).
"2.1.4 Small-scale Trials
Before attempting purification of serum cholinesterase from large volumes
of human serum , trials were done with 1 ml volumes. In the firsl trial, the serum
was diluted to 10 ml with the affinity colum n buffer (see above) and applied
slraighl lo the affinity column in the hopes of bypassing the lcn-exchanqe step. A
creamy layer appeared in the lop of the gel. The column was rinsed with 25 rnl of
buffe r. The creamy laye r in the gel did not move. Then elution of cho lineste rase
was attempted . 0.4 M NaCI in buffer was used , as Lockridge and La Du (1978)
found that the usual enz yme eluted between 0.2 and 0.4 M. Chol ines terase was
not defected in twenty 1 ml fractions. II was not found in the initial effluent or
washings, so had to be st ill on the column. 1.5 M NaCl in om M sodi um
phosphate , pH 7.4, was then adde d to Ihe column , and 1ml frac tions were
collec ted. The creamy mater ial in '~e top of Ihe gel im mediat ely started to move.
After collecting five fractions it was clea red, and after the sevent h, collection was
stopped. Polyacrylam ide gel electrophores is showed that there was a trace of
cholineste rase in fraction 4, and much more in fractions 5, 6, and 7. Stai ning for
prot ein showe d thai the pro tein also first appeared in frac tion 4, but had its
greatest amount in that frac tion a nd decreasing amounts in the subseque nt
fractions 10 a trace in fraction 7. It was encouraging that the c holinesterase came
off the column a lillie more slowly than most other prote ins, bu t it was clear thai
the ion excha nge step was required.
About 3 ml of DEAE-Sephace l (Pharmacia Fine Chemicals, Inc.) was
packed inlo a small column for tests , and equilibrated with the buffer used by
Lockridge et al. (1979) and used in the DEAE-Sephacel colum ns thro ughout in
this work, t.e. 0.02 M sodium aceta te with 1 mM EDTA , pH 4 .0. 1 mt of se rum
was diluted to 25 ml with buffer and run into the column. It soon beg an to run
very slowly , as did more buff er added after il. Das and Udde l (1970 ) dialyse d
serum repeatedly againslthe buffer unnlme pH reached 4.0, and Ihen removed
precipitate by centrifug ing . Presumab ly the column had become blocked with
protein precipi tated by low pH and low ionic stre ngth.
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The column was washed oul and the gel replaced, and this lime 1 ml of
serum was again diluted to 25 ml with buffer, but filtered through fine-grade filter
paper (Whatman 42) before putinq it onto the column . No runn ing problem was
encoun tered this time. 25 ml of plain buffer was passed through the column after
the diluted serum, to rinse out proteins that had not bound. and then elution o f
serum cholinesterase was attempted. 0.06 M NaC! in buffer was used, as
Lockridge and La Du (1978) reported that the enzyme eluted between 0.03 and
0.06 M. Twenty 1ml fractions were conecteo. Some chol inesterase was detected
in all the fract ions, but nearly all of the activity was in just four fractions (9-12). No
protein was detected in any of the fractions after staining the polyacryla mide
elect rophoresis gels in Amide Black for 24 hrs.
The lour fractions containing the bulk of the cholinesterase activity were
pooled and dialysed against Ihe affinity co lumn buffer (0.02 M potassiu m
phosphate, 1 mM EDTA, pH 7.0) and run into the affinity column. Alter rinsing the
column with buffer, elution of serum chotlnesterase was attempted wi th 0.4 M
NaCI in affini ty butter, as before. No cholinesterase (and no other pro tein) was
detected in twenty 1 ml fractions. Then 0.7 M NaCI in buffer was tried. A peak of
cholinesterase (ascending and descending activity) was found in six 1 ml
fractions, 5· 10, and further fractions were not examined. Some other protein was
detected, desp ite the fact thai none had been detected in the DEAE-Sephacel
column eluate that was put onto the affinity colum n. It was nea rly all in fraction 5,
but a trace was seen in fract'cn 6.
The cholinesterase thus eluted from the affinity column between 0.4 and 0.7
M NaC!. To narrow this , another 1 ml of serum was processed in the same way,
and this time elution from the affinity column with 0.5 M NaCI in buffer was tried.
As in the previous run, no protein was detected in the fractions Irom the lon-
exchange column with Amide Black. In case this was due 10 diffusion of protein
whilst waiting for the choline sterase stain to appear, before staining for prcte tn,
duplica te gels were run with fractions collected from the affinity column , and one
was stained Immediate ly for protein. The cholinesterase did elute with this salt
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co ncentration, but was spread over many fractions. It first appeared in frac tion 5,
peaked in fraction 10, and was still present in the last fraclion tested. 20. Other
prote in was detected only in fraction 5, and only in the gel stained immediately
lor protein, the duplicate. which was stained lor cholinesterase overnight , was
als o stained lor protein afte r abou t 1B hre, but showed nothing .
Apparen tly, 0.4 M NaCI in buffer had not eluted cholinesterase or other
proteins from the column, but 0.5 M NaC! in buffer had eluted both. Al this stage
it was decided to try displacing cholinesterase from the aHinity column with
cho line at a conce ntration that shou ld leave other proteins on the colum n.
Anothe r serum sample was processed by ion-exchange chromatograp hy
and dialysis as before, and this time, after running the pooled dialysed
cholineste rase-containlng fractio ns into the affinity column, the column was
rinsed wilh 0 .3 M NaCl in buffer and then elution of cho linesterase was attem pted
with 0.3 M choline. Twenty 1 ml fractions were collected. Choli nesterase was
detected in fractions 9-20, but the stain appeared slowly, and was sli ll no t very
intense after about three hours. II was therefore decided to Iry running 0.4 M
choline through the column to see whether there was any cholinesterase left on
it. Cholines terase was indeed cetec ted in all of thirty fractions collected. From
this, two conclusions were drawn. Firstly, 0 .4 M choline should be used direclly
next time, and secondly, since the cholinesterase stain depends upon enzymatic
activity and win even tually detect even minute traces of the enzyme jf allowed
long enoug h to do so, gels should be read after a fixed time period to avoid
misleading results. One hour was chosen .
When the next serum sample had been loaded onto the test DEAE·
Sephacel co lumn, and fract ions eluted with 0,06 M NaCI In buffer , the gels were
stai ned for protein after one hour in cholinesterase stain. For the first lime after
this stage. some protein was detected amongst the cholines terase-co ntaining
fractions . (Ohollneeterase appeared in fractions 6·12, mainly in 8· 11, and a very
Utile olher protein was detected in fraction 9.) After lhe pooled dialys ed
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cho linesterase-contai ning fractions had been loaded onto the affinity column, the
said column was rinsed with 0.4 M NaCI in buffer, and then twenty 1ml fractions
were collected with 0.4 M choline in buffer. A sharp peak o f cholines terase was
found in fractions 3-6. It was suspec ted that the choline soluuon had not been
completely mixed , so that the first few ml added to the column may have had a
high er concentration of cho line, which might have accoun ted for the prompt
appe arance of the cholinesterase and the lack of tailing. Howeve r, the latter
co uld also be accounted for by the limiting of the time of incub ation with the slain.
No other protein was detected in any of the fractions. 0.5 M NaCI in buffer was
then appl ied to the column and twen ty more 1 ml fractions collec ted 10see tile
prote in come off the colum n, and to check that no cholines terase had been loft
on it. There was no cholinest erase, but no other protein was detected either. 20
ml of 1 M NaCI w as applied to the column and more fractions collec ted. again .
no protein was det ected. The only exp lanation therefore was that the protein had
come off the column with the 0.4 M·NaCI-in-buffer wash thai was passed through
the column before elution of the cholin esterase with the choline. The effluent had
not been saved, as that con centration of salt had not been found previously to
mo ve the proteins. At this stage it was felt that the lime had co ma to proceed to a
larger-scale trtal,
2.1 .5 Full-scale Purification
2.1.5.1 Malerlal
Das and Liddell (1970) and Lockridge and La Du (1979) purified their
human serum cholinesterase from plasma from time-expired blood donations.
The Red Cross Blood Transfusion Se rvice here is able 10use allthis plasma, so
it was not availab le, but it kindly supplied out-dated bags of concentrated
platelets ('plate tpt-enriched plasma' ), which conta ined an avera ge of aboul 54 ml
each . Each bag co ntained maleria l from a single donor. The plasma was pooled
for cholines terase extraction, and no attempt was mad e to distinguish
cho linesterase variants be fore poo ling, as the aim was to raise polyclc na!
antibodies to any hum an se rum cho linesterase.
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Fibrinogen and platelets ware removed by adding 1 ml of 1 M calcium
nitrate per 100 ml of the pooled platelet-enriche d plasma and incubating a137°C
unti l clot had formed, and then at 40(; overnight to shrink the clot. The clot was
removed by straining through muslin. Das and Liddell (1970) centrifuged to
remove remaining clot, bu t this was not done in this wo rk, as filtrat ion was going
to be necessary after bringing the pH down to 4 for ion-exchange
chromatography anyway. The serum was div ided inlo portions and froze n.
2.1.5.2 lon-exchanqe chromatography
OEAE-Saphacel was packed in a colu mn of about 2.5 em internal diameter .
The preservative alcohol was run out and the gel rinsed with deionized wa ter and
equilibrated with but ter (0.02 M sodium acetate, 1 mM EDTA, pH 4.0). The gel
settled to a height of about 47 em (a volume of about 230 ml). Whilst the alcohol
was coming out, it was noted that it running very slowly, so a peristaltic pump
was attached. This was always used thereafter. With the pump at the same
setting (full speed) the flow-rate was found 10 vary aC!:ording to the material
passing through the column, but was at best about 22-23 ml{hr.
t 20 ml of the serum was used lor the first trial run of larger-scale
purification. 10.9 M sodium acetate, pH 4, was added to bring down the pH. 1.4
ml brought it down from 7.2 to 5.0. A further 5.2 ml was required to bring the pH
down to 4.4 and no more was added. The serum was centrifuged at 1500 r.p.m.
lor 45 min. but most of the precipitated protein remained in suspension. II was
decided not to centrifuge again, as more protein woutd be precipitated on
reduction of the ionic strength anyway. The serum was dialysed against the
DEAE-Sephacel column buffer. The pH of the last lot of buffer at the end of
dialysis was 4.02 but, when the serum was released from the dialysis bags, it
was found to have a pH of 4.4. Dialysis had not reduced the pH at all, though it
had no doubt reduced the salt concentration. However, it was decided to proceed
without further dialysis. The serum was filtered through coarse filter paper
(Canlab F2402) followed by fine paper (Whatman 42), and loaded onto the
column.
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The effluent was collected in tube- with an automat ic tractrco - collector set
10 8 min/tube . The yeuow colou r of the serum appea red in fraction 26, indicating
a bed-volu me of around 75 ml. The serum was followed by 100 ml of buffer 10
flush out ncn -adhe rrent proteins , and then elut ion of cholinesterase was begun
with 0.06 M NaCI in buffe r. The fraction-collec tor was reset 10 slarl collQcUng
from the time that the elutant started entering the gel. Alternate fractions were
checked lor the presence of cholinesterase and other proteins from no. 24
onwards. The cholines terase eventually appeared in fractions 178·208 with most
01 it in 186-190, the peak at 188. Other proteins were detected in fractions
186-192, also having their peak in no. 188. It was decided that since the
cholines terase took such a long time to elute, future batches would be eluted with
mol ar NaCI in buffer and that any extra protein accumulated by so doing could be
separated by puling all the poo led cholinesterase-containing frac tions back onto
the column at the end and elut ing with 0.06 M NaCl then. Fractions 183-195 were
poo led and frozen .
In the next ru n, 250 ml of serum was used . This lime glacial acetic acid wac
use d to bring the pH of the serum right down to 4.0. 7 ml was required. Serum
that had been kep t in a refrigerator for three weeks without r.-eezing, serum that
had been froze n and thawed but not acidified , and the serum that had been
adjusted to pH 4 were exam ined qualitatively by PAGE. All showed plenty of
choli neste rase activity . The 250 ml of ac.fltled serum was dialysed (without prior
centrifugat ion or filtra tion) lor two days in three 2 L ba tches of buffer . 11 was then
fi.tered through coarse and fine pape r, as before, and run into the column . It was
followed by 100 ml of buffer and the n 1 M NaCI in buffer was otnonto the colum n
and fractions were collected as before .
This time the choline , •erase appeared much earl ier, and spread over less
fractions. Alternate fractions were examine d and it was detecte d in nos. 60·76,
with the most in 64 -70. Muensch at al. (1976) and Lock ridge and La Du (1978),
using sodium chloride grad ients, found that cho linesterase eluted in a small
prot ein shoulder preceeding the main prote in peak, so it was to be expec ted that
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more protein would be found in the cholinesterase-containing fractions this time.
This was indeed the case. The prote in was found in more 01the fractions (62-72).
though cholinesterase was more bunche d, and thestaining was heav ier.
The cholinesterase -containing fractions were again pooled and frozen. It
was noticed that they were opalescent, and that opalescence tailed away in the
fractions on either side. Inspection of the rest of the fractions revealed
opalescence in the early ones loa, attenuannq. and disappearing al about
fraction 40. II was therefo re decided to check these fractions for cholinesterase
activity along with a sample of eff luent collecte d whilst the serum was passing
through the column. This sample was collec ted jusl after the last of Ihe serum
had passed into the top of the gel, l.e. when there was about 75 mt left to come
through. The fraction-collect ion started 100 ml later, when the last of the buffer
entered Ihe gel and the 1 M NaCI in buffe r started to enter. The sample of
effluen t contained jusl a little cholines terase , indicating that not all of the enzyme
was binding to the gel; there was, as expected, a lot of other protein. In the
opa lescon t fractions there was a little cholinesterase in the first six (and a lill ie
other protein in the firs t five) indicating that a lilli e cholinesterase was being
flushed oul of the column with the plain buffer.
Because of these findings, it was decided 10 coUect all the efflue nt in
fractions from the lime that the serum started entering the gel and to check right
through for cholinesterase. 250 ml was used again. The first 22 frac tions of
effluent were opalescent Fractions 23-29 were full of white precipitate despite
the facts that the serum had been filtered after dialysis and me column had been
washed since the previous run. The next two fractions were opalescent/yellow.
and following ones were clear yellow. No cholines terase was detected in the
fractions showing opa lescence or precipitate . The enzyme star ted to appear
somew here between fractions 38 and 48, l.s. after about 110-140 ml of effluent
had come out of the column after the serum started entering the top. A small
amount of cholineste rase was defected in all the rest of the efffuent from the
serum. It stopped coming off the column within the first 50 ml of the buffer rinse,
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as before . With 5 J.l 1samples for PAG E there was only faint stain ing throu ghou t II
did not increase 10 the intensi ty of sla in seen with samples of serum . so it was
deduced that most 01 the enzyme was binding througho ut the lime that serum
was "owing through the column and that therefore the amount of serum loaded
did not need to be decrea sed.
The cho linesterase peak , eluted with 1 M NaCI in buffer, was restricted to
even few er fractions than in the previous run . II was decided 10 dialyse the ne xt
balch of serum against buffer without adjusting the pH first. 250 ml was used
again. As in the previous run, the effluen t was collected in fractions from the time
that the serum slarted entering the gel. The appearance 01 the effluent fractions
was similar to thai seen in the previous run. The opalescence extended from
fraction 2 up to about Iracllon 45, the yellow colour appearing in rracuon 33,
immediately following a tube of white precipitate. Cholinesterase was first
detected in fraction 67. It was detected throughout the effluent from there on, but
only on staining lor about two hours, and the staining was only faint. This time,
gels were also stained for protein. The protein appeared somewhere between
fractions 30 and 40. Presumably, the material causing opalescence and frank
precipitate in the early part of the effluent was aggregated protein that had
passed through the filter paper but would not enter the polyacrylamide gel. li s
appearance in the effluent very soon after puting lhe serum onto the column and
well before the yellow colour (albumin bound to bilirubin) would be explained by
its Inability to enter the DEAE-Sephacel beads . The eluted cholinesterase peak
seemed 10 contain more this time in that more fractions showed heavy staining
on PAGE. Fractions beyond the cbounesterase > and completely overlapped
narrower peak 01other proteins - were examined for the presence of another
protein peak beyond. No such peak was found, confirming thai all the proteins
remaining on the column after rinsing with the (pH 4.0) buffer were lifted off with
the cholinesterase by 1 M NaCI in buffer.
In future, all serum was diatysed against buffer directly, without adjusting
the pH firs!. In the next run 500 ml was tried. After dialysis it was filtered through
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coarse filter-paper, laid on scinlered glass and layered with diatomaceous earth ,
using low vacuum . The effluent from the column was again checked for evidence
of cholinesterase overnow. The intensity of cholinesterase staining was
compa red with that from serum on the same gel. After the usual blank vo lume , a
slight trickle of Ihe enzyme was de tected throughou t the effluent , as before . It did
not increase in concentration towards that of the serum, so the capacity of Ihe
column did net seem to have been exceeded and a furthe r three batches of 500
ml of serum eac h were processed .
As was mentioned earlier, opalescence was noted not only in the early part
o f the effluent when running the serum into the column, bu t in a portion of Ihe
eluate coinc iding with the cholinesterase peak. Th is proved to be usefu l in
identify ing which fracllons to exami ne 10 lind the cholinesterase. With 500 ml
batches of serum, the pattern was very clea r-cut. A clea r fraction wou ld be
followe d by the most densely opalescent one, and in following fract ions the
opalescence would gradually fade away . The tirs t fraclion slaining heavi ly for
chol inesterase was always either the one with maximu m opalescence or the next
one, though Ihe one showi ng the mos t cholinesterase stain ing would be a few
tubes late r. The detection 01 cho linesterase and other proteins in the eluted
fractions is illustrated in Figs 1a and 1b, in which duplicate gels have been
stained for cholinesterase and pro tein respectively . The first lane was loade d with
5 III of serum and the others with 5 III eac h of representativ e fractions across the
cho lines terase peak. II is clear that the peak fractions conta in more
cholines terase and much Jessprotein than the serum.
Afle r Ihe tourth batch of 500 mt of serum had been processed , the
cho lineste rase-containing fractions save d from all runs were pooled. Some white
materia l was notice d on the bottom of the bottle containing the fractions from the
very first run. In case this was DEAE-Saphacel beads to which cholinesterase
would bind when the salinity was decreased, the whole pool was filtered throug h
coarse filter paper. It was then dialysed against the DEAE-Sephace l column
buffer 10 remove the 1 M NaC!. Despite the fact that all this mate rial had been
Fig. 1. Polyac rylamide gel electrophoresis of serum and chonnesterase-
containing fract ions eluted from the OEAE-Sephacel column
The figure shows duplicate gels: (a) stained for serum cholinesterase with
c-naphthylprcpicnate'sast Red, (b) stained for protein with Coomassie Brilliant
Blue R. The lane on the far left contains 5 nl, of human serum and the others
contain 5 )JL each of fractions 68, 69, 72, 75, 78, 81, 84, 87 and 90 counting Irom
the entry of the eluting 1 M NaCI into the top 01the column. The fractions were
collected over 8 min each at a flow-rate 01 about 22-23 mlJhr. In (a) the fastest
band in the serum lane is albumin. which shows slight esterase activity with
c-naphmylprcpionate. The other bands in (a) are all serum cholinesterase. (See
Section 1.5, p. 11) lor a disccussion of the multiple bands of serum
cncltneeterase.) The sharp leading edge to the serum cholinesterase peak is
illustrated by the difference between the adjacent fractions 68 and 69. Fraction
72 contains much more cholinesterase and there is a long tail.
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dialysed against this buffer before (when it was serum) more precipitation
occured in the dialysis bags this !lrne. The solu tion was therefo re filtered again
(through Wha lman No.2 filler paper ) before being applied to the column again.
In the meantime, of course, the 1 M NaCl had been washed cut 01 the column
with buffer . The t:'holineslerasa solut ion was followed with more buffer, and then
elution with 0 .06 M Nael in buffer was begu n. The flow-ra te, measured when tho
solution was going into the column, was 22.54 ml/hr . Ailihe effl uent was kepi and
lested In case of column overf low, but no cho linesterase was detected. despite
Ihe fact that there had been a steady small leak of cholines terase when serum
was being loaded on to the column . Dur ing elution , 12-minule fractions were
collected, sta rling at No. 1 again from the tlme that the 0.06 M NaCI star ted
enterin g the column. T he cholines terase appea red in fraction 109, was mo st
abundant in fractions 112-121 and diminished in a tong tail. Fraction 193 was the
last in which the enzyme could be detected within one hour. Tesling every third
tube, protein staining with Amido Black was only seen in fractions 112 an d 115,
which showed lightly-st aining bands of low molecular weig h!. Aller approxima tely
918 ml of 0.06 M Nae l in buffer had passed into the gel and no second peak of
protein had been detected, 1 M NaGI in buffer was run through. No more protem
was found. Fractions 109 -163 were pooled and dialysed against affin ity colu mn
buffer.
2.1.5.3 Affinity chromatography
The choli nesterase solution (about 250 ml) was loaded onto the affin ity
column and al1the effluent was saved in case of overflow. As all the eff luen t was
collec ted in o ne beaker, which would lead to dilution of any cboltaesterase that
might ov erflow from the column toward s the end of loading ,S, 25 and 50 pI
volumes were examined (by PAG E and staining as usual) and the " aining wi lh
the larger volumes at one hour was considered sufficient 10 warrant keeping the
effluent to pass through the column r.jain .
Twe nty 1 ml volumes of 0.4 M NaCI in affinity column buffe r were pul on to
79
the column and twenty 1 ml fractions collected , the expectation from the small-
scale trials being that thIs wou ld elute other prote ins but leave the cholinesterase
on the column . Then twenty-f ive 1011volumes of 0.4 M choline were put onto the
column to elute the cholinesterase and an equa l number of tractions collected.
Cholin esterase was present in all tourty -nve fractions . Disappointingly, much of
the enzyme eluted with lhe sod ium ctncnoe . the 71h to 201h fractions showing
staining in only three minutes. Other proteins were indeed eluted . They were
seen in the 4th to 81h fractions only , with only a trace in the 8th. See Fig. 2. In the
fractions collected after changing the elutant to choline, cholinesteraso
decreased in the first three, then inc reased aga in, being greatest in the next two
fractions , and then tailed down again . Slight protein slaining was seen in the 4th
to 6th of these but the position of the staining sugges ted that this was
cholines terase . The 4th to 8th fractions eluted with NaCI were pu t aside lor
further treatment and all of the other fourty fractions were pooled. Then the
choline was rinsed out of the colum n with 1a ml of buffer and ten more 1 ml
fractions were collec ted. Cholinesterase was detecte d in the first five of theca
and they were added to the pool.
The effluent con taining cho lines terase was then passed through the column
again. Again all the effluent was co llected, but no overflow was detec ted. This
time a more cautious approach was adopted in elution. As before , fractions were
collec ted after puli ng each 1 ml of elutant onto the column. First 20 ml of 0.1 M
NaCI in buffer were passed through, then 20 ml of 0.2 M and then 20 ml of 0.3 M
NaC1in buffer . In fractions 1-20 , a ve ry little cholinesterase was detected in 4 and
5, but other proteins were found in fractions 4-7. In fractions 21-40, there was a
lill ie cholinest erase in 25-27 , but other protein in 24-27, Ihou gh not nearly as
muc h as In the previou s peak . In the next twenty, alternate fractions were
sam pled and cholinesterase was seen in fractions 46-58. There was more than in
the previous two littre peaks, though still not very much, but no other prote in was
detected. Another 20ml of a.3 M Nac1 in buffe r was passed through the column
but no more cho linesterase or other protein was found.
Fig. 2. PAGE ot the first 10 fract ions eluted ' rom the affin ity co lumn wi th 0.4
MNaCr
The figure shows duplicate gers: (a) stained for serum cholinesterase with
u-naphltlylpropionale/Fasl Red, (b) stained for protein with Amido Black. The
fractions were of 1 ml each. Each lane was loaded with SilL
ab
I
I
J
81
82
Then fractions were collected with 20 mt of 0.3 M choline in buffer. Alternate
fractions were sampled . Cholinesterase staining appeared in fractions 86-92
within nine minutes, and in all fractions sampled by one hour. No other protein
was detected in any of the frac tions sampled. Rather than collecting a tail of
cholinesterase with this concentralion of choline, with diminishing returns, twenty
fractions (101- 120) were collected with 0.4 M choline in buffer. Sampling of
alternate fractio ns showed cholinesterase staining in 106 and 108 at 4.5 mlnu tee
and in all fraclions by one hour, with a peak in 106. Fractions 81-120 inclusive
were added to the cholinesterase pool and fractions 1·BO were discarded. The
column was then rinsed with 4ml of affinity column buffer and the efffuent run
straight into the pool. It was then rinsed with a further 25 ml of buffer to flush out
any remaining choline. The effluent was checked for cholinesterase and found
negative. The corumn was then ready for reprocess ing the fractions saved
earner.
The live cholinestera se-bear ing fractions from the first pass not put into the
pool conta ined the most cholinesterase but also the most protein. They had been
eluted with 0 .4 M NaCl (in 0.02 M bUffer) so the 5 ml volume was made up to 100
ml with water to reduce the molar ity to approximately 0.02 M, and then passed
back through the column. 50 and 100 IJI ccrucne of the effluent were Inspected
by PAGE. Traces of protein were detecte d, but no cholinesterase. Twenty 1ml
fractions were collected from the column with 0.2 M NaCI in butte r, to elute the
other proteins, and then twenty 1 ml fractions were collected with 0.4 M cho line
to elute the cholinesterase. In the first twenty fractions proteins were detecte d
with amide black in 4· 7, but cholinesterase was also found, starling in fraction 3,
coming 10a peak, visible within ten minutes, in 5 and tailing away by 17, in which
none was detectable at one hour. In the second twenty fractions alternate ones
were sampled and cholinesterase stain ing appeared in 24 and 26 in 3 minutes
and in all fractions tested by 10 minutes. There was enough cholinestera se in
fraclion 24 for it to be detectable with amido black, but no other pro tein was
found in these fractions. Fractions 3, 8·11 and 21·40 were added to the
cholinesterase pool.
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The c holinesterase solu tion (114 poo led fractions) was first dia lysed aga inst
10m M am monium bicarbonate . The idea behind this was tha t the solu tion cou ld
the n be freeze-dr ied and that the ammonium bicarbonate wou ld evaporate (as
am monia, carbon diox ide and water) leaving the choli nesterase 10 be rediso lved
in a much smaller volume. However, as the frozen solution became more
concentrated, it melted. The aim 01 purification was of course to ensure that
whe n the solution was used to imm unize a rabbit the ove rwhelming majority of
anti-human antibodies were against cholinesterase rather than contaminating
prote ins. Th e concentratio n achieved by the freeze drying cou ld have ele vate d
any contaminants from undetecta ble to de tectable conce nt rat ions. A small drop
of the concentrated solution was taken and serial one-i n-ten dilutions were made
with elec trophoresis buffer and exam ined by PAGE and staining with am ide
blac k, the idea being to est imate the number of orders of magnitude that the
choline ste rase was more concentrated than any contam inan ts. Howev er, a si ngle
cholines te rase band was seen in the first lan e and no bands were seen at any of
the dilutio ns . (A dup licate gel was staine d for cho linesterase activ ity . The slain
appeared in the fi rst two lanes within 4 rnm., and in decreasi ng intensity down 10
10-7 by 1 hr .)
The solu tion was then dialysed against 'normal saline ' (0.9% NaCI) . In tho
meantime a gel was prepared to illustrate the single cholinesterase band in the
sol ution of purified enzyme beside the mult iple bands of untreated se rum. When
it was des tained to remove background stai n, il beca me apparent thattbere was
anot her fain l band, indicati ng a low mo lecular weigh t contam inan t in the
cho lineste rase solut ion. See Fig. 3.
2.1.5.4 Gel filtration
The c holineste rase in normal saline solu tion was freeze-dried again, and
redi solved in a sma ll volume of delonised water for applica tion to a gel-filt ra tion
col umn. A Sephadex G75 colum n, 16 x 1 em was equilibrated wilh 200 ml 01
0.9 % NaCI. The cho linesterase solulion was lhen applied to the column and
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Fig . 3. PAGE of part ially puri fied cho linesterase after affin ity
chromatography compared wit h untreated serum
Left, human serum; right, partially purified serum cholinesterase. The gel is
stained for protein with Amido Black.
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eluted with further 0.9% NaG!. On electrophoresis, no protein was detected apart
from (he cholinesterase in the cholinesterase -containing fractions, and they were
pooled.
2.2 Estimation of the concentration of the purified enzyme
This was done in two ways . One was the Bio-Had Protein Assay Kit NO. 1
'standard assay procedure' (Bia·Rad Laboratories (Canada) Ltd.). This assay is
based on the observation that the absorbance maximum for an acidic solution of
Coomassie Bri lliant Blue G-250 shifts from 465 nm 10 595 nm when bind ing to
protein occ urs. The other method was the absorbance method which was used
by Lockridge and La Ou (1978) for their purified cholinesterase. In this the protein
concentra tion is calculated fro m the abso rbance at 280 nm using an extinction
coerncle nt of 1.8 cm-t lor a 1 mg/m l solutio n. Presumably by sheer chance the
results by these two methods were the same in the lirst three places of decimals:
1.072 mgfL. The spectro photometer used was a Philips Pye unlearn SP6·550.
With the more advanced Beckman Du-70 spec trophotometer used later to look at
the UV spectrum of the protein (see Chapter 3, p. 96) the resu lt was 0.988
mgfml. As ne ither metho d warrants this kind of accuracy, the found figure of 1
mgfml was adopted.
2.3 Raising antiserum
Antise rum was raised in a 4 Kg female New Zealand white rabbit. The inhial
dose was 1 mg 01the purified human se rum cholinesterase in 1 ml 0.9% NaCI in
an emulsio n with 1.25 mt Freund's comp lete adjuvant administe red in two i.m .
gluteal injec tions . A booster of 1 mg cho linesterase in alum suspension was
given l.v. afte r 16 weeks and a further booster of 1 mg choli nesterase in an
emulsion with 1 ml Freund's incomplete adjuvant in 2 i.m. gluteal injections after
a further 7 weeks. The antiserum used in this work was taken 5 weeks after the
secon d boos ter.
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2.3.1 Preparation of antigen emulsions
The emulsions of the chonnesrerase solution with Freund's adjuvant
(complete or incomplete) were formed by forcing the two liquids to and fro
between two glass syringes though a narrow connector. In order to produce a
water-in-oil emuls ion it is necessa ry to add a volume of the aqueo us antigen
solution equal to about half the volume ot rhe oily Freund's adjuvant at first, only
adding more antigen solution after thorough mixing, and then in at least two
portions. In all, the liquid has to be passed though the connector several hundred
limes. The formation of a water -In-ell emulsion was tested by putting a small drop
of the emuls ion onto the surface of water in a beaker. If a water-in-ca emulsi on
has been formed the drop will remai n discrete, bu t if emurerrcaton has not been
successful (t.e. an oil-in-water emuls ion has formed ) the drop will rapidly spread .
If all the required ant igen solution had been added and a water-m-oil emulsion
had not formed after prolonged mixing, a little more of the Freund's adjuvant was
added.
2.3.2 Preparation and administration of antlqen-In-atum
suspens ion
The suspension was prepared as follows. 1 ml of the 1 mg/ml serum
cho linesterase solution was mixed with 2 ml of 0.5 M sodium bicarbonate and
then 1 ml 01 10% aluminium hydroxide was added drop-by -drop with constant
mixing. The mixtu re was then left at 4°C overnight and formed a gel. The gel was
washed three times with phosphate -buffe red sa line (PBS: 0.8% NaCI, 0.05 M
NazHP0 4), 5-10 ml each time, by mix ing, centrifuging and removing supernatant.
The gel was resuspended in about 1 ml of PBS.
Before l.v. administration of the suspe nsion, prophyla xis aga inst
anaphylactic shock was given. The antihistam ine tripelennamine hydroch loride
(Vetaetirn') was used at a dose of 1 mg/Kg Lv.
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2.3.3 Use of Ouchtcrlony gels to monitor anti body titre
Ouchterlony gets were used to monitor antibody titres. These were
composed of 1% agar In PBS poured onto a glass plate . (15 mt was used on a
plate 1.25 inches square .) The plate fitted lntc a dev ice which enab led wells 10 be
bored at regular intervals in a honeycomb pattern. Antiserum could thus be
compared with up to six dilutions of human serum in surrounding wells and
different batches of antisera, each with surrounding wells of diluted human
serum, cou ld be compared on the same gel. The same volume of antiserum or
diluted huma n serum was used in each well. The gels were kept in moist air in a
closed container and incubated at room temperature lor up to fOUT days.
Between any pair of wells, the higher the antibody titre in the antiserum the
nearer would the precip itin line be to the serum well, and the soone r would the
line become visible. After the second booster, the titre continued 10 rise for the
first four w eeks . The titre at five weeks was sligh tly less than thaI at four wee ks
(though greater than that at three weeks) and the rabbit was exsanqulna teo the
fo llowing day.
2.4 Radial immunodiffu sion
In this technique gels are ma de which con tain antise rum. Solution
containing antige n is placed in well s in the gel and antigen diffuses out until il is
all immobilized by lmmuncpreccltauon. At this time the area of the
immunoprecipitin ring is proportion al to the amount of antigen in tho lnnocuium
(Mancini at aI" 1965). Agar must be brought to the boil to melt it but the
temperature would denature the antibodies so the hoi gel has to be cooled to a
temperature at which its solution is still liquid but which will not dena ture the
antiserum.
2.4.1 Method of making gel s
Agar was used for the first radial im munodiffusion gels but, while working on
the technique, agarose was tried and round to be easier to handle, disol ving
much more readily, and was always used thereaft er. The method used was as
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follows. 2% agarose was made up in 0.15 M NaCI conta ining 1% sodium azide
and olsotvec by bringing 10 the boil in a microwa ve oven. Enough agarose for
many gels could be made up in a conical flask and stored in a refrigerator ,
melting in a microwave oven on subsequent occasions . A beaker was tared on a
balance with a sheet of polystyrene foam on the pan for heal insulation. The
appropriate amount of 2% agarose for the numbe r of gels to be poured was then
weighed into the beaker (plus a lilli e exira because some would remain on the
sides of the beaker - 4% exir a was found to be ,enough) , covered , and left 10cool
in a 54°C waterbam. (A plast ic Petri dish served well as a beake r lid.) A second,
slightly heavier beaker was then weighed without changi ng me taring of the
balance, This was used to contain a solution of antiserum of twice the
concentra tion requ ired in the gel and exactly the same volume as the weighed
2% agarose, including the exira 4%. The solution was made with the same 0,5 M
NaCl, 1010 NaNj as for the agarose. As the bottle of this saline solution was kept
refrigeraled a little less than the required amount was weighed our, warmed
slightly in the microwave oven, and made back to the same weight with drops of
deionized water from a Pasteur pipette to replace evaporation. The approp riate
amount of antiserum was then added and the solution made up to the requ ired
volume with the saline from a Pasteur pipette. This beaker was then covered also
and placed in the same waterbalh to warm.
After half an hour the beaker containing the antiserum solution was litted
from the waterbaih . its outside dried, and its content s poured into the other
beaker and the solutions were mixed with a epatuta warmed by running hot tap-
water. Condensed water on Ihe sides of the beaker was returned to the mixture
as much as was practical. Then the baakercontaining the mixture was removed
from the bath, its outside was dried, it was placed on the balance and the
evaporative loss made up with deionized water. lt was then rapidly returned to
the bath, stirred and covered again. The mixture now contained 1% agarose and
the required concentration of antiserum. The balance, still bearing the sheet of
polystyrene foam was now tared to the weight of a plastic Petr i dish. The gels
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were then poured. The dishes were J 7/ 11>inches (8.75 em) intern al diameter and
8 9 of gel was weighed into each dish . The dishes we re pre -warmed in a 37PC
oven . The procedure for each was as follo ws . The beaker of gel was remo ved
from the beth and its outside dried 10 prevent bath-water from running in to the
dish. The gel was weighed into the dish and the beaker covered again and
returned 10 the bath. Then the dish was removed from the bata.tee, lilled in a
rotary manner 10 spread the gel even ly. and placed on a table 10 cool , partiall y
cove red by its lid . T he next dish was It-en taken from the oven to the balance and
the tare adjus ted.
When the gels had set, wells were bored. If the wells were to be bored the
same day, the gels were left in a refrigerator fo r at least ha ll an hour as the gel
was soft at first and tended to lear. If kept overn ight , they were stored in a moist
atmosphere to prevent dry ing (a screw -topped jar with wet paper at the bo ttom).
19 wells of 3 mm diameter were cut in a hexagonal array as in Fig. 7 (p. 105,
legend no t relevant yet) with 1.5 em between the centre s of the wells. The wells
were bored ma nually , with the layout of the we lls on a piece of paper under tho
dis h as a template , and the cores were rem oved by conne cting a syr inge to the
end of the borer .
2.4.2 Dispensing samples
A Ziptrol 'del ivery system' (Drummond Scie ntific Company , aroomhatt ,
Pensylvanla) was used for loading the wells. Co nsisting o f a glass capillary lube ,
S wire piston and a scale (1-5 1Jl) , this device is very simple and very accurate. It
has the advan tage over orpceabre-up mlc rcptpe ttes of having direct conta ct
between liqu id and piston , and the advantage over the Hamilton syringe of
having no dead-s pace. Before dispens ing each samp le the capilla ry lube was
wiped to remove drops on the ou tside . After dispen sing it was wiped again berore
inserting into the next serum sample . !t was then rinsed with the new sample
three times to remo ve any traces of the previous sam ple on the inside surface of
the tube.
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2.4.3 Measurement of ring area
Mancini st al. (1965), the authOrities on radial immunodiffusion, pro jecte:!
the magnified silhoue lles of the precipitate rings onto cardboard paper, drew
round them with a pencil, cut them out and weighed them. They said thai this
was better than merely recording diameters because the precipitates may depart
from ideal circular shape. II is however very nme-consumlnq and impractical if
many measuremenls are made. In this study tna diameters of the prec ipitates
were measured in two directions at right angles and the mean taken. The
measuremen ts, in tenths of a m Illimetre, were made with a 'calibrating viewer'
(Transidyne General Corporation , Ann Arbor, Michiga n). To calculate the 'area'
the mean diameter was squared and the square of the diameter of the well (t.e.
900 square tenths of a millime tre) subtracted. Division of the diameter by 2
before squaring, and multiplication by n, were unnecessary as they apply to all
measurements equally. The reaso n for subtracling the (constant) area of the well
is given in Section 4.2.1• p. 136.
2.4.4 Other detail s
The concen tration of ennsenm in the gels , time and temperature of
incubl'ltion, and time of staining are given in Chapter 3 after description of
preliminary experimen ts. Samp le volume, calculation of concentration of
cholines terase . contr ol and error estimates are discussed in Chapter 4.
2.5lmmunoprecipitation
Immunoprecipitalion of prote in in human serum with the rabbit anti-human-
serum-chol inesterase antiserum was carried out essentia lly by tile method
described in Davis at al. (1986). The procedure WASas renews. In each of two
tubes 5 j.ll of human serum were mixed with 10 III o r preimmune rabbit serum and
35 1.11of immunoprecipitation buffe r (see below), the tubes were centrifuged to
bring the mixtures back to the bottoms of the tubes. and incubated for ten
minutes at room temperature . Then 20 III of an approximately SO/50 v!v
suspension ot protein A·Sepha rose 'beads' (Pharmacia Fine Chemica ls, Inc.) in
AIPA buffer (Perbal, 1984) was added to each tube 10 remove any resultant
nonspecific immunoprecipilates and the tubes were incubated for 30 min at 4°C
on a slowly-turning rotor 10 invert them gently. Then they were centrifuged and
the supernatants removed to fresh tubes. This step was repeated. To one tube
40 1-11 of rabbit antiserum was then added and to the other a further 40 ~d of
preimmune rabbit serum and the contents were mixed, spun down, and
incubated overnight at 4°C. For removal of the immunoprecipitates after
incubation a further 20 1-11 of the protein A-Sepharose suspension was added to
each tuba and they were again incubated on a rotor at 4°C for 30 min. Belore
electrophoresis the supernatants were removed from the protein A-Sepharose
beads and saved and the beads were washed 7 times, with 250·500 ~d of
immunoprecipitation buffer each time, before being resuspended in sample buffer
(see next section) like all the other samples.
The constitution of me immunoprecipilation buffer was 5 mM
tris(hydroxymethyl)aminomelhane (hereafter referred to as 'trts'), pH 7.5, 0.15 M
NaCl, 1% Ncnldet P·40, 2 mM EDTA. 'Nontdet P·40' is a non-ionic detergenl,
used to stop protein aggregation which could cause inappropriate precipitation.
The EDTA is Included to chelate divalent cations.
2.6 Sodium dodecylsulphate-polya crylamide gel electro-
phoresis (SOS.PAGE)
The method of l aemmli (1970) was used with a vertical slab-gel apparatus
(gel cross-section 1.5 ~ 140 mm). The ecrylamlde concentration was 3% (wfvl in
the stacking gel and 10% (w/v) in the separating gel. The sample buffer
contained 2% 8DS, 5 % z-mercaptoethancl, 1()1l/o glycerol, 50 mM Tri::;-HCI, pH
6.8 and 0.1% bromophenol blue at final volume. The samples were heated to
100°C for 4 min before electrophoresis at 20 V overnight. The molecular mass
markers used were those of the Pharmacia High Molecular Weight Calibration
Kit. The other solutions used were as follows:
Acrylamide solution: see 2,1.2.1, p. 62
sa
'Lowe r tris ( ~4) ' : 1.5 M Trls-Hot , pH 8.8 +0.4% 5 0S
'uppe r Iris ( -4)': 0.5 M Tris-Hel , pH 6.8 + 0.4% 5 DS
Tris-glycine reservoi r buffer ( ><4): 12 9 Iris base + 57 .6 9 glyci ne made up 10 1
L with deionised water . 0.1% 8 0S is inc luded when dilutin g to " 1.
Ammonium persulphale solution: 10% w/V, made up immediately before use
The gets were m ade up as follow s:
Lower gel
Mix 1 ~.3 ml acrylamide solu tion
5.0 mllower Iris (><4)
2.8 ml water .
'De gas' the solution under v acuum.
Add S ilL TEMED.
Make up 10% ammon ium per eup hate and add 0.6 mf.
Mix . Pour gel. Layer Isobutan ol on top of gel while preparing upper gel. (N.B.
The lsobutanot is stored with water. T he lsobutanol is the lop laye r.)
Upper gel
Mix 1.5 ml acrylarmde solution
1.87 ml upper tris ("4)
100 11 L 0.1% brcmopheool blu e
2.82 ml wate r.
Degas. When lower gel has set, rem ove isobulanol.
Add 7.5 fl l TEMED
112 III 1i)0f0ammoni um persulphate.
Mix. Pour gel. Inse rt comb.
A 20-loothed comb was used. The lanes were loaded palindromically, so that
one half was the mirror image of the other (for contents of me lanes, see Section
3.4.1, p. 107). After electrophoresis the gel was cut in hall using the teeth ollha
upper gel as a marker . Then the upper gel was removed. The left hall of the
lower gel was then stained with Coomassie blue for 7 min and destained in three
lots of 10% acetic acid, 20% methanol over about 20 hrs. During staining of the
left half, the right half was bathed in transfer buffer (see below) prior to western
blotting.
2.7 Western blotting
Western blotting (Burnette. 1981) was carried out using nuroceuurcse filler
(Schleicher & Schuell , lnc., Keene, NH 03431, USA) and a current 01150 mA for
about 18 hrs. 1COlo goat serum in PBS was used for blocking, and qoat-antl-
rabbit-Ig antibodies linked to horee-raddieh peroxidase (Jackson
lmmunoResearch l aboratories, Inc, West Grove, PA 19310, USA) as the
indicator system. The protein marker lane on the blot was cut off and stained wnh
amide black before the rest of the filter was exposed to antibodies. AI values
Were calculated for the marker bands from the blot and the gel and averaged to
plot a calibration curve from which molecular masses of proteins on gel and blot
were estlmated. Further details were as follows:
Transfer buffer: dilute 1 L of tris-glycine reservoir buffer (" 4) as above to 4 l but
add enough SOS solution (e.q. 10 ml of 5%) 10 make final (5 L) volume only
0.01%. Add 1 l methano l.
After transfer (blotting) the gel was stained with Cocmasate blue for 2 min and
cestained to check that transfer had been complete. No protein was lef! in the gel
except a little at the origin in some lanes. After blocking the filler for 1 hr (in a bag
containing 10 mt of the 10% goat serum, on a rotor, at room temperature), 50 III
of the rabbit antl-human-eerurn-chollnesterase antiserum was added 10 lhe bag
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and incuba ted for 1 hr (on the rotor, at room temperature). The filte r was then
given 4 tan-minute washes, the first , second and fourth of 100 ml PBS each. the
third of 100 mJ triethanolamine buffer (50 mM triethanolam ine-Hel pH 7.4 . 100
mM NaCI, 2 mM EDTA, 0.5% Triton X-100, 0.1% 5DS, Otta viano and Gerace
(1984), which is more stringen t). It was then blocked again with the 10% goat
serum, incubated with the secondary antibod y solution (above), 20 J.lL in the 10%
goal serum, and washed again before staining for peroxidase thus: weigh .24 mg
of t- ctnorc -a-metnyl naphthol into a tube ; add 8 mt methanol; pour lntc 40 ml
PBS; add 20 f,lL of HzOz and pour on to filter immediately.
2.8 Subj ects
The Janeway Hospital Chemistry Laboratory receives blood samples for
estimation of serum lipid profiles from a large area and has for a num ber of years
measured serum cholineste rase activity of these samples routinely. The staff
kindly saved samples for this slud y after these estimations had been made and
checked. 282 of these patien ts were included in the study and their ages ranged
from 8 1086 years. Further description will be given ill Chapt er 5.
For comparison, 117 blood donor samples were also assayed . When blood
is donated, the collecting-bag contains anlico agulent but at the end of collection
the tube is clamped and blood is milked from the tube into a containe r without
anticoagule nt and tested for evidence of H1V, neoenne and syph ylis. These
samples were released for use in this study immediately afte r testing. The ages
of the individual donors were not availab le, but the limits for donors are 17 · 70
years (up to the 71st birthday).
Pooled serum from another 56 blood donors was used as a secon dary
standard in estimat ion of serum cholines terase concentration.
2.9 Statistics
The calculations of statislics and displays of data used in interpretation were
made wi th the use of the compute r software 'Minilab', VAXf\l MS version (various
editions, Minilab Inc.).
"Chapter 3
RESULTS (1)
Cholinesterase impu rit ies, antiserum spec if ic it ies
and
immunological variat ion of serum cholinesterase
3.1 Initial inspection of the purified serum cholinesterase
On PAGE of the product of the last stage of purification, only one protein
band was seen (Fig. 4). The ultravio let absorbance spectrum was then examined
with a Beckman DU·70 spectrophoto meter (Fig. 5). There was a peak at 275.6
nm. a trough at 251.1 om, and a sma ll shoulder a1289.5 nm. This result was lIery
similar though not identical to that obtained by l ockridge and La Du (1978). They
reported a peak at 280 nm, a trough at 254 nm and a small shoulder at 290 nm.
3.2 Initial trials of the antiserum for serum cholinesterase
concentration measurement
3.2.1 Immunot urbldlty
It was originally hoped 10 use the antiserum to measure serum
cholinesterase concentration by immunoturbidily with the IL Monarch
autoana lyser wi th which cholines terase activity and serum lipids were measured
(for details see Chapter 4, p. 128). There are kits for measur ing the
concentrations of several other proteins on this machine and the manual gives
details of how to set up new tests. An initia l attempt was made to develop such a
method for serum cholinestera se. The details will not be given here because the
method was not SUbsequently used, but the attempt was importa nt because it led
to an investigation of the purity of the purified cholinesterase and the speci ficity of
the antiserum. Very poor corre lation was found between the imrnuno turbldtty and
activity measurements of serum samples and after carefully examining the
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Fig. 4. PAGE of the serum cholinesterase after gel filt ratio n compared wit h
human seru m
Left, 10 ut, of a 50/50 mixture of human serum and 20% PVP; right , 5 119 of the
purified human serum cholinesterase (5 IJL, 1 mg/ml) after gel filtration. Both
lanes are overloaded to improve detection of faint bands . The stain is Coomassie
Brilliant Blue A.
Fig . 5. Ult ra violet absorptton spectru m o f the pu rif ied seru m ch o lineste rase
Panel a shows the spectrum from 200 10300 nm. The large peak on the left is
due to absorption by Ihe peptide bonds; the top is truncated. The peak on the
right is due mainly to aromatic rings and is generally more useful in distinguishing
different proteins. Panel b shows the second peak on a larger scale (line A) and
the first different ial (line B). The vertical scale runs from 0.500 to 2.000 for A. For
some reason not explained in the manual of the spectrophotometer I this
instrument plots the differential in reversed sense, l.e . upside down, and zero for
that curve does not correspond to one of the lines on the grid. However, the
shape of the curve is otherwise correct and serves to define the position and
single nature of the small shoulder.
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method for other source s of error it was decided to check (hean tiserum by tryin g
another method.
3.2.2 Radial immunodiffusion
The antiserum taken five weeks after Ihe final booster w as chose n for the
Initial tri al as it would have a h igher an tibody t it re than the serum from Ihe fina l
bleed and there was m ore of it than the slightly higher titre se rum collected th e
previous week. This an tiserum was subsequen t ly used in all the restot the work.
Two o f the fac tors that come into pray in deciding the precise para m eters o f
maiertats in rad ial imm u nodiffusi on are b alancin g the w is h to conserve an tiserum
with Ihe need to produce a visible imm unopre c ipilate and the need to produce
precip iti n rings large e nough to givea reasona b ly sma ll measurement error but
not so la rge as to interfere with one ano ther. As antigen diffuses out from Itle we ll
and an ti body b ecome s incorpo rated in to prec ipitate, a zone surrounding the
develop ing immunoprecipifate forms that is retatively deficient in antibody and a s
precip iti n rings from neigtlbouri ng wells approach one anothe r lhey eventually
come into a region m utually depleted and the rings will bul ge towards one
another and, if there is enough antigen , fuse (Heremans, 1971). Variat io ns were
made in amoun t of gel in the dishes , size of we ll, volum e of inoculum, dil ution o f
antiserum and d ilution of serum in order to find the op ti mum par amete rs for the
antiserum used.
The first satisfactory rings with blood dono r sera were produced a t ratios o f
concen tr ancn of antiserum to concentration o f serum inoculum of 1:4 to 1:8. It
was then seen that aro und most wells t here we re two r ings. In a few cases on ly
one rin g was visible, an d In a few cases three. T here was no correlation betwee n
the se rum cholinesterase activity and the a rea of the outer ring, and the
correla tion wilh the area of ltle inner ring was o n ly 0.21 (p c 0.05) . Howe ver, bot h
ring areas correteted w ith the immunoturb ldily, wi th r '" 0 .61 for the outer, 0.48 for
the inner, bot h p c 0.001. The obvio us concl usion was th at the a nt iserum
contained ant ibodies agai nst two ncn -chojneeterese human serum proteins ,
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despite the tacttha t serum cholineste rase was the only p rotein detected in the
purif ied prod uct with which the rabbit had been immunized. This prompted further
investigation .
3.3 Simple tests of antiserum affinity
The immediat e questions were of w he ther the antiserum contained any
anti bodies a gainst serum c holinesterase an d. if S0, whether they inactivated the
enzyme. Three exper iments were set up. The Ouchterlo ny gel used \0 mon itor
the antibody litre in the antiserum was stained for cholinesterase, a radial
imm unodiffusion ge l was stained fo r cholin esterase, and human serum reacted
with antiserum or pr e-immu ne rabb it serum was subjected \0 etec trcpnorests 10
see whether the choli nesterase activity was remove d.
The O uchter lony gel was was hed in fo ur changes of 1M NaCI over 5 days
to remove unprecip ltated pr oteins before sta ining. The res ult is illustrated in Fig.
6. It shows that the precip itated cholineste rase is confined closer to Ihe serum
wells than the precipitin li ne previous ly pr esumed to be cholinesterase. The
phot ograph h as de tected another precipit in line much close r 10 the antiserum
well , though this had not been noticed with the naked aye. A preclptm line is not
the boundary of diffus ionof antigen from the serum well; it represents the point of
equ ivalence , where the concent ra tions o f antigen and antibody (diffusing in
opposite directions ) are equal an d lhe greatest precipitatio n occurs . The
choli nesterase stain appears wherever there is an act ive mole cule of the enzyme
so is visible further away from the serum well than tile prec ipitin line would have
been if it co u ld have been seen. T his is un doubte dly lhe reason why the slain
overlaps the most prominen t precipitin line in some places . The two precip itin
lines and the cholineste rase front ar e all diffe rent shapes, related to their re lative
distances from the serum and antiserum wells. These exptanauons are obvious
with hindsig h t, but at first the appearance w as interpr eted as meaning that the
gel h ad not b een was hedfor long enough .
The similarly w ashed and stained radi a l immunodiffus ion gel is illustrated in
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Fig. 6. Ouch ter lo ny gel stai ned for se rum ch olinest erase
The central well in each rosette contains rabbit antiserum from successi ve weeks
after booster immunization ; top left one week to bottom right five weeks . The
peripheral wells contain dilutions of human serum with isotonic saline. The top
well in each rosette contains undiluted serum and then in clockwise order 1/2
dilutions to 1/32.
103
Fig. 7. The cholinesterase slain was confined to a th in line round each well. In (a)
the photographic sensitivity was increased to show the oute r non-cholinesterase
precipitin ring. (The inner ring had faded by the lime the gel was stained and
photographed.) At this sens itivity the ring of slain app ears mu ch more substantial
than it did 10the naked eye . The actual appearance was mo re like thai of the ling
in the cen tre of the top line in the less sensit ive photograph (b). In case the slain
represen ted enzyme whic h had been lao highly po lymerized to enter the gel or
thai had ,101bee n bound by antibody but by ionic binding 10 the agar which had
been used for this gel. a corurot gel was set up wi th samples in the wells but no
antiserum in the gel. When this had been incubated, soa ked in saline and
exposed to stain , no sta ining was seen. This sho wed that the antiserum did
contain antibodies against serum cholinesterase.
For the elect rophoresis, 10 j.lLof human serum was mixed with 40 pl of the
immune or pre-immune rabbit serum and incubated at 37°C for 4 hr and then at
40C overnight Then approximately 50 ut, of 200/0polyvinylpyrrolidine was added
10 each tube, and to lubes containing 50 I1L of human or pre-immune rabbit
serum and the contents were mixed and centrifuged at t 4,000 r.p.m. lor 5 min.
Then the gel was loaded with 10 ut, of the superna tants from the tubas
containing both human and rabbit serum, 2 ul, from that containing only human
serum and 8 J-l L fro m that containing only rabbit serum so that the control lanes
contained the same amounts of the sera as the rea ction lanes. The gel, stained
for serum choline sterase, is illustrated in Fig. 8. It shows that human serum
cholinesterase (lanes 1 and 5) was unaffected by pr e-immu ne rabbit serum (lane
2) but was removed (by precipitation) by the antiser um (lane 4), confirming the
result of the radia l immunodi ffusion gel. (One would expect to see rabbit serum
cholinesterase in lanes 3 (pre-immune rabbit seru m) and 4 but none is visible.
Rabbit serum cho'lneste rase activity is more specific for acetyl- and
propionylcholinest erase than for butyrylcholinesterase , which was used in
staining the gel, and even with those substrates rabbit serum cholinesterase
activity is lower tha n jilat of humans (Augustlnsson, 1961). The gel was already
Fig. 7. 1 In 8 antis e rum RI D gel stalned for serum chcnnestemse
Two photographsof the same radial immunodiffusion gel with different sensitivity.
The gel contains 1 in 8 rabbit antiserum . The we lls con tain human sera.
Photograph (a) is more sensitive and shows the Petr i dish and the outer cn o of
the non-chotlneeterase precipi tin rings. The dark ring round each well is serum
cholinesterase stained with specific stain. Because of the increased sensitivity
these rings appear m uch broader than they did to the naked eye. Photograph (b)
more closely approximates the naked eye app earance .
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Fig. 8. PAGE showing removal of human serum cholinesterase by rabbit
antiserum
Lanes 1 and 5, human serum; Lane 3, preimmune rabbit serum; Lane 2,
supernatant of human serum incubated with preimmune rabbit serum; Lane 4,
supernatant of human serum reacted with rabbit antiserum. The gel is stained
specifically for serum cholinesterase.
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slightly overstalned at the time of photography. Several hours after rinsing slain
off the gel a cholinesterase band appeared in lane 3 but no band appeared in
lane 4. It appeared from this Ihal the rabbit may have developed autoimmune
echouneeteraeeeemla.)
These experiments showed thai the antiserum did bind serum
cholinesterase but did nol inactivate it. II was subsequently found that
cholinesterase precipitin rings suitable for measurement (up to about 1 em in
diameter) could be produced with undiluted serum by reducing the antleerum
concentration In the radial immunodiffusion gels to only 0.15%. They were
invisible unstained but cou ld be visualized by specific staining. As only serum
cholinesterase was stained it was not necessary to wash the gels in changes or
saline to remove the other proteins.
(This called into question the rabbit's autoimmunity status. The first 1 in 8
antiserum gel stained was pink all over. This was taken to be so because of
rabbit serum cholinesterase in the antiserum, hence the washing in saline of
another gel before staining to produce the result shown in Fig.? (p. 105). With
only 0.15% antiserum in the gels but the same quaniues of human serum in the
wells there was no background staining despite the fact thai the gels were not
washed in saline. Therefore the pink staining seen in the first gel must have been
due to unprecipitated rabbit serum cholinesterase. The non-appearance of a
rabbit serum cholinesterase band on PAGE is thus rather puzzling.)
Having discovered two trace impurities in the cholinesterase preparation , it
was decided to explore this further by western blotting.
3.4 50S-PAGE and western blotting
3.4.1 Resull s
The results of 5DS- PAGE and western blotting are shown in Fig. 9. Tho
purified cholinesterase lane In the gel (fane 1) shows two bands which
presumably correspond to the monomer and dimer. l ockridge el al. (1979) found
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Fig . 9. 80S-PAGE and corresponding western blot
Lanes from one half of the gel (a) are shown , stained with Coomassie Blue. The
other half was used for a western blot (b) with the rabbit anti-human-serum-
cholinesterase antiserum in the primary reaction. Lanes are: lane 1, purified
human serum cholinesterase; lane 2, human serum; lanes 3 and 4, supernatant
and immunoprecipitate respectively from reaction of human serum with rabbit
antl-serum-chclinasterasa antiserum, prepared as described in Section 2.5, p.
90; lanes 5 and 6, supernatant and precipitate from control reaction of human
serum with pre-immu ne rabbit serum; lane 7, pre-immune rabbit serum; lane 8,
rabbit anti-seru m-cholinesterase antiserum . Labeled bands are: Alb, albumin ;
IgGH, IgG heavy chains; IgGL,lgG light chains .
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two bands of unequal intens ity on 50S/PAGE, the dimer and a trace of monomer
in the absence of reducing agent , or the monomer and a trace of dimer in the
presence of dlthlotbrelto! or mercaptoe thanol. The sample buffer used in this
work contained z-mercaproemanol. The estimates for the molecular masses
were 98 kDa fo r the dark band and 190 kDa for the faint band. The es tima tes of
Lockridge at al. (1979) from 80S/PAGE were 90 and 180 kOs, but revised
estimates from the complete amino-acid sequence and estimated carbohydrate
content are aOOu185.5 and 171 kOa (Lockridge at al., 1987a).
Lane 4 of the gel, was loaded with immunoprecipitate from 10 limes the
volume of serum used in lane 2 but the serum cholinesterase monomer band
seen in lane 1 is not visible here. In addition to Ihe IgG light and heavy-chain
bands two other major bands of higher molecular mass are seen. The estimates
of their molecular masses are 190 and 83 kDa. These bands are also present in
the protein A.Sepharose precipi tate from the reaction 01 human serum with
prelmmune rabbit serum (lane 6) $0 are presumably also immunoglobulin
subunits. Since the cholinesterase is not completely broken down inlo monomer
it seems reasonable thai not all of the S-S bonds in the immunoglobulins would
have been broken either. The heavier band might be a single IgM subunit, which
has a molecular mass of about 180 kOa, and the lighter band might be a half IgG
(one light and one heavy chain), molecular mass about 80 kOa.
On the western blot, lane 1 shows only a faint smudge in the position in
which the major protein band is known to lie from lane 1 in the gel , indicating that
the human serum cholinesterase monomer is not very immunogenic to the rabbit.
There is a very faint line corresponding in position to the much less abundant
dimar. There is however a dark band between these postucns. lis estimated
molecular mass is 130 kOa. It Is possible that this represents the serum
cholinesterase C2 compound. The immunoprecipitate lane, lane 4, shows a lone
band of high molecular mass. The estimate was 175 kDa. It seems likely that this
is the serum chol inesterase dimer.
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In addition 10the above-mentioned bands , the western blot reveals that the
rabbi! antiserum contains antibodies 10 et least five other proteins. More
confidence can be placed on the estimates of the molecular masses of these
proteins as the log molecular mass ve. At graph was linear in this molecular
mass range and the human albumin and immunoglobulin bands in the gel give
checks of accuracy. Two of these proteins. 65 kDa (probably albumin) and 60
kna. are seen as dark bands in the lanes of human serum and
immunoprecipitate from human serum (2 and 4) but are barely present in the
purified cholinesterase (lane 1). Two others, 53 and 46 kDa, are seen as dark
bands in Ihe purified cho linesterase lane but only lightly in me human seru m and
lmmunoprecipitate lanes, and a further band , 16.5 kOa, is seen only in Ihe
purif ied cho linesterase lane. The blot shown is a repeat of an earlier blot not
used because some of the other lanes were seen to be over loaded in the
corresponding gel. The earlier blot clearly shows the same three da rk bands
present in the purified cholinesterase lane in positions in which no protein is
delec table with Coomassie blue staining in the corresponding lane in the gel.
Lane 3 contains supernatant from the im mune reac tion. The protei n pattern
in the gel is thai of a mixture of human and rabbit serum proteins with the
immunoglo bulins remove d. On Ihe blot no bands are seen, confirming the
removal of all proteins that reac t with the antiserum to the lm muno prectpitate
(which was run in lane 4).
Lanes 5 and 6 contain supernatant and precipitate respectively from the
control reac tion with preimmune rabbi t serum. In the gel the appearance of lane
5 is abou t Ihe same as Ihat of lane 3, indicating no discern ible difference due to
proteins preci pitafed from one but not from the other . In lane 6 one sees, as
expec ted, immunoglobulin bands in lesser density from prelmmune rabbit serum
than from the serum of the immunized rabbit, but one does not expect to see any
other bands. The appearance therefo re of an extra pale broad band is pUZZling.
Its average mo lecular mass is about 70 kDa which is the size of the 19 M heavy
chain. It see ms possible Ihat this is indeed what it represents and that it has
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largely disappeared at ter three imm unizations when the immune system has
gone over largely 10the production of IgG.
The blot appearance of lanes 5 and 6 is easily explained. Since the
preimmune rabbit serum should fail to prec ipitate the prote in precip itated by the
antiserum , one expects the appearances of lanes 5 and 6 10 be the revers e 01
those of la nes 3 and 4. In lane 5, however, only one pale band is visible. The
exp lanation is in the relative amounts of material used. The limits 10 amounts
used 10avoid distortion due 10over loading were deduced from an earlier get. The
who le of the lrnmuncp reclplta tes from the reactions detaited in Chapter 2 were
used, divided between the duplicate lanes. but only about 1% of the supernatants
were used, containing material from about 10% of lhe amount of human serum
run in lana 2. This reduction was necessary because the reaction mixtures also
contained rabbit serum of total vo lume equal 10 ten limes thai of the huma n
serum (see Section 2,5, p. 90). The lanes contained material derived from the
following volumes of human serum: lanes 2, 0.25 III each; fanes 3 & 5; 0.025 III
and lanes 4 & 6, 2.5 Ill. Lanes 1 contained 2.5 j.l1 of purified serum cholinesterase
and 0.25 Jll of rabbit serum was used in lanes 7 & B.
No bands are seen on the blo t in lanes 7 and B, This shows Ihatthe goat
anli·rabbi t· lg antibodies do not bind to denatured rabbit immunoglobulins and
therefore Ihat none 01 the bands In the other lanes are due to rabbi!
immunoglobulin.
3.4.2 Discuss ion
3.4.2.1 Impurities in purified serum cholinesterase
Western blotting clearly showed that the purified human serum
cholinesterase contained etleaet three proteins (53, 46 and 16.5 kDa) that were
highly immunogenic yet were present in concentrations below the level of
detection by Oocmassle blue staining of the gel. The highlighling of lwo o ther
proteins (65 and 60 kDa) in human serum demonstrates that the antiserum
contains ant ibodies against these two further prctelne and therefore presumab ly
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thai the purified cholinesterase contains these proteins even though only weak
slain ing is seen on the bioI in this region in lane 1 (Fig. 9, p. 108).
Radial immunodiffusion of human serum demonstrated at leasl two protein
components precipitated by the antiserum whose concentrat ions did not correlate
with serum cho linesterase activity and were therefore presumably not breakdown
products of the cholines terase. Furthe rmore, the fact that they required tor thei r
containment on radial immuno diffusion antise rum a concent ration about two
orders of magnitude higher than that requi red 10 limit serum cholinesterase to
rings of about the same size suggests thai these were proteins that are present
in human serum In much higher concentra tions than serum choline sterase. Direct
comparison of concent rations of the prote ins however cannot be made since the
ratios of the concentrations of the antibodies to the different prote ins are
unknown.
Both of these proteins were much more variable in concentration than is
albumin (which might be the 65 kOa antigen ). It is probable that the larger and
more easi ly seen of the non-cholinesterase-staining rings represented the 60
kDa protein as it was the only one present in high enough concentration to be
seen in lane 5 on the blot. The 46 kDa prote in presumably accounts for the other
ring since it Is the only other contaminant that is abundant in the
immunoprecipitate. It may be u1~proteinase inhibitor (ul ·antilrypsin).
fl l -proteinase inhibitor is acidic (pKa 4.6) making it quite a good candidate to be
copurified with serum cholinesterase in the first stage of purification at pH 4. It is
also abundant in serum at around 1.3 gIL and as an acute phase protein its
concentration is known to be highly variable. lis molecular mass has been
estimated as 47-55 kDa (Carrell and Owen, 1979) . u l -acld glycoprotein is more
acidic and is also abundant in serum (around 1 gIL) and an acute phase protein ,
but it has been found to be a poor antigen (Jager , 1953 ) unless its sialic ac id
moieties are removed (Amtneos . 1962), and Its molecular weight Is some what
lower, the highest estimate being 44.68 kDa (Oss and 8ronson, 1974) but
probably the best 39.5 kDa (Schmid, 1975 ).
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Further speculation as 10 the iden tity of the contaminants seems po intles s,
but it Is of interes t to look to see whe ther one of lhe impurities was 01 the right
molecular mass to be diP"!Plidyl peptidase IV. In 1982, lockridge reported
hydro lysis of substance P by highly purified human serum cholinesterase.
Hydrolysis was found 10 occur at both the N· and C·terminus. Nausch and
Heymann (1985) showed clearly that the aminopeptidase activity could be
accounted for entirely by the trace presence of dipeptidyl peplidase IV (also
known as post -proline dlpep tldyl aminopep tidase , dipeplidyl aminopeptidase IV
and ori ginally as gJycylpropyl IJ-naphlhylamidase). They round that dipeplidyl
peptidase IV eluted from the prc.cainamide-gel affinity column behind the serum
cholinester ase peak but ove rlapped it. and thai pass ing lhe cholineste rase peak
fract ions through the affinity col umn a second time reduced (he dideptidy l
pept idase IV activity 10 a level undetectable by incubation with substance P for
48 hr at 37oe.
Human didep Udyl pepndase IV was pur ified by Oya at al. (1971), who
estimate d its molecu lar mass by gel filt ration to be approximately 225 kOa.
Yosh imoto and Walter (1977) purified lhe enzyme from lamb kid ney and
estimated its molecular mass by the sed imen tation equilibrium method and by
SOS/pAG E to be 230 ± 15 kDa and found it to consist of two identic al subunits
of 115 kOa. As described in Chap ter 2, p. 61 , the method of purification of serum
cho lines terase was derived from that of Lockridge but include d gel-filtration after
the affinity chro matography. On the blot there is a possible band, est imated at
117 kOa. If this is indeed dipeptidy l pept idase IV, it strengthens the estimate of
130 kDa for the presume d cho linesterase band .
(The investigation of the apparent carboxypeptidase activity of purified
serum cholinesterase is not ye t comp lete . Boopathy and Balaeubramantan
(1987) found that the two activities coelute d from a prccainamlde-Seph arose
affin ity column with NaCI and still coeluted when passed through a secon d lime
and elute d with 0.05 M proca inam ide. They also coeluted from a concana valin -
A-Sepharose colum n and a Sephadex G·200 gel-filtrat ion column and
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comlgrated on PAGE. SUbsequently, AciOand Batasubramantan(1990)reported
isolation of the peptidase activity 10 a 50 kDa peptide fragment produced by
limited u-chymotryps in digestion of purified serum cho linesterase and the
sequence of the five N-terminal amino-acids of this fragment corresponded to
part of the cholinesterase sequence . However, Checler at al. (1990) showed that
diffe rent prepara tions of puriflEld serum chol inesterase differed in their pept idase
activities and that monoclonal antibodies against serum cholinesterase could
remove the cho linesterase activity and electrophoretic bands wi thout affec ting
the peptidase activity. This evidence seems conclusive but the enzyme
responsible for carbcxypepudase activity has yet 10 be Identified.)
Co mpariso n of lanes 1 in the gel and the blot makes it very c lear that all of
the contaminants noted are more immunogenic than the serum cholines terase
monomer since though they cannot be seen on the gel their labelling is at least
as dark as that in the position in which the monomer lies. The nucleolide
sequence of the rabbit 'butyrylchol inesterase' gene has now been pUblished
(Jbilo and Chatonnel, 1990). The amino-acids show 91.6% identity with lhose of
the human protein.
3.4.2.2 Nature of the Immunogenic serum cholinesterase
The results raise twomap, questions about the cholinesteras e itself; in lane
1, why is the darkly-sta ining high-molecu lar-mass band on the blot in a different
position (corresponding to 130 kOa) from the major protein band in the gel
(corresponding to 98 kDa), and why are the bands In different positions in the
purified cholines terase and immunoprecipita te lanes on the blot?
With regard to the first question, firstly, the portion of gel shown and the par t
used for blotting were parts of the same gel. There was no distortion of the dye-
front (which is seen to be straight in the portion shown) and indeed the
cholinesterase lane was next to the protein marker lane In each half and the two
halves were of identical appearance before blotting . Secondly, the two lanes 1
were loaded from the same reactio n tube. There can be no doubt then that very
few antibodies have bound to the free serum cholinesterase .
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The darkly-staining band can therefore only be either yet another
contaminant or a combination of the serum chol inesterase monomer with another
molecu le . The obvious candidate lor the latter possibility is the C2 compound
(see pp. 14"5). Its mass is about 150 kDa (Masson, 1990), whereas the
estimate for the band on the bioI was 130 kDa. However, as will be shown later
(Fig. 11, p. 123, lanes 1 and 2), in PAGE the purified cholinesterase migrates
mora rapidly than the cholinesterase in serum, presumably because of the
retardant effect of a large amount of albumin in the serum. This was a consis tent
finding in PAGE. Assuming Ihat the same occurred in tho SDS·PAGE, tho
purified cholinesterase would have an apparent molecu lar mass a lillie less than
the same molecule in serum. The molecular mass markers accurately identified
the molecular masses of the IgG light and heavy chains in the serum so it seems
quite pos sible that the band in question could represent a molecule a little
heavier than estimated. If the band on the blot does correspond to C2, this could
explain why there appear to be so many antibodies to the 65 kDa protein seen in
lanes 2 and 4 even though there is lillie if any of this protein free in the purified
cholines terase preparation, l.e. antibodies to the albumin moiety of C2 bind to
the albu min in the serum .
If the estimate 130 kDa is correct, this rules out a combination of serum
cholinesterase mo nomer with albumin and the protein has to be either another
contaminant or a combination of the monomer with another, smaller molec ule.
The plasma from which the cholinesterase was purified came from 67 donors so
almost certainly contained Cs (see pp. 14·20). A Cs band was not seen on
PAGE of the purif ied cholinesterase but, as the contaminan ts have shown , this
does not preclud e its presence at a concen tration too low for detection by
Coomassie blue but detectable immunologic ally. There was therefore a
possibility that the band in question cou ld represent a partial-reduction
breakdow n-product of Cs' As the band was not seen in the serum sample used
for the blot PAGE was performed on that 10make sure that it did not contain Cs'
It did net exhibit Cs but surprisingly showed two other low-mobili ty bands (Fig.
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11, lane 6). Whether these represent higher polymers of a variant cholinesterase
or combinations of cholines terase with ot her proteins, it appears that they were
dissociated by reduction as no bands heavier Ihan 65 kDa appear in Ihe serum
lane on the bioI.
({I -antitrypsin has a single free Ihior group and can link with the free thtcl
group of K light chains in vivo as well as in vitro, and normally about 1% of the
f.l ranlitrypsin in plasma occurs as a complex with IgA. linked by disulphide
bridging to the heavy chain (Carrell and Owen, 1979). It is possible that serum
cholinesterase can also form a dlaulphide bond with Ie light chains because an
exi ra serum cholinesterase band has been observed on erecirchccresre in some
patients with myeloma (Gallango and Arends, 1969). The molecular mass of a
combination of Ihe K chain and Ihe serum chol inesterase monomer would be
about 110 kOa, which is 100 light to account for the band on the bioi, but the
molecular mass of a combination of Ihe cholinesterase monomer with
u , -anlilrypsin would be aboull40 kDa. This and other similar combinations could
possibly occur.
Specific enzyme staining is of course much more sensitive than general
protein staining. Though the gel in Fig. 11 is slightly overstained with specific
stain for serum cholinesterase, neither Cs nor C2 is seen in the purified
cholinesterase (lane 1). On using 25 limes as much purified cholinesterase, a
strong C2 band was seen, bUI there was no distinct Cs band or any unusual
band. The C2 compound thus seems the most likely explanation for the '130'
kDa band on the blot.
With regard 10 the second question, the high-molecular-mass band in lane 4
on the blot is well placed to be the serum cholinesterase dimer. If Ihe dimer is
antigenic enough to attract this density of labelling then the question arises as to
why the dimer band just visible in lane 1 In the gel Is not labelled. There does
actually appear to be a trace of labelling in this position on the blot. It may be that
there was much mere dimer in the lmmuncpreclpttate. In defence of this
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hypothesis, it may be noted that there is no labelling in lane 4 in the places
expected for the monomer or the 130 kDa protein so the cholinesterase might
near ly all have been in the dimer form in this mbe. The gel does net contradict
this. There is a band in the right position and it is much heavier than the dimer
band in lane 1. There is, howeve r, the l ikel ihood thai at least part of the protein in
this band is immunog lobu lin because of the presence of a weaker band in the
same pos ition in the control lane 6. However , if as discussed earlier, this band in
lane 6 cor respo nds to one subunit of IgM WG should expect titt le of this in lane 4 if
the interpretation of the 70 kOa band is correct, suggesting that there is much
less IgM in the antiserum than in the preimmune rabbit serum. It still has 10 be
explai ned however why the choli nesterase should be less dtssociated in lane 4
than in lane 1. The solutions were all boiled in the same wa terbath al and lor the
same lime . Since some dlmer remained in the purified cho linesterase sotcncn
alter 4 minutes boil ing wi th 5% merceptcethancl it seems that il takes some time
for all disulphide bonds to be reduced . Unlike the protein in the purified
cholinesterase tube . the protein in the immunoprecipilate tube was bound \0
antibodies boun d to protein A·Sepharose at the beginn ing of the 4 minutes so
ma y hav e requ ired longer for reductio n.
An alterna tive possibility raised by the finding of extra bands in the serum
on PAGE is that the '130 kOa' band relates \0 one of them, but the need for an
explanation for the non-appearance of this band in the serum lane on the blot is
the same.
3.5 Adoption of radlal lmmunoditfusion
For the immunologica l measurement of prote in concentrations in clin ical
laboratori es. radial immuno diffusion has now largely been superceded by
automated lmmunoturbl di ty and immuno nephalome try. They require absolutely
monospecific antibody preparations . The raw antiser um was clearly not suitable
for these techniques. However . the comb inat ion of radial immunodiffusion with
specific staining for serum cho linesterase obv iates lhe nee d lor a monospeclfic
ant iserum and it was decided to use this techn ique.
Fig. 10. Human serum cholinesterase radial Immunodiffusion ring s
(3) The appearance of the rings or about 75t'AJ of samples. (b), (c) Two examples
showing ring E. The division of ring 0 lntc 0 1 and 02 is just visible in (a) and (b)
but is much more easily seen in (c). (d) A specimen showing very broad 0 rings.
Tnere is no definite ring E but there is a trace of stain ing round the well.
3.6 Time and temperature of incubation of radial
immunodiffusion gels
Mancini at af. (1965) showed that the lmmunoprecipttates grow to a
maximum size dependent upon the concentrations of antigen and antibody, after
which no further growth occurs. Only when the maximum size has been reached
is the area (or square of diameter) of the precipitate linearly proportional to the
concentration of antigen. Before that lime, measurements have to be referred 10
a complex calibration curve and accuracy is severely reduced. The final size Is
independent of temperature, but is reached sooner at higher temperatures. They
also found that the time required for a precipitate to achieve its final size
increases as a function of molecular mass, disc sizes of about 1 cm in diameter
being achieved at 37°C in less than 24 hr by aence-Jonee proteins (25 kDa), 3
days by albumin (65 kOa, Heremane, 1971, Mancini's co-author, says 4 days), 7
days by IgG (160 kDal and 10 or more days by antigens as large as IgM (900
kDa). The molecular mass of the serum cholinesterase tetramer is about 342
kDa (Lockridge at al., 1987a). It was therefore decided to conduct a small trial to
establish the appropriate incubatlon lime. An RID plate (Le. a radial
immunodiffusion gel, as described in Section 2.4.1, p, 87, in a Petri dish) was
inoculated with 5 IJl of pooled human serum in each well and incubated at S7OC.
The gel surrounding two wells was cut out daily and stained for cholinesterase
and fhe rings measured, and il was found that ring growth ceased after about
seven days. On this basis. plales were always incubated at 3]llC and no plates
were incubated for less than 7 days, though occasionally for convenience they
were left a day longer.
3.7 Immunological variation of serum cholinesterase
3.7.1 Observations
On staining plates inoculated with sera of different individuals for serum
cholinesterase for 1 hr, il was noticed that the immunoprecipitates were
composed of a se t of five concentric rings which varied between individuals, The
ringswere designated A-E (Fig. 10).
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Ring C was nearly always the darkest and both Its inner and outer edges
were sharp. The main variability in ring C was in its width, l.e. distance between
inner and outer edges. The main variability in the other four was in their
darkness, and indeed, whether they could be seen at all . A might be darker than
B or vice versa and only one might be visible at first, but with sufficient stainiflg
both could be demonstad in all specimens. This was not so for D and E. Ring E
was sometimes a very distinct darkly-staining annulus wllh fairly well-defined
inner and outer borders and sometimes a pale disc surrounding the well, but was
only seen In any form in abou t 25% of sera. Ring D was sometimes discrete, in
which case it was usually nearer 10ethan 10E but sometimes nearer to E, etten
abutted C and sometimes abutted E as well, and was sometimes not discernible
at all.
The exact appearance was found to depend upon the time of staining.
Eventually, pale rings will become darker until the divisions between the rings
can no longer be seen, but the above description comes from comparisons of
specimens on the same gel. On repeating radial immunodiffusion several times
with some specimens it was found that the most striking feature, the presence or
absence of ring E is consistent. On photography it was discovered that ring D is
subdivided into two (0 1 and °2): this is more easily seen in some specimens
than in others. Fig. 10 shows examples. The spec imen in Fig. 10d is described
later in this section. There seeme d to be two main possibi lities as to the origin of
these rings.
The first was that the rings might correspond to the bands seen on
electrophoresis (see p. 14 at seq.). The position of an immunoprecipitin ring at
the termination of diffusion is the position of equivalence of antigen and
antibodies . It is possible that the different size isomers of serum cholinesterase
might precipitate in differont positions because with increasing polymerization
there should be less different epi topes exposed. The association of the enzyme
with anomer protein, as in C2' wou ld also be likely to produce a ring in a different
position by this means even If there were no antibodies agains t the other protein.
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The second possibility came from the descr iption of Herema ns (197 1), who
reported that the distribution of protein within a disc of lmmunopreclpftate in
single radial immunodiffusion is far from uniform , even at termination of diffusion .
The protem accumulates along the rim of the precip itate while mo ving oul of the
centre of the system. His diagram showing the change in distribution of human
albumin precipitated with rabbit antiserum with lime illustrates this and shows
mat at termination there is a sma ll slep in conce ntration on the tra iling edge, and
his photog raph shows Ihat this gives the appearance of a secon d ring. Probably
the ring appearance described here is due to a combination of these teeters.
Mancini at al. (f 965) say that sudden changes in temperature can cause
concentric striae in precipitin discs, but the gels were incubated In a 3lOC
incubator and 991s incubated at different times all showed the same ring
structure.
The areas of all of the rings were correlated with one-another and with the
serum cholinesterase activities of the samples. Rings A and C gave the beat
correlations with activity, both greater than 0.9.
InitiaUyCs seemed the most likely explanation for ring E because it is a
common variant. lis occurrence varies widely between populations but its
incidence is about 10% In the British Isles (Whittaker, 1986), Ihe ancestra l origin
of most Newfoundlanders. This is considerably less then the frequency with
which we found ring E, but it should be remembered that Simpson (1972)
reported that though polyacrylamide gel electrophoresis detecte d 33% more
cases than starch gel electrophoresis it still failed to detect the band in 50% of
sera typed as negative by the starch method but expected to have the band from
family information.
PAGE of 9 sera that showed weH-defined E rings and 9 that showed no E
rings revealed an extra band in just one specimen, the specime n whose radial
immunodiffusion pattern is shown in Fig. l Ob (p. 120). The band, illustrated in
Fig. 11, lane 5, was not CS' The serum chosen for use in the western blot was
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Fig. 11. PAGE of serum samples showing extra RID rings and/or exira
PAGE bands , and controls, stai ned for se rum cholinesterase
Lanes are: lane 1, purified human serum cholinesterase; lane 2, fresh human
serum (The other samples had all been frozen. This sample was taken just
before runn ing the gel as a contro l in case the other specimens showed storage
bands. Radial immunodiffusion had not been pertomed with iL); lane 3, serum
Ihat showed no radial immun odiffus ion ring E (This is the specime n used in Fig.
l Oa., p. 120): lanes 4, 5, sera which did show ring E (The one in lane 5 Is tho
one in Fig. lOb.); lane 6, the serum used on the western bioi and in Fig. toe.The
maier band present In all lanes is C 4' el l C2 and C3 are nOI visible .
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thai o f the blood donor with the highest serum cho linesterase activity oul of 117
tested. The activity was 5195 U/L (mean of all the donors 3562, S.D. 704). As
already mentioned, PAGE of this specimen showed two exira bands , Fig. 11,
lane 6. The radial immunodiffusion pattern of this specimen is shown in Fig. 10d.
There is no definite ring E, but ring 0 is un usually broad.
3.7.2 Discussion
While ii has been demonst rated tha t the presence or absence of ring E is
repeatable in individual specimens , it is not known whether this is a constan t
finding in serum from the same subjects at different times. It remains possible
therefore that this is some kind of physiolog ical phenomenon, but if il is genetic
then the majority of cases with ring E must be due to variants which are
immunologica lly but not etectrccroreucauv distinct from the usua l variant The
high frequency of ring E then has 10be explained. Two points can be deduce d at
the outset from the ring appearance alone . One is that if il is genetic the cases so
far seen are heterozygotes since the rings A-D are present. The other is that
since ring E is smaller than the other rings, either the compoun d respons ible for it
is less abundant than those respons ible for the other rings or there are more
antibodies in Ihe anliser um directed aga inst the ring E compoun d than aga inst
the othe rs. In the latter case the only candida te could be a cholines terase
molecule which on reduction produced a componen t responsible for the ?>130
kOa band on the blotlhat we have already decided is probably Cz' In the former
case there are other possibi lities.
Now that butytylchollnesterase cDNA and portions of the genomic DNA
have been craned, an increasing number of variants at the DNA level is being
found (Bartels at al., 1989; Arpagus at al. , 1990). II is likely that some variants
will be found that have amlno-actd changes which do not affect substrate/i nhibitor
affinity characteristics or electrophoretic mobility but yet could be immunologically
distinct. There is however already a know n variant which is abundant enoug h as
a heterozygote 10 be a candidate. As men tioned in the Jr urooucto n the K variant
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(Rubinstein atet., 1978) has been es timated to have an allele frequency of 0.115
(Evans and Wardell, 1984), giving a heterozygote frequency (2pq) of 20%.
Bartels at af. (1989) have reported a DNA polymorphism at nucleotide 16 15,
resulti ng in an amino-acid polymorphism (ala/lhr) at position 539 . The ir estimate
for the frequency of the heterozygote is 22% and they are investigating tho
poss ibility that this could be the polymorphism responsible for the K var iant. Th e
K variant was found to be a qu antitative one, reducing the number of
cholinesterase molecules by 33%, either by reduced synthesis or increased
degradation (Rubinstein at al., 1978). This variant is thus not only o f the righ t
frequency to correspond to Ring E but could account for ring E bein g smaller
than the rings due to polymers formed by the product of the other a llele. The
variant was originally thought to reduce the number of usual cho linesterase
molecu les, but if the studies of Bartels at al. show that their polymorp hism does
correspond to the K variant, this could explain the immunological difference.
Serum cholinesterase concentration was first measured by radi al
immunodiffusion followed by specific staining for the enzyme by Aurand and
Goedde (1970) and SUbsequently by Rubinste in al al. (1976) and Eckerson at al.
(1983) . None of these authors cescnbed the multiple rings. This may be because
they did not incubate their gels as long as was done in this work.
Fahey and McKelvey (1965) , measuring immunoglobulins by rad ial
immunodiffusion, incubated for 24 hr at 4-lOoC (i.e. a much shorter lime than that
required to reach 'equivalence') and found a linear relationship be tween the
diameter and the log of the antigen concentration. Rubinstein at a l. (197 6),
measuring serum cholinesterase, used the latter method, except that they
incubat ed at room temperature. Their pho tograph shows lillie ev idence of
concentric rings. Eckerson at al. (1983) used the relationship of conce ntration to
area but incubated for only 48 hr at room temperature; they give no illustration .
Altland and Goedde (1970) incubated for two days at 37oe . Their photograph
shows at least two concentric rings with most samples and possibly three wi th
some, but no gaps can be seen betwe en the rings.
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Ru binstein at af. (1976) quot e Berne (197 4) In support of the me t hod they
used. Actually, after a detailed examinalion of several possible methods of
estimat ing antigen concentration by radial im munodiffusion, Berne co ncluded
that the Mancin i method was the only reliable one. T his was because smaller
circles cease g rowth first and the refore interme diate re adings p roduce pl ots that
are partially straight and partially curved and critically dependent on time an d
temperature. Also, the range of d iameters is g realest at equivalence
(termina tion).
3.8Choice of ring and time of staining
Having inc ubated the gels for 7 days and found multiple rings il h ad to be
decided which r ing 10 measure . At first the outermost diameters were m easure d
and the multiple rings ig nored. However , it soo n became apparent that this was
leading to red uced co rrelation betwee n serum cholineste rase activity and the
areas so obta ined beca use in some case s r ing A had been measured and in
other cases , rin g B, because ring A w as very faint or invisible . Ring C , because
otlts d arkness and sha rpness of edge in most cases, gave the best correlation
wilh cholinesterase activi ty, bu t it was obscure d in some cases . It was therefor e
decided that it would be besl to stain long enough for ring A to be seen in a ll
cases an d to m easure that. This usually require d staining for 2 hr and so metimes
it was necessary tomake up a fresh ba tch of stain and wait longer. l ong staining
eventually obsc ures div isions between concentr ic rings. Because an enzymic
activity stain will eventual ly ren der even a few e nzyme molecule s detect able, th e
final size visua lized is depende nt on time of sta ining and therefore it is imp ortan t
10 have controls on every plate as it is also to control for small diffe rence s in
thickne s s between gels.
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INVESTIGATION OF CONCENTRATION OF
SERUM CHOLINESTERASE
IN BLOOD-DONORS AND PATIENTS
"8
Chapter 4
MATERIALS AND METHODS (2)
including results of investigations of measurement
errors
4.1 Estimation of serum li p id indices and ch olinesterase
activity
Serum choles terol, tr iacylglyc erors. 'total LOL' (LOl ... VLOL), HDL·
choles terol, and ch olineste rase acti vity were measured on an IL Mona rch™
2000 chem istry eutoan elyeer (Instrumentati on Laborat ory, Ledngtc n, MA, U SA).
The Lpt -cholesterot was calcula ted from the results of the choles terol,
lrlacylglycerol and HOL-cholesterol mea surements. In addition , lipop rotein
elec trophoresis was carried oul, fo llowed b y densito metryI and percen tages of a t
pre-fl and fJ lipoproteins were de rived fro m this, along with ch ylomicro ns if
pres ent The results 01~poprolein electrophoresis we re used in combinatio n with
the assay res ults iT) theclassifICation of ind iv idual se ts of re sults into Fredric kson
hyperl ipidae mia typ es an d in the calcula tion of LD L. VLD L and HDL
concentr ations from the 'total LOl ' c oncentra tion.
Below, the details of lipoprotei n electrophoresis and densitometry w ill be
give n fll'Sl, fo llowed by deta ils 01the autoanalsser-meesurec lipid co ncentrations
and menthe derived indices and c lassification. Afte r this the details of the se rum
cno unesrerase act ivity measur eme nt will b e given belore going on 10 fu rther
details of the es timation 01 the conce n tration 01 the enzym e by radial
imm unodiffu sion.
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4.1.1 Serum lipoprotein electrop horesis and dens itometry
Agarose-ge l electrophoresis of serum lipoprot eins was carried out with
equipment and rea gents comprising the Par agon Lipoprotein (lipo)
Electro phores is Kit (P I N 6559 10, Bec kman In st rumen ts, Inc., Fullerto n, CA, U S A)
and repeal s upplies f rom the same source. 0.5%1 agarose gels are supp lied
ready-m ade in sealed sachets. The ge l is a thin layer on the surface of a fle xi ble
plastic sheet. A gel, re moved from its sachet, is blotted \0 remove excess bu ffer
on the surface and a flexible plastic 'temp la te' is la id across the free surface,
aligne d by means of dots on the suporting sheet, a nd gently rubbe d to en sure
sealing with the gel. 5 ul, vo lumes of serum samples are placed in slots in the
template and allowed to stand for 5 min 10 diff use Into the gel. The templa te is
then blott ed to remove excess serum and is itself remove d. The electropho resis
tanks are on the same horizontal leve l and the gel on its supo rting plastic sne er is
filted onto a fr ame ('t he gel br idge assembly ') which holds the gel in an arc wi th
oppos ite ends in the two tan ks, wit h the positions of the absorbed sam ples
paralle l 10the tanks bu t out o f the buffer on the posit ive side. Electrophores is is
then c arried out with b arbital buffer (10 mM 5 .5-diethy lbarbitur ic acid , 50 mM 5,5-
diethy lbarbitur ate sod ium, pH 8.6) at 100 V, co nstant voltage , for 30 min. The gel
Is then fixed in 30% re agent alcohol, 10% ac e tic acid , aq. fo r 5 min , dried w il h a
gel-dry er, stat ned In 0 .07% Su dan Btack B fo r 5 min , destained with 3 washes of
45% reagent alcohol. rinsed In cetonrsed water and dried agaln. Th e 'reagent
alcoho l' Is 95% ethano l denatured with methano l.
T he inte nsities o f the lipo protein bands are then estimated with a Beckman
Appra ise™ densitome ter by absorption al600 rvn. Th e instrument scans the gel
and m easures the areas under the absorption peaks and calculates their
individual perc entaqes of Ihe total area under the curve.
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4.1.2 Totalcholesterol concentration
This was measured with reagents of the IL Test™ Cholesterol Kit
(Instrumentation Laboratory). The method is a mod ification of that of Allain et al.
(1974). Cholestero l esters are hydrolysed with a m icrobial cholesterol esterase
and the released cholesterol, along with previou sly free cholesterol, is then
oxidized with a mi crobial cholesterol oxidase to cho test-e-en -a-cne and hydrogen
peroxide. In the pr esence of horse-radish peroxidase me hy drogen peroxide then
reacts with 4-am inophenazone (a-amlr oantlpyrene ) and phenol to produce the
red co loured 4-(p ·benzoquinone-mono·imino)·phe nazone (qulnonalmlne) and
water. The original total cholesterol concentration is the n proportiona l to the
optca t density at 500 nm.
4.1,3 Triacylglycerol concentration
This was me asured with reagents of the 'T riglycerides GPO-PAP' test
(Boehringer Ma nnheim Canada, Dorva l, Quebec). Triacylglycerols are
hydrolysed by a lipase to latty acids and glycerol. Th e glyce rol is then
phosphorylated by glycerol kinase and ATP 10glyc e rol·3·p hospha te (and AD P).
The glycerol-3-phosphale is oxidi zed by a glycerolphosphate oxidase to
dihydroxyacelone phosphate and hydrogen peroxlde. The last stage is then the
same as thaI used in chotesiercl measurement e xcept th at e-ctticrophencl Is
used instead of ph enol and HCl appears as an additional pro duct.
The measur ement of triacylg lycerols by hydro lysing them with lipase and
estimating glycerol was suggested by Wahlefeld (19 74), He suggested using the
method of glycero l estima tion proposed by Eggstein and Ku hlmann (1974). They
suggested the co nversio n to glycerol-3-phosphate but thei r next stage was the
production of pyru vate and subsequently lactate an d measurement by decrease
in optical density du e 10oxida tion of NADH. The es timation of hydrogen peroxide
product ion by reaction wi th 4-aminoantipyrene and phenol was first proposed by
Trinder (1969) for estima tion of blood glucose . The modifica tion of the fast stage
presum ably Improves sensluvlty since when 4 -chlo ropheno l is used, one
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molecule of quinon imine is produced for every molecule of hydrogen peroxide
whereas when ph enol is used one molecule of qulnonelmine is produced for
every two molec u les of hy drogen peroxide.
As in cholesterol measurement, the concentration of triacylglycerols is then
estima ted by me asuring absorpt ion due to qunonermlne at 500 nm.
4.1.4 'Total LDL'
The total he parin-precipitable lipoprotein concent ration was measured by
the method 01Burstein an d Samaille (1974) , adapted locally for the autoana'yzer.
ApeB-containing lipoprote ins form insoluble complexes with heparin in the
presence of calcium ions and the rate of change of turbidi ty is measured at 620
nm. The standard used to calibrate the machine when the test was eet up was
LOL prepared by ultracentrifugation as described by de Lalla and Golman (1954)
and modified by Ewing et al. (1965).
4.1.5 HDL-choleslerol
Chylomicrons , VLOL and LDL were precipitat ed from serum samples with
'HDL Cholestero l Precipi tant' (Boehringer Mannhelm Ca nada) which contains
phosphotungstate and magnesium ions. This is part of the method of isolating
HDLdescribed by Burstein at st. (1970). The HDl remains in the supernatant.
The Hnt-cholestero! was then measured by measur ing the cholesterol in this
supernatant by the method described above (4.1.2).
4.1.6 Quality control o f autoanalyzer methods
As previously stated (2.8, p. 94) the serum samples (from patients) provided
for cholinesterase concentration measurement in this project were samples lor
which serum lipid profiles had been requested . The lipid analyses by tho
methods given above had already been perfo rmed and the coefficients of
variation given below are derived (rom lipid estimations of quality-control
standards carried out at the same time. Serum cholesterol, triacylglycerol and
'total LOL' conce ntrations (and cholinesterase activ ity) were measured in the
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same 'run' of operation of the autoanalyaer o n up to 30 specime ns. In each run
the laboratory included one or two of each of al le ast two of three different
serum-based quality-c ontrol standards. The standards were 'P recinorm' , 'Precilip'
and 'Precilip EL', Boehringer . HDL-choles leroJ estimat ion was run separate ly
and a different qualtty-control, produced by Sigma. was used, though in the
second mont h (see be low) Preclnorm was also used.
Lipid measurem ents on these controls were rec orde d and means and
standard deviatio ns calculated althe endof eachmonth . AI the end of each run
the results of each lip id index in the controls were compared with the prevtous
results, and if lor any particu lar index more than one contro l result w as outsi de
the 95% confidence limits fo r the prev ious rnonm, tha t test was repeated on all
the samples in the run. Within·run and within-day va riation was not estimated.
The specimens used were m easured in a peri od whic h overlapped two months.
The coefficien ts of varialion for the above lipid indices for the two mon ths were :
Precilip cholesterol 4.75%, N "" 19 a nd 4.62%, N ... 53
Precinorm cholestero l 4.890,.0. N ""20 and 4.35%, N - 44
Preclnp EL ch olesterol 2.76%, N ""19 (second m onth on ly)
PreciJiptrlacylglycero ls 6.22%, N .. 17 and 5.94% , N "" 53
Precinorm triacylglycerols 8.37%, N .. 18 and 6.22 % , N "" 4 7
Precilip EL Iriacylglycerols 4.37%, N .. 21 (second month only)
Precilip'lotal lOl ' 7.83%, N '" 16 and 11.95 % , N = 53
Precinorm 'total l Dl ' 2.89'%, N .. 18 and 4.85 % , N'" 43
Precilip EL 'to tal LDL' 5.24%, N .. 18 (second m onlh o n ly)
Sigma HDL 5.45%, N .. 31 and 7.75 % , N - 9
Precinorm HDl 8.32%, N .. 41 (second m onth o nly)
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Thes e results come from the time when the la borato ry first started to keep
regul ar monthly statistics . It is know n that the res u lts from some runs were not
rec orded, particula rly in the first month, and that results from some runs thai
we re rejected were included, so the variation in the accepted results was
so mewhat less than indicated by some of these figu res.
The lipid ass ays on the blood donor specime ns were all carried out in the
first of these months except for the first 25 specimens, which were assayed in the
pr eceding month. The cont rol results for lhese 25 spec imens were however
within the sameran ges as theother specimens.
4.1 .7 Formulae for calculated lipid indices
lDL-cholester ol was calculated thus:
LOL·cho leslerol = total cbolester ot- HD L-cholest e rol - triacylglyce roI/2.183
Where all terms refer to concentrations in mmoht, Thi s is ' the Friedewa ld
equallo n' of Frledewald at al. (1972) con verted to S .1. units. The original
equation predicted LOL-cholestero l in mg/100 ml and the lriacylglycerol
concent ration was then d ivided by 5. Friedewald et al. found that there were
three circu mstances in whi ch their equation would not give accurate predictions'
in the presence of c hylomicrons , in type HI hyperlipoproteinaemia, and when the
triacytglycerol concentration was greater than 400 mg/1oo ml (4 .56 mmo l/L).
Not e was therefore taken of these conditions in ana lysis of the data.
The other three calc ulated indi ces are all based on th e relative proportions
of the lipoproteins on elec trophoresi s.
L OL '" 'Tolal LOL' • % [1/(%11 t % pre·[S)
V LOL - 'Total LDL' • % pre·[U{%/' ...%pre ·fl)
HO L = 'Total LOL' • %fl/(%[1 t % pre·m
Ag ain, these equations ref er to concent rations in mm olfL.
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4.1.8 Classification into hyperlipoproteinaemla types
Classification into the Fredrickson hyperlipoproleinaemia types was carried
out with the results of the serum lipid assays and the information "om lipoprotei n
elec trophoresis by the criter ia laid down in a memorandum of .n _ World Health
Organization (Beaumont s f al., 1970) except that the acceptable limils of serum
lipids used were those more recently laid down in a position statement of the
Canadian Society of Clinical Chemists (Dinwoodie at af., 1988).
4.1.9 Choli nesterase ac tivity
The method was a modification 01 that of Dietz at al. (1973) using S-
butyryllhi.:lcholine iodide as substrate instead of S-propionyJlhiocholine iodidtl
and adapted locally for the autoanalyzer. The serum cholinesterase hydrolyses
the butyrylthiocholine to form butyrate and thiocholine and the Ihicchcline then
reacts with S,S'dithiobis-(2·nilrobenzoic acid) to form S-thio-2-nitrobenzoate and
2,2'dilhiobischoline. (The buffer used here is 0.05 M tris, pH 7.4 rather than the
phosphate buffer pH 7.6 used by Dietz at al.) The thionitrobenzoate has a yellow
colour. The machine measures absorbance al405 nM at 15·second intervals and
determines the maximum rate of reaction. The enzyme activity is expressed in
units per litre (U/L) where 1 unit represents 1 umol thiocholine released per
minute.
4.1.9.1 Linearity of activ ity measurement vs. concentration
Table I shows activity results on five dilutions of purified choffnesterase. In
Ihe first run it was seen that the activity of the second concentration was very
close 10 twice that of the first, and that of the third close to three times the urst,
but that the activity of the fourth was much less than four l imes the first and the
fifth less than the preceding two. Because of this, the run was repeated. The
results were similar. This suggested that the activity assay was not reliable at
high ectlvttes so the top two concentrations were diluted 1 in 2 and remeasured.
When these results were multiplied by 2 they were found to be very close to what
would have been expected. From these results it was concluded that the assay
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Tab le L li nLlr ity of se rum cholines te rase act ivity assay
-' Relative concentration
1 2 3 4 5
'... ': un 17 1 2 3458 50 16 5258 3916
= 1654 33 10 5038 5382 4 54 5
1683 3384 5027 5320
..,. .,.
.: ..' ' .: 34 3 1 4297
I . & 6862 8594
Acti vity measurements lUlL) on dilutio ns of purifie d serum chol inesterase
to determine the uppe r limi t to linearity o f the assay .
ta
became non-lfnear above about 5,000 Ufl. Therefore, when the serum
cholinesterase concent rations of Ihe human serum samples had been measured
and an initial regression equation had been derived, the activities were
remeasured af hatt dilution on all samples for which activ ity was predicted fa be
over 5,000 U/L Then, if the new estimate was closer to the predicted result than
to the original result, the new estimate was accepted, but if not then the original
result was retained.
4.2 Further details of cholinesterase concen tration
measurement
4.2.1 Derivation of relative concentration from ring
measurement
Mancini et al. (1965) ensured that all their gels were exactly the same
thickness by pouring them between two spaced glass plates. As the gels used in
the work reported here were weighed into Petri dishes it was necessary to contro l
for small differences in thickness of gel between dishes. This is because the gel
contains the anliserum and it is the number of antibodies rather than their
concen tration that counts . A thicker gel will contain more antibodies and so
restrict lhe diameter of immunoprecipitate to a smaller size. Since a control is
required for between-day variatio n in amount of antiserum due to measurement
error in making up gels. as well as for differences in size of precipitate visualized
because of between-plate variation in staining (see Sect ion 3.8, p. 126) this did
not require any extra diversion of wells from holding samples.
Pooled human serum was used as a (secondary ) standard against which to
compare lhe precipitin rings of the samples measured. One way of making this
compar ison would be to use severa l different amounts of the pooled serum and
to draw (or calculate by regression) a separate calibration fine for each plate. If
this was done it would be unnecessary to subtract the well 'area' (square of
diameter , see Section 2.4.3, p. 90) from the square of the overall diameter , but it
would require using several of the 19 wells on every plate, and more labour in
pouring more gels and more calcula ting . The alternative method adopte d was to
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have pooled serum in one well on each plate and to express the areas of the
rings of the samples as a percentage of that of the pooled serum. This requires
subtraction of the well area beca use a proportion is calculated and having a
constant added to the numerato r and the denominator would obviously cause
distortion . The division of the diameter by 2 and the multiplication by it to gel the
real area (rrr2) is rendered redundant because these factors would cancel out.
The defensibili ty of this method will be discussed further in Section 4.4, p. 154.
The pooled serum was always put in the central well. This proved to be very
important (see Sec tion 4.3.2.1, p. 147).
4.2.2 Calib ration of seco nd ary standard
In order to calculate the actual cho linesterase concentrations of the serum
samples it was necessary to use the purified cholinesterase (the primary
standard) to measure the concentration of cholinesterase in the pooled serum
(the secondary standard). For this estimation alone, a calibration line was used. It
was decided that this should be done with all dilutions of calibrator and calibrated
on the same gel to avoid between plata variation. However it was not known
what size the rings produced by any dilution of the purified cholinesterase might
be and it was Important to avoid ring interference. Because of this, and rather
than make multiple large dilutions of the purified cholinesterase, integer volumes
of the pooled serum from 2 10 10 III (whose precipitate sizes were predictablo)
were used to consluct a calibration line with which to calcu late their own
concentration in reverse from three spaced dilutions of the primary standard. The
correlation of the squares of the ring diameters wtth the serum volumes was
0.999 and the derived concentration of serum cholinesterase in the pooled serum
was 23.7 mg/L. To express the sample concentrations in mg/L instead of as a
percentage of that of pooled serum it was then only necessary to multiply the
ratio (sample ring diameter squared- well diameter squared)/(pooted serum ring
diameter squared - well diameter squared) by 23.7 instead of mUltiplying by 100.
Severa l est imates of the concentration of cholinesterase have been made
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before and these have recently been reviewed by Brock et al. (1990). They
ranged between 5 and 15 mg/L. Brock at al. comment that this 'consensus' is
not surprising since all the studies were based on the same polycronar antiserum.
They present their own result. They have a monoclonal antibody for serum
cholinesterase and have used it to purify the enzyme by immunoaffinity
chromatography and 10 measure concentrations in serum by enzyme-linked
lmmuoo-sorbent assay (ELISA). They obtained a mean serum cholinesterase
ccncentratlon in 33 blood donors of 4.51 mg/l.
The estimate reported here is more than five limes that of Brock at al.
(1990). This difference is probably largely due to the different methods used for
measuring the protein concentration of the primary standard. Brock er al. used
the Lowry method (Lowry er al. (1951) with bovine serum albumin as the
reference protein whereas the method used here was that of the Bio-Rad Protein
Assay Kit No.1 with bovine gamma globulin as the reference. The Blo-Had kit
information booklet lists various advantages over the Lowry method likely to
increase accuracy. It also gives a table comparing estimates of the
concentrations of 23 proteins by the two methods . Even though in this
comparison the same reference protein (bovine gamma globulin) was used for
both methods, the concentration estimates for some of the proteins differed by as
much as three times . The estimates reported here for serum cholinesterase by
the Bio-Rad kit method and the absorbance method agreed very closely.
Certainly the impurities found in the purified cholinesterase in this study could not
account for such a large difference between estimates of the serum
concentrations . since they were only present as traces. The concentrations
reported in the ligures in this work are given in mg/L rather than as a percentage
of the secondary standard but the actual concentrations are not important to the
findings. The corre lations of serum cholinesterase concentration with serum
cholinesterase activity and with lipid indices are unaffected.
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4.2.3 Linearity of concentrati on vs. r lng~a rea graph
It w as necessary to determine how large the cholinesterase precipitin rings
could grow before interference between rings from adjacent wells reduced
accu racy and howmuch sensn should be used to produce rings of optimu m size.
Six gels were inoculated with 2, 3. 4, 5 . 6 and 7 J.I L of pooled human se rum in
ev ery wen. On the gel with 5 jJL per w ell all the rings had sharp edges . On the
one with 7 III per well aU the rings had faint fluffy edges and some were
obviously begiming 10 merge. On the one wit h 6 j.lL per well most rings had
sharp edges but a few showed some loss of def inition; ibese were ones sligh tly
larger than the others due 10 within.plate variation (see 4.3.2.1, p. 147). The
means of the squares of tho diameters of the rings on each plate were
calculated, and corre lations with volume of Inoc ulum computed for the fir s t lour
plates (2 to 5 Il l) , the next lour (3 to 6 jll) and the last four, and for the fi rst live
and for all plates. (There is no need to subtract the well for corretatcn purposes.)
Using the means of all rings on each pl ate eliminates erro r due to with in ·plate
va riation and cons iderably reduces erro r from measurement of ring diamete rs.
The result s are given in Table II. Th ey agai n show very good correla tion
betwe en ring area and amoun t of cholinesterase, but do show a reduc tion in
correlation with the larger rings . The different vo lumes of serum of the same
concentration of cholinesterase were of course used to simulate the preci pitates
that would be produced by samples all of the same volume but with d ifferent
concentrations of cholinesterase. On lhes e trial plates all the rings on any plate
were of similar size. On plates of individual samples the precipitates would all be
of d ifferent sizes. Based more on the appearance oune rings Ihan on the figures .
it was decided that 5 III should be the maximum inocu lum volume an d that
estima tes of concentration in samplos giving rings over about 100 tenths of a
millimetre in diameter should be repeale d with a smaller volume of ino culum
unless all the adjacent rings ha ppened 10 be rather sma ller and there w as no
sign of bulging or fraying 01the edge s of the prec ipi tates.
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Tab le II . Linearity of serum cholinester ase conc entration estimation
a Volume·ot'.serurii"lPLf'· 2 3 4 5 6 7
b 65 .08 76.8 3 86.35 94 .8 5 104 .4 107 .9
' · ~i .' " .' :. .... ', ~"~ ' 'i: '' ~
3339 5006 656 2 8103 10005 10 755c Square of. ,d lameter~,,',
. .. \", . · Cpt relations·-{d .~f (C;;~th~a·-::; 1h~'\(~~\~'f;2X;?,;t;i:;1 '
..
. 's~des used::·,.' .' 2-5 3-6 4-7 I 2-6 2-7
. ," >0.999 0 .999 0 .987 I 0_999 0. 99 6
Relationship of mean serum-cholineste rase-stain ed radia l Immunod iffusio n ring area
to number of microlitres of serum used on a series of gels. each conta ining 19 w ells
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4.2.4 Sample volumes
Serum cholinesterase concentrations of the blood donor samples were
estimated using 5 IJL volumes and a few were repeated using 3 ut, As serum
cholinesterase activity tends 10 be high in hyperl ipidaemia il was anticipated that
many of the samples from patients might produce large precipitin rings that wou ld
interfere wi th one-another. These samples were therefore divided on the basis 01
their cho lines terase activity results. For those with activities greater than tho 95th
percen tile of the activities of the donors 3 j.lL volumes were used . FCl(
hyper1ipidaem ic patients with norma l cho linesterase activities . S I,tL volumes were
used al first. The rings of the tatter were found 10 be large and very diff icult 10
measure because of indistinct edges. It was realized that though their activities
were within the normal range they tended to be towards the top end of the range
so that their mean was higher than that of the donors, and it was clear thai
interference was affecting estimation of concentration. For this reason they were
aUretested at a ut,
In order to make sure that any difference in specific activity that might be
found between hyperlipidaemic patients and blood donors could not be due 10
the fact thai their concentrations were measured with different sample volumos.
the estimates of 50 blood donors were repeated at 3 ~L In keeping with the
finding ot excellent linearity of ring area vs. amount of cholinesterase. no
significant difference was found between the means of the two sets of estimates.
The mean ring diameters at 5 and 3 ",L were 96.5 and n .Dmml10 respectively.
4.3 Error in cholinesterase measurem ents
4.3.1 Activity
4.3.1.1 Within-run variation
This was estimated by putting portions of the same serum sample into 25
cups of the IL-Monarch and running activity measurement twice. The results are
shown in Table III. In each run, one result (the minimum in each case) stood out
from the rest of the group on casual inspection. This was not the same cup 01
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Table III. Wit hin-run variation of serum cholines terase ac tiv ity measurement
/'Me;;;
F c'
II Run'!', 3969.2 6 1.8 1.56
II Run:i;·> 3975 .3 69 .2 1.74
Result s for two runs of the same 25 ident ica l cups of human serum. S.D.,
standard deviation; C.V. coeff icient of variat ion.
serum in the two runs, showing that this was due to random measurement error
rather than to a specific problem related to one cup of serum. As the coeffic ient
of variation is derived from the standard deviation and it is variances, not
standard deviations that are additive, we have 10 take not the mean but the root
mean square of estimates of the same coefficient of verteton. In this case the
result is 1.65%.
4.3.1.2 Between -run variation
The serum cholinesterase activity was initially measured at the same time
as the lipids on all specimens. In each run the laboratory included one or two of
each of at least two of three different serum-based quality-control standards. The
standards were 'Precfnorm', 'Precuip' and 'Precilip EL', Boehringer, These
standards were used routinely by the laboratory for lipid analysis runs, in which
thecholinesterase was also measured. They contained serum cholinesterase but
the manufacturer did not market them for cholinesterase standardisation. When
the serum cholinesterase concentrations had been determined, specific activities
(activity/concentration) were calculated to see whether the raised activity ir, any
cases of hyperlipidaemia could be due to increased specific activity. The specific
activities of the patients showed a bimodal distribution, the group with higher
specific activity containing a greater number than the other. The specific activities
of the blood donors, however, had a roughly normal unimodal distribution, the
mean corresponding to the lower peak of the patients' resulls. This was a very
exciting result, suggesting a distinct difference between the specific activity 01
serum cholinesterase in the majority of hyperlipidaemic patients and that of
controls. The data were however examined carefully to see whether there might
be some other explanation.
Investigation of the distribution of different types of hyperlipidaemia in the
two peaks of the dlstrfbutlon showed no tendency of any type 10 cluster in one or
other peak, immediately raising the suspicion that the result was an artifact.
Plaiting specific activity against the order in which the specimens had been
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assayed showed thai specific activity madefairly suddenshifts up and down with
relatively level stretches in between. Calculation of mean specific activity of
samples measured in different runs showed significant differences betweenruns.
Attempts were then made to correct for between-run variation by using the
quality control standards. Taking first one standard. the mean cholinesterase
activity result for that standard in all the runs was calculated, and then the aclivlty
results for all the specimens in any particular run were multipliedby the mean of
that standard for all runs divided by the mean of the usually two results of that
standard in the particular run. Whichever standard was used the distribution of
specific activities of the hyperlipidaemic patients became roughly normal and the
mean considerably lower than thai of the donors, with small differences
depending upon which standard was used.
The patient specimens saved by the laboratory for this study had not been
assayed at the same time as the donor samples, so the question arose as to
whether thls result was reat or due to a change in batch of reagent or quality
oomrots in the meantime. The laboratory records were inspected and lhe means
of serum cholinesterase activity were calculated for 50 each of patients found to
have normal lipid levels and ones with type lIa, type lib and type IV
hyperlipidaemia and compared with equivalent groups from the saved
specimens. The means of all groups from the time when the donor samples were
measured were lower than those of the saved samples. Using the means of all
200 samples at the two times to correct the donor activity results, instead of
using the quality control results , brought the mean specific activity of the donors
closer 10 thai of the hyperlipidaemic patients, but it was still very significantly
different. The quality control records were then examined and it was found that in
the intervening period between the times when the donor and saved patient
samples were measured there was a sudden step in cholinesterase activity
results of Precilip but no change in the lipid results for the same standard. The
obvious explanation was that there had been a change in balch of Precillp and
lha t the manufacturer contro lled lipid levels in different batches but not serum
'"
cholinesterase. The laboratory did nol have any record of limes of changing 10
new batches . It was therefore decided that cholinesterase activity measurements
of all specimens from patient s and donors should be repealed but that the lipid
resutts could stand.
Donor and patient samples were put in the same runs so that between-run
variation which had been observed amongs t the previous patient measurement s,
could not be held 10 account for any differences between the two groups. In
every run, two port ions of each of 'Precinorm ', 'Preclnp' and 'Precilip EL', were
included, one of each at each end of the series of samples. All the reported
measurements of serum chol inesterase activity were made with standards from
the same balch of each.
Because of the previously observed between-run variation, attempts were
again made to correct for this. Several funs were repeated in 1010. The two seta
of activity results of the human samples were then plotted against the same
concentration estimates to see whether between-run variation caused change in
the intercept or of the slope of the plot. Adding or subtracting a small amount
from every result would be the appropriate means 01 correction for change in
intercept , whereas multiplication of all results by a calculated factor would be the
right method if the slope changed. The investigation showed thai both slope and
intercept could vary. The six quality-control result s from each run were then
compared. It was found that they were quite good at predicting changes in slope
but poo r at pred icting change s in intercept. Several methods of using the qualit y
control results to correct the activity measurements were tried but in every case
the adjus tment red to slight decrease In the correlation between activity and
concemrancn . It was therefore decided 10 use the activity reeuns uncorrected and
to be aware of the error.
Table IV shows the variation 01measurements of the three standards in the
same 15 runs. It can be seen that the variation in estimates of cholinesterase in
Precilip was greater than that in the other two standards. This was also seen in
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the estimation of within-run variation. The means of the iwo Precinorm
cholinesterase estimates in the two runs of table III (p. 142) were 3329 and
3028, whereas lhose of Precilip were 2429 and 2459.5. The means lor
choles terol, lriacylglycerols and toter LDl respec tively for a representative month
in the laboratory were for Precinorm 4.57, 1.45 and 2.64, for Precilip 3.98, 2.21
and 1.74, and for Precilip EL 9.36, 3.73 and 5.89. Thus the difference in error of
measurement of cholinesterase activity between the standards cannot be
all ributed 10 interference with the cho linesterase assay by lipids. As the reason is
unknown, the root mean squa re of all six est ima tes of coeff icie nt of varia tion was
laken. This was 2.76%. As single samples measured in different runs are subject
to both within- and between-run variation, this is the overall va riation due 10 both
sources of error. The coefficient of variation due to between-run variation alone
is the square root of 2.762 - 1.652 - 2.20%.
4.3.2 Concentration
4.3.2.1 Within-plate variation
Originally, one plate was inoculated with 5 nl, of pooled serum in every well
for this estimat ion, but the plates eub.sequenuy prepared to check the limit to
linearity of the amount of cholinesterase with immunoprecipitin ring area are also
useful. Random error in measurement of the diameters of the rings with the
calibrating viewer will be a larger percentage of the ctameter the smaller the ring
so the relevan t plates to look at are those with rings of about thr. same size as
those of the samples. For the blood donors, the 5 J,lLplates are appropriate. t t.e
mean ring diameter of the 111 high·activity samples measured was 89.0 mm{10 ,
which is slightly larger than that of the 4 ul, pooled serurn rings, and the mean
ring diameter of the 117 normal-activity hyperlipidaemic samples was 80.6
mm/l 0, which is between those of the 3 and 4 IIL rings. Though in fact all the
wells contained the pooled serum secondary standard, the co ncentrations given
by each of the 18 per ipheral rings were calculated using the central ring as
standard just as for all the plates of clinical samples. The coefficients of variation
of these concen trations from the 3, 4, and two 5 III plates were respectively 6.26,
6.49, 5.62 and 5.83 percent, root mean square 6.06%.
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Table IV . Betw een-run variation of serum cholinesterase activity measurement
>~tM~th'sHji :;h~:fJh(~~;,: VG~~'~m*i;;~:'
' - " ,
,<>; ' ; ,:St.~;': ; 3369.5 93 ,0 2.76
.,,: 3385 .4 62,8 1.86
I :, . "d:' Sta"'d~; 2516 ,9 78,0 3,10; .;.:~~}gn'd 'j \\ 24 72 .9 87 .1 3 .5 2
~ , ;' :~YStaft\~: 2145 .8 58 .2 2,7 1
I ',";; -;_<;':E ri~:i"#';! 2158.7 48 .8 2 .26
Results for three different commercial Quality-control preparations at the
beginning and end of each of 15 activity assays
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This is quite a large error . The two components of this error that migh t come
to mind first are in pipelling the serum samples into the we lls and in measuring
tho diameters ot the j)(ocipil in rings. The Ziptrof device used for pipening is so
simple thai very little of the error is likely to come from this source. The
measurement error was not large either. At first. rings were measured twice in
each of two directions at right angles . For 67 pairs of measurements (the two
measurements in each pair made on different days) the diffe rences were
calcutaied 1llen all negaUve signs were changed 10positive, each difference
expresse d as a percentage of the firs t measurement of the pa ir, and the mean of
these percentages taken. The result was 1.34%. Th e dia me ters recorded we re
small because al the l ime ring C was being measured. By the time the decisio n
had been made to measure ring A the rings were only bei ng measured once In
each direction. The mean of the diameters from which this result was derived
was 78.12 mm/10 for the fi rs t meas urement and 77 .66 for the seco nd. For the
larger rings A , the diff erences would have been a smaner percentage.
Two othe r sources acco unt for most of the erro r . These wera revealed only
by no ting the positions 01rings of different sizes on the plates. The first is terme d
here 'the posi tion effec t'. An impression was gained ea rly in the measurement of
Ihe samples that the rings might be la rger towards the outsi de of the dish . It was
10examine this poss ib ility tha t the tirs t plate with 5 J.lL of pooled serum in every
wen was prep ared. The arra ngeme nt of the wells on the pla tes has a six-fold
syme try and there are four c lasses of position with respect to distance from the
centre 01the plate: the cen tra l well, the six wens of the inner hexagon, the six
walls in the middles of the out s ide edges, and the six outer corner wells (see Fig.
7, p. 105, again). On the trial plate Ihe (ring C) diameters o f the ce ntral ring and
the means of the six rings in each of the other classes of po sition in the same
order were respective ly: 70 .25 , 72.7 1, 76.71 and 76 .88 mmno. O n this plate
(which later proved to show an excep tionally large position e ffect) the mean of
the outer corner well dtameters was 109 .4% of the mean of me asurements of the
centra l wen diameter . Using lhe figures from this plate It was decided to correc t
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the calculated serum cholinesterase concentrations lor the 117 blood donor
samples according to the position thai each sample had occupied. When this
was done, it was found thai the corrected concentrations corre lated slightly less
well with the cholinesterase activities than did the uncorrec ted results .
Looking at the problem ano ther way. it wac decided thaI the results of tho
specimens could be used 10 look for evidence of the effect even though their
cholinesterase concentrations were aU different. The central wells always
contained the pooled serum standard so the samples were in three classes of
position. It would be possible for the mean concentration of the sampler- in one
position class to be different from that of the sampl es in anothe r position by
cha nce, but this could be controlled for by looking at the independently-measured
serum chOlinesterase activities of the same samples. In the blood donors , the
mean activity 01the samples in the corners was by chance highe r than that of the
samples in the inne r hexagon with the mean of the activities of the samples in the
middles of the outsides intermediate. II was no surprise therefore to find that the
mean concent rations were distributed in the same way. When the activities wero
divided by the concentrations it was revealed that there was no significant
difference in the mean spec ific activities in the three position classes.
Calculation of the means of the ring diameters in the four different position
classes on the six pooled serum plates used to look al linearity showed that on
some plates the rings were smaller in the middle than at the outs ide and in some
ve e versa, and that all the differences were much smaller than on the first pooled
serum plate. It seemed then that chance operating on small numbe rs could be
responsible. This was because the effect had been assumed to be due to some
kind of interference because the central and inner hexagon wells are each
surroun ded by six other wells whereas those in the midd les of the outsides have
only four adjacent we lls and Ihose on the corners only three . By Ihis explanation
the gradation in ring size should always be in the same direction . In retrospect
another mechanism can be proposed. The Petri dishes are made of plastic.
Around the edge under neath there is a lillie ridge about 0.5 mm high. It is
150
therefore possible for the cent re of the plate to buckle sligh tly, e ither upwards or
downwards, without drawing attention by causing the plate 10 rock. Th is could
perha ps occur when the 'hot' (54OC) ga lls poured lntc the dish. If the cen tre sags
the gel will be a lillie thicker there so there will be more antibodies and the
precipi tates will be restricted to a slight ly smaller diameter than those furth er out.
and if the centre buckles upwards the reverse will hold.
II is thus possible for the position effect to causa error without being
apparent in the addition of a series of plates because 01cance lling. It would
seem however thai the buckling is more often downwards than upwards . If the
rings are smaller in the centre the calculated concentrations will be larger in the
outer samples and so these outer samples will apparently have lower specific
activities. No position trend in specific activities was found in the results of 48
ncrmouptdaemrc patients. The apparent mean specific activities of the outer
hexagon samples were slightly smaller than those of the inner hexagon in the
normal-cholinesterase-activity hyperlipidaemic patients at both 5 and 3 I-l but
this was not statistically significa nt. There was however a statistically significant
difference in the same direction between the means of the corner and inner
hexagon samples in both the donor samples repeated at 3 I-lL and in the high~
cholinesterase-activity patients. The greatest difference was in the tetter, the
mean of the corner samples being 6.6% lower than that of the inner hexagon
samples. The mean error from this source over samples in all three classes of
position would of course be less. Because this ::;,for will affect the mean
concentration estimate of samples on a plate it contributes not only to within-
plate error but to between-plate error. The lesson from this discovery would'seem
to be to useglass.
The other source of error was discovered from the linearity plate data only
after writing out the results for each plate in the same pattern as they appeared
on the plate. It was noted that the largest of the 19 rings was nearly always on
the outside and that the smallest ring was also nearly always on the outside, and
that these fwo rings were always on opposite sides of the plate, though in every
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case the direction across the plate was different The obvious explanation was
that the table on which the dishes had been [aid while the gals sol was not
perfectly level, so mat the gers were very slightly thicker on one side than on thu
other. This was indeed found \0 be the case. Because the pooled serum
standard was always in the central well, this does not affect the mean
concentration but only increases the standard deviat ion . By the l ime this error
was realized, all the specimens had been measured and the nonetheless good
correla tio ns (see Chapter 5. p. 157) were known. and it was decided to interpret
the resu lts in the full knowledge of the errors rather than repeal all of the work.
4.3.2.2 Between·plate variat ion
Extra controls . apart from the pooled serum - were not included on the
plates for the purpose of calcu lation of between-plate var iation because it had
been intended to elimina te this source of error by calcu lat ing the concentrations
o f the samples on each plate with respect 10the pooled serum standard on the
same plate . With the discovery that there was a position effect which could make
all the sample rings larger or smalle r wi th respect to the centra l ring made it
necessary to de vise a way of assess ing the magnitude of th is error , Two
methods were use d.
The first was 10ex tract the information Irom the data of the clinica l samples
in a similar way to that used fo r the posi tion effect. By this time, any samples
w hose results had appeared to be affected by interference had been retested.
Also , for any sample in which cholinesterase concentration and activ ity had been
foun d to be at var iance , one, o r usually both estima tes had been repeated to
check thi s. Thus the first thing 10 do was to go back to the original results and
look at the data Irom each individual plate . Second ly, it would obviousl y be
poin tless to com pare the mean concent ration of a plate of blood donor samples
with that of a plate of hyperlipidaemic pat ients since the lauer we re known to
have higher serum chol inesterase activities and, by this stage of the
investigation, conce ntrations also. Uke would have to be compared w ith like.
152
However , if one could assume that there was no difference in speci fic activities of
choline sterase between different groups of subjec ts one cou ld use the acti vities
to control for such differences in concentration, leaving only the variation
attributable 10 betwee n-plate error, and could use etlme plates for the estimation .
Analysis of the data separated into plates led to the conclusio n thai one could not
make this aeumpnon (see Section 5.4, p. 161). Thus like would still have 10 be
compared with like. Amongst the patient samples there were ones in which
repeat lest ing showed that their specific acti vity was considerably lower Ihan tha i
of the others. These results disturbed the within-plate means. For this reason the
estima tion of between-plate variation was restric ted to pla tes of blood donor
samples .
The re were seven plates on which the donor samples had been tes ted w ith
5 ul, and another three plates on whic h samples had been repeated at 3 il L.
Amongst the donors it was still true that the mean concentrations of the samp les
on two plates could be diffe rent due to chance, so the system of contr olling for
this w ith activity by calculating spec ific activities was used. The specific acti vity of
each sample was calculated (using the best estimate of activi ty if activit y had
been repeated , but of course using the orig inal concentration resu lt) and the
mean specific activity on each plate foun d. Calculation of the means eliminated
Ihe within-plale variation so that comparison of the ten means as individual data
would give the between-plate variation. The coeff icient of variation was therefore
calculated from the mean and standard deviation of these means. II was 2.68%.
This w as howev er the between-p late variation of specific activity estima tes and to
find the variation in concentration alone it would be necessary to remove the
variation derived from activity measurement. This however is more easil y said
than done . The samples on each plate did not all have their activities measured
in the same run and there were not the same number of sample s in a run as in a
plate, but calculation of Ihe mean speci fic activity on each plate should remo ve
most of the erro r from measurement of act ivity leaving most of the between-plate
variation from activity as chance variation (sampling error). The best that can be
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said is therefore matthe between-plate variation in concentrati on is probab ly a
little less Ihan 2.68%.
The othe r method was 10look at the means otthe concentrations ca lculated
from the rings on the plates of pooled serum used to investigate within-run
variation. In the latter work the 2 ul, plate was excluded because the rings were
small and the within plate error therefore likely to be larger than in the plates of
clinical samples (the CV was actuall y l .lo/G). This should nol affect the mean, so
it could be used for the between -plate examin ation. The 6 and 7 ul, plates w ere
net used however as the linearity analys is had shown thai their me ans were
affected by interferen ce. Thus there were five useful plates: the 2, 3, 4 , and two 5
IJL plates. The coefficient of variation of the mean concentration s on these pla tes
was 3.55%. This however is based on an extremely smarr number of data. In
that light it is remarkably close to the other estimate and the best estimate is that
this sou rce of error contributes variation of about 3% (CV).
Because measurements were repeated when suspected to be incorr ect , for
example because of poor corresponden ce between activity and concentration,
the ac tual mean deviations of the final da ta from their true values are probably a
lill Ie less than those indicated by the error calculations.
4.3.3 Limitation of Interpretation of results Imposed by
measurem ent errors
In the next chapter it will be sho wn that the overall variation in serum
cholinesterase activity and concent ration in the samples was much larger than
that due to errors, and that very good correlations betwee n the two
measu rements were still found desp ite these errors, as well as interesting
corre lations with lipid indices. However I specifi c activity is calcu lated by divid ing
activity by concentra tion and the erro rs are compounde d. In the course of the
study of (oe errors in both measurements it was found that small differen ces in
means due to between-run or between-p late variation cou ld cause statistically
significant differences in specific activity between runs or between plates when
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no such difference was likely in reality . It was therefore concluded that
statements about quantitative diffe rences in specific activity could not be made
without considerably more precise measurements of the compo nents and that
any such compenscne should be restricted to well-cons idered qualitati ve ones .
4.4 Justification of the use of well diameter in calcu lation of
serum cho linesterase concentration
The method of calculatio n of the cholinesterase concen trations of sa mples
from ring diameters with reference 10 the concentration and ring diamete r of the
pooled serum standard has been explained. II invol ves subtracting the square of
the well diameter from the square of the ring diameter. This implies the
assumption thai jf the square of ring diameter is plotted against amount of
cholineste rase in the sample the intercept on the ordinate will be the square of
tile well diamete r, 900 (mm/10)2. The findings of Mancini et al. (1965) Indica ted
lll at lhis is usually not exactly so but that the interce pt is slightly larger Ihan the
well. They proposed that the Iwo were re lated by the equa tion
So "p +q·Sw
where So is the area of the intercept and Sw that of the well. Unfortunately they
did not give values to p and q and they ne ver gave any units for their areas from
which Ihese values might have been de rived. (Probably they were in mg of
cardboa rd or somet hing similar and so not rela table by the reader to the well
diameters .) They also found that the amo unt of sol vent dilut ing the same amount
of antige n appears 10affect slighlly not only the size of the intercept but the area
of the precip itate , both being larger by the same amo unt for any given incre ase in
volume of diluent This means that me use of diffe rent volumes of undiluted
serum 10 simulate different amounts of cho linesterase in serum sam ples all of the
same volu me is not exactly correct - though making dilutions would have
introduced an additional source of error • and that lhe calibration of serum
samples, which all have different ratios of so lute to solvent , is not exact.
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It is the pu rpose here to show that the figu re of 900 (mm/ 10r is p robably
not far from the true valu e, and th ai alte ring it would ha ve very little effect upon
the corre lations be tween the calculated concentrations and other measurements .
For a sta rt, i( was noticed that sl ight alterations of the p osition o f points used to
calcula te a regre ssion line may h ave la rge effects upon the inte rcept calculated
whilst ba rely altering the slope. In looking altha position effect, th e means of the
squares of the diamete rs of the six rings in eac h of th e three sample position
c lasses were ca lculated for each of the plates used \0 look at linearity .
Regressions ag ainst vo lume of inoculum were calc ulated for th e squares altha
cen tral well rings for the first four plates (2 to 5 ~L) and for the first five plates ,
and for the means 01the squares of the rings in the diffe rent position classes for
the same series of plates . Thus eight reg ressions were calc ulated and the ratioo f
solute to solvent and the wei! size wasconstant. T he correlation coefficients were
very high: 0.997 in one, 0.999 in two and :>0.999 in the other five. The coefficien t
of variat ion of the slopes was 5.62% . The result for the intercepts was 39.4%,
the range being 334 to 1296. However , the mean of the eigh t intercept s was
898.2 which cou ld hardly be cl oser to 900. (Th is little investigation ve ry nicely
explains why the results of the qua lity control samp les in the ecflvlty
measurem ent were quite good al pred icting slope but useleas for p redicling
intercept in between-run vanauc n.)
One other little test was do ne at an ea rly stage . For 10 2 of th e blood
donors, correlations were ca lculated between their orig inal activity
measurem ents a nd concentrations calculated using 900 and a range of othe r
intercepts. The correlation was 0.912 using 900 but 0 .911 at 1000 and fell to
0.9 10 by 1400. G oing the other way, it remained at 0.912 dow n to 500, below
which, s urprisingly, (t graduall y incre ased, reaching 0.916 at -4,0 00 and
remaining at tha t down to at feast -200,000. 11 was decided to use the th eoretica l
value of 900 derived from the we ll diameter.
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4.5 Summary of method of cholinesterase concentration
measurement
The concentration of the enzyme was measured by ra dial immunodiffus ion
in Pelr ; dishes contain ing 8ml of 1% agarose containing O.15% rabb i t anti-serum-
cho linesterase antiserum. In each g8119 wells of 3 mm diameter we re cut in a
hexagona l a rray wi th 1.5em betwee n the centres. T he cent ra l well o n every p late
was loaded witha standard, consisting of pooled human se rum from 56 donors
wh ich was ca librate d agains t the purified c ho lineste rase, and 18 samples to be
measured were placed in the other wells. 5 )JI vo lu mes were used for sam ples
expec ted to have normal concentrations and 3 J.l, 1 whe re concentration was
expected to be hig h fromknowled ge of the activity . Tha ge ls were incubated at
37°C lor 7 d ays and then staineds pecifically for se rum cholines terase lor at le ast
2 hrs. The diameters of the discs of immunoprecipitate were then m e asured with
a calib rating view er in two directions at right a ngles. Concent rations w ere
calculated in relatio n to the standard on the sa me p late by the formula :
Conc. (mg/L) = 23.68(sample diam.2 - 9OOl/(standard diam.2 - 900)
whe re 23.68 is the concent ration o f the standard in mg/L, diam. is diamete r in
tent hs of a millime tre, and 900 is the square of the diameter of the well. Any
sam ples creating pr ecipitin rings of diameters greater than abou t 10 mm or
showing any sign of Interfe rence w ith other rings we re re tested with a smaller
volume 01seru m.
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Chapter 5
RESULTS (2)
5.1 Further deta ils of the sub jects
It is on ly 100 easy 10 derive a falsely high c orr elatio n coeffici ent by selecting
samples wi th results toward s both ends o f the dis tribution s of the variables under
study. The patient sample s used in this stud y we re already lrom a selected grou p
in that thei r physi cians ha d had some re ason 10 reques t serum lipid profiles. for
e xample because of fam ily histo ry or be cause the patie nts had conditions wi th
w hich hyperlipidaem ia Is associa ted, or because they ha d previo usly been found
to have hy perlipid aemla a nd were on tre atment. Th at bias could not be remove d ,
bUI further bias could be avoided by not using further se lection in the samples
used for correlation calculaucns . In this study there was particular Interest in
ca ses in w hich se rum cholineste rase an d/or lipid indices were at the extremes .
but for the purpose of correlation calculations. only consecutively -recefve d
samples of the same ag e-range as the blood donors were used. Of the 282
patient sam ples in whom serum cholinesterase concentration was mease ed .
20 9 lilled these cntena. They co mprised 35 who had normal lipid profiles, 72
wi th type lIa hyperlipidaem ia, 70 with ty pe lib, I type Ill , 30 type IV and 1 type
V. Their mean age was 44.3 years. The othe r 73 patients comprised ones
se lected because 01 high serum cholines terase activity or low or normal lipid
levels as w ell as ones exc luded from the consecutive series on the basis 01age .
They were composed of 1 hypolipidaemic patient , 2 with hypo-beta -
tlpcp rcteln aemla. 18 normolipidaemic, 17 type Ha hypertipidaemia, 21 type fib. 1
type Ill, 12 type IV and 1 type V.
5.2 Variation between sam p les
The variation in serum chol inesterase lor the blood donors and consecutive
age -matched pat ients is shown in Table V . The total variation in both
concentration and activity estim ates is much larger tha n that due to errors .
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Table V. V ariation in serum chonnesrerase for don ors and patients
"Maari' s.o;" CVlo/.}1 'Mfr;:! ;Ma:x".
Blood I ~ctlviiv"jUJl)<',~',: 3562 702 19.8 21 '2 5 ' 95
donors"~~ ""' -conC;~ ~ltr~tjon ;(. ·
N ;'l17 ' :
" :': ~' ~ lm'glL f;':: ,~:::' 25.1 4.6 18.4 14 .9 35 . 7
Matched - J)atlent~~~:;'}:~S"':'::L; ,:> ~:::-~
.- , - ,:< >:;..."scilvlr/"IU,U .i,:" 3715 807 21.7 17 78 6542
All
c6n'C"entratio'nN ~ 209. .. 27.7 5.8 20.8 15 .4 50 .0
.:,'" '. ·:' (mglll~·:.·
Fe~i8 '·-;r :~-'a'cih;liV (Oil,' ;; 3513 802 22.8 1778 65 42
N ' ~ 112 ·: r, ·conc(i~trat ion·.-: 26.2 5.6 21.4 15 .4 50 .0
.. ...• '":··{; I",gltl';'··".,
:ectivitY (i:iIi.I :~~~; : 3949 75 ' 19.0 1846 5806Male" c~~hf~~~,~f:·:~· ·~N . 97 29.5 5.5 18.6 15.4 47 . 7
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Although many of the additional patient samples were at the upper and lower
ends of the range, none were beyond the extremes of the consecutive aqe-
matched patien ts . For the patients the sexes are known and Ihe means of bolh
activity and concentration are significantly higher for men, p .. 0.0001 for activity
and even less for concen tration. For the donors the dist ribution of activity and
concentration measurements were slightly positi vely skewed . For the matched
patients howeve r, the distributions were normal for the whole data and for the
sexes separately .
5.3 correlatlon between serum cholinesterase acti vity and
concentration
Serum cholinesterase activity is p'otted against its concentration for blood
donors and for all the patients in Fig. 12. The correlation coefficient, r, for the
blood donors was 0.95. p < 0.001, but for the consecutive age-matched patients
0.88, p < 0.001. The regression equation calculated from the donors was
Activity (U/l) - - 80 + 145 • concentration (mg/l) .
Ideally this line should pass through the origin. It is close. The intercept is only
about 2.25% of the mean activity of the donors.
The regression line has been drawn through both plots. For the donors
there was only one individual whose result stood out noticeably from the rest.
The serum cholinesterase concentration 01 this sample was 22.7mg/L. The
observed activity was 2329 U/L but the activity pred icted from the concentration
on the basis of the regress ion was 3209.4 ± 45.5 U/l (95 % confidence interval).
The residual (t.e. difference from expected) was thus - 8 80.4 and the standard
residual (l.e. number of standard deviations of difference from expected) was
-3.99. Both act ivity and concentration estimates were repeated and confirmed
that this was an unusual result. No clinical deta ils are known except that the
individual was acce pted as a blood donor .
For the patients it can be seen that there are many more below the donor
regression line than above, and that some ate very much lower than expected.
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Fig, 12 . Activity plotted against concentration fo r serum cholines terase
(a) 117 blood donors: (b) 282 patients for whom serum lipid prof ileshad ber .
requested. The regression line calculated fromthe blood donorresults has been
drawn on both gr aphs.
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Samp les standing out, and those furthest from the tine o n the border of the main
group were retes ted. The orlginal estima tes were alw ays kept lor all fUlure
calculations unless the repeal res ult was substa ntiaDy closer 10 the expecte d
value, in which ca se lhat result was substituted . The fig ure shows the results
after this had been done. Thus the results appear to show mat ihe mean specific
activity of se rum c ho lines terase for thepa te ntsw as lower lhan that for the blood
donors and lhal fo r some individu als ~ was much lower. Thenext two questions
then had to be of whether mere was a rea l difference in specific activitj and. if
so , what the cause migh t be.
5.4 Comparison of specific activit ies
The mean specific activities (1 standard error in parenthoses) of the 117
donors and the 209 ma tched patients were 14 1,7 (0. 83) and 134.3 (0.90).
Applying Student's t lest, t - 5.98 , P < 0 .0001. However , this result is not valid
be cause it assumes that the indiv idual measu remen ts we re indepe ndent, and of
course they were not. Activi ty measurements were grouped in runs and
con centrati on mea s ureme nts were groupe d in plates. As has been mentioned in
Sec tion 4 .3.1.2 (p . 143) bejween-run variation in the in itial measurements of
ac tivity of the pati ent sa mples resu lted in statistically si gnificant differences in
me an speci fICactivi ty be tw een runs thoug h none was likely in rea lity. When !he
activity measu rements w e re all re peated , donor a nd pattern samples were put
in to the same runs so tha t beiwee n-nn va riation could not be held 10acco unl lor
a dif.erence between the groups . The conce ntra tion m e asurements, howe ver,
had been made wi th dono- and patient samples on different plates and so
provided a possible source 01difference ir. specific activity estimates.
The specific ac~vity estimates for patients a nd bloo d donors derived from
the concentration results on the individua l radia l immunodiffusion plates, as
described in Sectio n 4.3.2 .2 (p. 151), are compared in T able VI. The two plates
of normollpi daemic pallents had mean speci fic ac tiv ities within the range 01 the
m eans of the dono r plates but 9112 of the plates of hyper lipidaemi c cenerue had
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Table VI. Compar iso n between blood don ors and pa t ients of mean specific
activi ty est imates of sa mples whose se rum cho lines te rase co nce ntration was
measur ed on th e same gel
Blood donor plates ulling 6 pL serum
N Mean S.D. C.V.l%1
18 140. 9 8.3 5 .9
14 14 1 .0 8.4 5.0
18 150.7 11.0 7.3
18 138 .2 9 .5 7 .0
18 146.6 5 .5 3.8
18 :18.6 12 .7 9. 1
16 14 3 .4 9 .3 6.5
Blood donor plates using 3 pl serum
N Mean S.D. e.v. (% 1
18 143.8 9 .7 8.8
18 144.0 8.3 5.8
14 140.4 10 .4 7 .4
' N 'eMaan s.o. C~V.j%l
18 13 7.2 9 .8 7.1
18 14 8 . 1 5 .8 3 .9
Hyperlipids llmicpalienls with '
. normal ChE activity!] pL eeruml
N Mean S. D. C~V.(% I
18 126.5 12 .5 9.7
18 138.8 10 .6 7.6
18 128.9 6.3 4.9
18 127.5 8 .5 6.7
16 124 .1 15 .4 12.4
14 13 1.8 14 .2 10. 8
Pa ti ~nts 'with high~erum "<";
' ch~li neste ra se activi~ ' : - :' :_::_'
t3plserum) ' - ,
N Mean S.O; C.V.I%)
17 14 2.0 10.4 7.3
15 13 1.7 9 .1 6.9
18 14 3 .1 8.7 6 .1
16 136 .6 15 .4 11.2
18 13 1.4 9 .0 6.8
18 13 1.7 7 .7 5.8
In those cases where less than t he 18 poss ib le samples on a plate are reco rded, th is
is because the othe r wells were either irregular and cou ld not be used or co ntain ed
samples in a different category . If less than 14 of the samples were of the same
category the plate was excluded from t his comparison . For examp le, 12 sam ples from
normouprdaemrc patients we re on a pla te with 3 sampl es selected because of low
lip id concentrations, 2 with low cho linesterase activity and 1 blood donor sample .
{Ch E ~ serum chcttnesrerase .)
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means below the lowest one of the 10 donor plates. This strongly sugge sts thai
the difference between patients and donors cannot be attributed to cnence.
despite the size of between-plate variation. II may also be noted that tho
coefficients of variation are generally larger in lhe hyperlipidae mic pati ent plates
as might be expected from the distributions in Fig. 12 (p. 160). The two don or
plates with the highes t variation are those on which the one outstanding sample
(see p. 159) appea red.
5.5 Investigation of reduced correlat ion in patients
In order 10 determine whether the reduced correlation for pat ien ts could be
caused by one of the serum lipids or lipoproteins inhibiting the enzyme or
interfering with the activity assay, the expected acti vities of all the patient
samples were calculated from the donor regre ssion equation. The cnterenceo
between obse rved and expected were then compared with the lipid indices. No
correlation was found between the difference an d any lipid index.
Another possibility was that me reduced, and more variable, speci fic activi ty
in the patient samples could be caused by aging of the samples. The blood dono r
samples wer e handed over for this study one or at most two days after they were
taken, being refriger ated till then and frozen from then onwards. The patient
samples however were kep t by the hospit al laboratory for several weeks befo re
being handed over (the longest seven weeks) and were only refrigerated durin g
that time. However, serum cholinesterase is a very stable enzyme. Whittaker
(1986) reviewed reports on this . The enzyme has been found to be stable for at
least several weeks at a_soc and sev eral years when frozen. As a check, 55
blood donor samples refrigerated at 4°C were compared with the 117 (frozen)
samples used in this study. The concentrat ions were estimated when the
samples were 7 months old and the activities were assayed when they were a
year old, the assays being done at the same time that the pa tient and donor
spec imens used in thi s study were remeasured. The results are shown in Table
VII.
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Table VII. Se rum cholin este rase age ing at 4GC
N Mean S ~D . S.E; t P DF
Frozen 11 7 24 .93 4.63 0.43
CONCENTRATIONS 0.29 0.77 84
Refrigerated 55 24.66 6 .05 0 .82
Frozen 117 3562 704 65 .1
ACTIVITIES 2.58 0 .01 104
Retrigl3f 8ted 55 3262 715 96.4
Comparison of the serum cholinesterase concentrations and activities of blood
dono r sam ples kept refrigerated w it h ones kept fro zen . The concentrations w ere
mea sured w hen the refri gerated samples we re 7 mont hs old and th e acti viti es
when they were 1 year old .
Key : I, tw o-sample t similar to Student' s t: p, probability of means being as
di ffe rent by chance; DF degrees of freedom . The DF are different in the two
comparisons despite the nu mbers be ing the same because in this test they are
c a l c u l a t e d f r om t h e varia nces of the sample s .
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As the concen trations of the two sets of samples are the same, the figures
suggest that the mean activity diminished. The activities of the old donor
specimens were measured when they were fresh but those results could not be
com pared wi th the taler resul ts because of between-run variation and change in
batches of quality-controls (see Section 4.3.1.2, p. 143) $0 this comoartscn
between the two sets of donor samples is the best Ihat could be done. Just as
there is a small possibility that the apparen t difference in specific activity between
donors and patients was caused by between-plate variation in concentration.
there is a possib ility that there was actually no detclable loss in activity at the old
dono r sampl es but Ihal there was a difference in mean concentration which tho
conce ntration assay failed to detect. This possibility is greater because there
were less old donor samp les than patient samples. However , if we assume that
there was reat loss of activity. this loss comes to 8.426'0 in 357 days . If this loss
was linear then in 41 days this would have been 0.97 °,'0. Actually the loss should
be exponenti al, but with an asymp tote 01 zero this would make virtua lly no
differe nce over such a short period in compa rison to the obvious ly 1001g in vitro
half -life of the enzyme.
Thus ou r estimate is that slow decay of serum cholinesterase activity at 4°C
might account for an approximately 1% difference in mea n speci fic activ ity
between the blood donor and patient samples. This is not enough to account for
the o bserved difference , so again we come to the conclusion that there probably
was a real difference between patients and donors. An additional factor is th at
some of the patient samples come to the laboratory by post. Whittaker (1986)
says that 'pla sma cholines terase is able to withs tand the rigou rs of most posta l
serv ices', but Is possible that the lower correlation of cho linesterase activity wit h
concentration for pa tients than for donors could be due to this. It might also be
part of the explana tion for the lower correlations of cholinesterase activity than
cholinesterase concen tration with serum lipid indices (see 5.7.1,? 173) but it
will also be shown that the concentration of the enzyme corre lates less well w ith
serum lipids for patients than for blood donors and thai for this there is a different
expla nation ,
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One outer source of variation for which 10 check was a sex· difference in
co rrelation in the patients. The correlation between activity and concentration in
the women was 0.93 but in the men 0.80. Plotting the two measures 101" the two
se xes, Fig. 13, shows the reason . By chance presumably , all of the four resu lts
furthest be low the regression line were from male patients. 1he important
question was 01whethe r there was Bny differe nce in specif ic activity between the
sexes . SpecifIC act ivities were calculated for all the individuals and the means
calcu lated (rather than dividing mean activity by mean concentration). The
resu lts are given in Table VIII. They show no difference in spec ific act ivity
between the sexes . This is nOI subject to between-plate error since the samples
rrom the male and female patients were interspersed at random on the same
Petri dishes for concentration mea sureme nt but, as discusse d above , the actual
size of the difference in speci fic activity betwoon patients and blood donor s, if
real , should not be judged from these figures. It is evidentthatthe poin ts furt hest
rrom the line disturb the correlation result more than the mean and it shoul d be
noted that for the wome n patients . not jus t for the men, the standard devia tion of
apecnc activ ity is cons iderabl y larger than that found for the donors.
5.6 Serum cholinesterase in hyperlipidaem ia types
The mean cholinesterase resul ts of the consecut ive age -matched patients
categorized by hypen ipidaem ia types are shown in Tab les IX and X. The
relat ionsh ips between the means of concentration in the diffe rent groups close ly
mirror those of the activity means. The blood donors had not been asked to fast
over night before the blood w as taken , as is usual for serum lipid prof iles. but their
se rum lipids were examine d. Only cho lesterol. triacylg lycerols and 'total LDL'
wer e measured. The Janeway Hospital Laboratory was not asked to perform
lipoprotein electrophoresis and type class ification on the samples, but rough
class ification was possible on the basis of the indices measured. The same
maxima and minima of serum choles terol and trlacylglyce rol tar the groups were
use d as for the patient s. The result s for the donors are give n In Tables XI and
XII.
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Table V III. Specific activities of serum cholinesterase for male and female
patients compared with blood donors
N ',Mean Min. . Max.~ . S.D. ' S.E.
I Blood donors 117 14 1.7 102.6 15 8 .7 9 .0 0 .83
I Female patients 11 2 1 34.3 101 .1 160.2 12 .1 1 .14
I Male patients: . 97 1 34 .4 53.3 157 .6 14 .2 1 .4 4
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Tab le IX . Serum cholinesterase activity in the common serum lipid categories
drawn fro m the age-ma tched pa tients
Diffe rence
Type N Mean Min. Max. S.D. S.E. between sic .
means
Norm 35 3186 224 2 4635 560 94 .6
72 3666
Norm & Iia 0 .0004II, 177 8 5228 77 1 90.9 lIa & lib N.S.
lib 70 3868 2051 5806 76 1 91.0 lI a & IV N.S.
lib & IV N.S .
IV 30 403 7 2482 6542 950 174
Norm :no rmo lipid aemic Significance test : tw o-sample t . N.S .: not sig nificant.
Table X. Serum cho lines terase co ncentra tion in the common serum lipid
categories drawn from th e age-matched patients
T~~.e DifferenceN Mean Min.- Max. S.D. . S. E. between 5ig.
.' means
Norm 35 22 .2 15.4 30 .4 3.75 0 .63 < 0 .0Norm & lIa 00 1II, 72 28 .0 16 .6 40 .2 4.84 0.57 lta & lib
lib & IV N,S.lib 70 28 .9 18 .0 4 7 .7 5.39 0.64 N.S .lib & IV N.S .IV 30 30.4 17 .6 50 .0 6.68 1.22
17.
Table XI. Serum cholinesterase activity In the common serum lipid categories
drawn from the blood donors
" ;.;,x: I ~ :D ' 1 5'1:' Ciffare'hee' v:Type N Mean Min. > 'bst~e,e.n>, ·' 1 :: ;:S,l~Y:~,
-- means
Norm 56 3265 21 12 5195 602 80 .4 No rm & lIa N.S.
II. 26 3477 2657 4959 603 118 Norm & lib < 0.0001
lIa & lib 0 .0019
lib 24 4036 2834 5084 596 122 Ha & IV 0.0062
IV 11 4236 2897 4898 696 210 lib & IV N.S
Table XII . Serum cholineste rase concentration in the commo n serum lipid
catego ries drawn Itom the blood donors
Norm 56 23 .3 14 .9 34.9 3 .96 0.53 Norm & lIa N.S.
II. 26 24 .4 17. 9 33.0 4 .16 0 ,82 Norm & lib < 0 .0001
lIa & lib 0 ,0017
lib 24 28 .1 18 .1 33 .5 3 .85 0 .79 ua & IV 0 .00 24
IV 11 29 .7 21 .6 35 .7 4 .24 1.28 lib & IV N.S,
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In the donors too, the concentration means closely mirror the activity
means. Logica lly speaking, one should say that activity mirrors concentration. but
historically, activity was studied first. II was noted thai there is a difference in
pattern between the palients and the donors. In both, the means of serum
cholinesterase activity and conce ntration ascend in the order normoftptoaenucs.
type Ha, type lib, type IV, but whereas in the donors the means in type lIa are
closer 10 those of the normo lipidaem ics , as found by most other lnvesttqatcrs. in
the patients the type lIa means are highly significanlly higher than in the
normo lipidaemics and not significantly lower than those ottype lib and IV. The
patient dala were therefore divided to see whether there was a sex difference in
this. The results are shown in Table XIII.
In activ ity and concent ration measurements the mean for every group is
higher for men than for wom en. In concentration for both sexes and in ac tivity for
women the mean for type lla is signi ficantly differe nt from Ihat for
normolipidae mia. In activity for men the mean for type l1a is closer to that of Ihe
normolipidaemics than 10 that 01 type lib but neither difference reaches
significance. Between the hyperlipidaemic grou ps, the means for type li b ere the
same as those of Jla for women but the same as those of type IV for men , but tile
differ ences between lIa and IV are not siqniflcan t. Partitioning data in seve ral
ways at once always leads to reduc tion in numbe rs in individual cells so that
eventually statistically meaningful conc lusions cannot be reached. Having
elimin ated the data of patients outside the aqe-flmits and then partitioned by
lipidaemia type and by sex the numbers in the groups are rather small.
The term 'significance' used in this section refers to probability calcu lated by
Student's t test. The rationale for accepting the valid ity 01the test for these da ta
is tha t sera from individuals belonging to the different uptoaernra types were
distributed at random in the runs and pla tes of activity and concentration
measuremen ts, and the same goes for the sexes. This is completely true of the
blood donors , but in the patient group the one exceptio n is tbat the
cholinesterase concen trations of the normolipidaemic patients were mea sured on
Ta ble XIII. Comparison of mean serum cholinesterase activities and concentrations in different serum lipid groups
between sexes for patients
: ~' .;:.-: ~.:Ac'ti:.tity" : I Concentration
S.D. I S.E.
Difference
between
means
Sig.
Norm 1 24 1 3080 1 5 12 1 10 4 21.3 I 3.4 I 0 .7
II.
li b
44 3590
34 3598
807
' 21
122
121
~
: 27. 1
4 .9
4.3
0 .7
0 .7
<0.0001
N.S.
N.S. s
9 I 3826 I 127 9 I 4 26IV
.Mear
I I 29 .4 I 9 .6 I 3 .2 I I
,5U-: ;>: ~~ Men "'. c~
::$;;fW, 'K)';:,r ~I 1' (:_ ::},:?.';~ , . ,:.; --C~nt~ntrat'ion ~:,," ':/ .,-'.
Norm 11 3417 6' 4 185 24 .1 3 .8 1.2
21 I 41 28 I 79 2 I 17 3 30.8 I 5.2 I 1.1
30.7
0 .00 22
N.S.
Norm & lIa
lIa & IV
0.9
1.0
4.6
-----t--
5 .8
'J.9.1N.S .
0 .0048 f- "
N.S.
707
729
378 6
4124
28
36
II.
lib
IV
different plates from the rest. However . as we have seen, the pattern of
concent rations between npldaemta groups was the same as for activities (Tables
IX and X) so this does not appear to have made a serious difference.
5.7 Chol inesterase and lipid indi ces
5.7.1 Correlations
The correlat ions between the serum cholinesterase measurements and tile
serum lipid indices are shown in Table XIV. For the patients with the sexes
pooled the best correlations were with 'total LDL' (LDL + VLDL) and within that
were better with VLDL than with LDL. The correlations were lower with
triacylglycerols than with VLDL and about the same with total cholesterol as with
LDL and with tut-cncresterct There was no significant correlation with HDL and
there were negative correta tions with Hp t -chclesterot, The correlations were in
almost the same order with concentration as with activity and in every case were
better with the former even though the measurement error was greater with
concentration.
It should be remembe red that the Lnt.- chclesterot concentration was
calculated by the Friedwald equa tion (4.1.7, p. 133) which is not accurate for
cases with triacylgl ycerol concentrations over 4.56 mmol/L or those with
chylomicrons or type III hyperlipoproteinaemia . These restrictions required the
exclusion (for this index only) of 25 of the 209 pat ients, one with type III and 24
with high triacylg tycerols, of whom one was type V. When the calculation was
made for the exc luded patients, two sets of data gave nega tive results, one with
type IV and a triacylglycerol of 9.3 mmol/L, the other with type V and a
triacylqlyce rcl of 15.5 mmol/L. If only these two were excluded the corre lations
fell to 0.21 and 0.27 with the activity and concentration of cholinesterase
respectively. However, it will be shown below that the exclusion of individuals
with high lriacylg lycerols improves the correlations not only of Lnt-c holssterot
with serum cholineste rase but of triacylglycerols with cholinesterase. The reason
for thIs will be dlsoussed later.
Table XIV. Correlations of serum cholinesterase with lipid indices for patients and blood donors
0.36 <0.001 0040 <0.001
0043 < 0 .00 1 0045 < 0. 001
0.46 < 0 .00 1 0 .51 < 0 .0 01 I 0 .60 I <0 .00 1 I 0.61 I <0 .00 1
0 .38 < 0 .00 1 0 .42 <0 .00 1 I 0 .51 I <0.001 I 0 .52 I <0.001 I ~
0 .35 < 0 .001 0 .4 1 <0 .00 1 I 0.48 I <0. 00 1 I 0.48 I <0 .00 1
0 .33 < 0 .00 1 0 .41 < 0 .00 1
-0 .29 <0.001 -0 .30 < 0. 00 1
·0 .0 5 N.S . ·0.0 1 N.S.
Correlation coefficients Ir) and respective probabilities (pi of serum lipid indiceswith serum cholinesteraseactivity and
concentration in the blood donors and matched patients. t" For t rn-choiesteror N = 184 after exclusionof cases in
which the Friedwald formula cannot give accurate predictions. See 4 .1 .41
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For the blood donors the correlat ions with the three lipid indices measured
were in the same order as lor the patients but were all greater . The correlations
between each lipid Index and the two cholinesterase measures were much close r
than for the patie nts, being only slight ly better with concentr ation for ' total LOl '
and lriacylglycerol.
When the patient data was divided by sex . Table XV • the correlation
results were found to be cons iderabl y bette r for women Ihan men. The reason for
this is apparent from examina tion of the plots of serum cho linesterase agains t
lipids (next sec tion). The r rder of size of the cor relation coeffici ents is the same
as in the whole data except that, In women only, the results for LDL-cholesler ol
are much higher. Inclusion of the only six excluded patients who were women
reduces the correlations of this index with cholinesterase activity and
concentration to 0.34 and 0.42 respectively, l.e. to less than the correlations of
total cholesterol with cholinesterase, as for men. For men, inclusion of the
seventeen excluded patients whose results were not negative reduces the
correlations to 0.11 and 0,19 respectively, neither of which is significant.
5.7.2 Distributions
Taking the two measures with the best correlation, serum cholinesterase
concentration is ptotted against 'total LOL' for the patients in Fig. 14. The addition
of the 73 extra penente excluded from the correlation calculations (b) helps \0 fill
some of the gaps in the distribution and does not after the shape. We now see
why the correlation is not higher; the relationship is not linear, With low levels of
'total LOL' the cholinesterase concentration tends to be low. With increasing 'tota l
LOL' there is a steady slow increase in the minimum cholinesterase found
whereas the maximum cholinesterase found rises steeply up to about 3 gIL of
LDL (stili a low level) and then remains approximately constant except for three
very high cholinesterase results. Thus, though with the lowest 'total LOL' levels
the cholinesterase is low, with moderate levels of the former there is a wlde
range of cholinesterase concentrations. This range is progressively diminished
Table XV. Correl ations of serum cholinestera se wit h lipid Indices for male and female patients
0 .4 1 < 0. 001 0.47 < 0.001 0.31
0 .43 < 0 .00 1 0.49 < 0. 00 1 0 .37 < 0 .00 1 0 .37
0 .49 < 0 .00 1 0 .56 < 0.00 1 0.39 <0.001 0.43 < 0.001
0.42 < 0.0 0 1 0.47 < 0. 00 1 0.31 < 0.01 0.35 <0.001
I ~
.' Cholesterol 0.42 < 0.00 1 0.49 < 0. 00 1 0.32 < 0. 01 0 .37 < 0. 00 1
u)L~~K~~t;rol · 0.45 < 0.00 1 0 .56 < 0.001 0.2 4 < 0.0 5 0 .37 < 0. 0 1
"-'HO'L-~h61~ste~ol -0 .26 < 0 .0 1 -0 .3 1 < 0. 00 1 -0. 18 N.S . -0.15 N.S .
HDl + 0. 08 N.S . + 0. 11 N.S. -0.04 N.S . + 0.03 N.S .
Correlat ion coeffi cien ts of serum lipid indices wi th serum cho linesterase activity and concentration in
the matched patient s div ided by sex. Co N "" 106 fo r women and 78 for men for Lp t -chotestero! afte r
exclusions. See Table XIV legend.)
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lal th e 209 consecutive samples for patients in the same age range as the
donors; IbJ all of the 282 catlents measured
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from the lower and as 'total LDL' increases so that with the highest lipid levels
only h ig~l cholineste rase is found .
The plots of cholinesterase concentrat ion against other lipid indices and the
plots of cholinesterase activity against the lipid indices are similar, the shape
tending to be lost as the correlation coefficient diminishes . Two examples are
shown in Fig. 15.
When the data is plot ted for the sexes separately , Fig. 16. it is seen that all
the individuals with Ihe highest 'tote! LDL' happened to have been men. The
dlsnlb unon is thus truncated in women aod appears more linear. The same
expianation applies to the higher correlation in blood donors, whose plot is shown
in Fig. 17. Inspection of plots of cholinesterase against LDL-cholestero l showed
that the reason for the improvement in the correlations on exclusion of individuals
with high triacylglyce rol concentrations was that the excluded results tended to [IEl
in the top left quadrants of the plots. The excluded individuals tended to have
high cholinesterase - which we have seen is associated with high triacylglycero ls
- and low LOL·cholesterol results, no doubt related to the fact that the
triacylglycerolterm in the equa tion is subtracted. The effect of exclusion of these
individuals was thus to make the plots less triangular and more linear. However,
the reason for the correlations of LOL·cholesterol with the two cholinesterase
measurements being greater for women than for men or for the sexes combined.
and batter than most other indices in woman but not in men was not apparent.
The results of the sexes are compared in Fig. 1B. Because of uncertain ty as to
the actual LOL·cholesterol concentrations of the excluded individuals, Ihis index
is not considered further.
5.8 The effect of using logarithms
Cucuianu at al. (1975) stated that because of very accentuated skew in the
distributions of serum triacylglycerols and prebeta lipoprotein conce ntrations
these data were transformed to their logarithms for statistica l purposes . They
quoted the correlations of serum cholinesterase activ ity with the logar ilhms or
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these lipid indices. They also mentioned thai the increase of serum
cholinesterase activity lended to flatten with increasing triacylglycerol. They said
that it was their belief thai the cholinesterase activity was correlated with
triacylglyceroJ secretion rate and thai the f1allening occurred because of "'igh
lriacylg lycerol concent rations due (0 decreased removal rather than increaseo
secretion .
Cucuianu at af. (1976) gave correlations of cbotnesterase aclivily with
serum triacylglycerol and prebeta lipoprotein and their logarithms side by side.
Showing considerable improvement in the correlation coefficients on using the
logarithms (0.252 (0 0.447 for lriacylglycerols and 0.252 to 0.505 for prebeta
lipoproteins). They also gave a graph of cholinesterase activity against
(riacylglycerol to show the f1altaning to which they had referred. They did not
show the raw data. as in Figs. 14·17 (pp. 177, 179, 180 and 181), but divided
the resulls into qulnmes of triacylglycerol and cetculated the means for each
quinlile. The result was a convex curve with a fairly linear increase In
crouresierase activity with lriacylglycerol turning to a ptateau at higher levels.
Their work prompted an investigalion of the effect of taking logarithms on the
date presentedhere.
Fig. 19 shows histograms of the five lipid indices correlating best with
cholinesterase. Only the patients used for the correlation calculations are shown.
Triacylglycerols and 'total LOL' show skewing which le more marked in the
patients than in the donors. The cholesterol distributions are not significantly
skewed. The VlOL distribution is more skewed than that 01 LOL The effects of
taking logarithms of these indices on their corretaticns with the measures of
serum chcllnceierese are Shown in Table XVI.
As expected from ttanormal distribution, the correlatIons with cholesterol do
not improve with logarithms. The effects on the other Indices are much more
slight than found by Cucuianu et af., (1976) some only appearing In the third
place of decimals (not given). For the patients the changes are at least in the
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Tabl e XVI. Effect o f logar ithms on serum cnc uneste eese-nptc co rre lat ions
log ." Log. . l og.
Trig'·
l og. Log .
LOL lOL VLOL VLDL tlOL tlOl . Trig · Chol Chol
"" " " Pati en ts 0 .36 0 .37 0.43 0 .4 3 0.46 0 .4 7 0.38 0.42 0 .35 0 .35Act;vit~ • po nors 0.60 0.56 0.51 0 .4 9 0. 48 0.45
·. ··c·' Pat ients 0 .40 0.44 0_45 0 .48 0.5 1 0 .54 0.42 0.47 0.41 0 .41
Co nce ntration
Donors 0. 6 1 0 .5 6 0 .52 0 .5 1 0. 48 0 .45
Comp arison of co rrelati on coefficients (rl o f serum cholinesterase act ivity and concentration w ith serum lip id
indices against th ose with t he logarit hms of the lipid indices . t LOL - 'Total LOL' . Tr ig - t riacy lglycero l.
Chct e cnoresterct . All resu lts p < 0 .001 .
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same direction as those found by Cucuianu et el., but for tho donors the
correlations become worse.
The fol1owi19 explanation seemed likely for these results . A convex curve is
IJrought closer to a straight line by laking logarithms of ihe variable on the
abcesa. The original line is curved because the individuals \ : ilh the hi~hesl
triacylglycerol levels do not have much higher cholinesterase Ihan ut ose with a
little lower lriacylglyceroi. for whatever reason. The blood donors do not include
individuals with very high trlacylglycerols so their curve should be much more
nearly straight in the first place. The effect on a ntraiqht-fine graph of taking
logariths of the variable on the abciasa is to make il a concave curve. This will
reduce the correlation. The theory provides an explanation of why Cucuianu et et.
(1976) found greater improvement in correlation than was found with the data
presented here. Cucuianu at al. had relatively mom subjects with high
lriacylg lycerol and LDL levels; Their numbers of normolipidaemic, type ua. type
lib, type IV and Type V subjects were 24, 22, 31, 42 and 11 whereas in tho
series used for correlatio n calcula tions in this work the numbers wore 35, 72, 70.
30 and 1.
The 'heory was tested. Because the best correlation was between serum
cholinesterase concentration and 'tota! LDL ' that was used instead of
cholinesterase activity and triacylglycerols , and as the investigation was into the
shape cf the curve rather Ihan calculation, the who le 282 patients were included.
By the quintiles method, Cucuianu at st. (1976) arranged their subjects in order
of their serum triacylglycerols. They then took the 2()O/o with the toweet
triacylglycerols and calculated the means of triacylglycerol and cholinesterase
activity, and c.d the same for each successive 20%. With the data used here this
msthod does net adequately represent the shape of the distribution; even with
the ext ra data, subjects with the higher lipid levels are still relatively less
represented than in the data of Cucuianu at al. (1976) , Individuals in the top
qulntlte of 'total LDL' • with results from 6.8 to 14 gIL . occupy more (han 50% of
the whole range, 1.2 to 14 gIL. To cope with this problem, instead of dividing the
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number of individuals into five, the range of 'total LDL' was divided into fifths,
This inevitably meant thai the top two fifths contained small numbers of
individuals, but it did serve to illustrate the shapes ot the curves .
Fig. 20 shows the etrect of using logarithms of 'total LDL' in lhe patients and
donors. JI illustrates It:al the explanation re- the changes in correlation results
was indeed correct. It would seem that Cucu ianu at al. biased their cor relanons
(uninten tionally) by selecting extra subjects with high Iriacylglycerol levels and by
using logarithms, a practice which they continued in subsequent papers.
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Fig. 20. The effec t of tak ing logarithms of 't otal LOt' cor.centrattcn on
chcunesterase-tto te t LOl ' plot shapes
Serum cholinesterase concent ration in relation to serum ' toter LOl ' ta.c) or its
logarithm {b.dl . The points are the means of the results f<llling into sucesslv e
f ifths of th e ranges of serum 't otal LOl ' conce ntrat ion for all the 282 patients
[a.b} and blood dono rs tc.c t. The numbers under the points represent results in
that fift h of the range. Note that the horizonta l scares are different for patients
and donors.
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Chapter 6
6.t DISCUSSION
6.1.1 Prelimin ary remarks
6.1.1.1 Rel iability of cholinesterase measu rements
Very careful assessment was made of the &rTOl"S involved in the two
cho linesterase assays in or der 10 be ful ly aware of the ijmila lions 10 interpre ta tion
of results. Though, with hindsight, some of these errors could have been
red uced, 1" 0 correlation between concentra tion and activity compares well wilh
with the results o f the lWO other groups who have published correlation
coe ffic ients. Ailland etal. (1971), who used radial im munod iffusion (Altland and
Goe dde, 1970) to m easure concen tration and lhe method ot Kalow and Lind say
(1955) for act ivity and claimed Ihallhe repro ducib ility of beth their measuremarns
was better Ihan 3% . found a correlation (f) between the two of only 0.87 in 269
blood donors. Broc k at a/. (1990) measured concentration by E~SA. They
measured the cholinesterase concentration of all the ir 33 blood donor samples
and -=:.Iibrators in duplicale on a single microtitre pla te and quoted a within-run
C.V. of 1.36% judged from the deviations of duplicates. The activity was
measured by an au toanalyser method (Brock and Brock, 1990) for which their
estimates of CVlotal were 1.34%, 1.92% and 1.36% with different lots of quali ty
cor urot material. For u.e ccr reauon between activity and concentration they
quoted r2 - 0.90. In the work presented hete, the error in concentration
measurement was certainly larger than those claimed by the other authors, even
after repeannq a rew measurements, yet the finding in 117 blood donors was r •
0.95, r2 - 0.90.
6.1.1.2 Sex diffe renc e In serum cho li nesterase
A sign;ficant sex -dlne-ence in human serum cholinesterase activity, the
mean usually higher in males, has often been reported. Propert and
Brackenridge (1976) reported such a finding and reviewed other reports from
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1951 onwards, some fll1ding a difference and some not. Repo rts 01 a difference
have continued (AI.Azzawi at al., 1984; Yucel at ~1.• 1988; Brock. 1989; Brock
and Brock, 1990), but the most pertinent report is probably that of Simp sOfl
(1966). She found thai the ~ctivjty in serum was signifICantly affected by
haematocrtt SlId we ight and thai ....he n these were taken mtc account Ulera was
no sex-difference . Un fortun ately these varia bles ca nnol be eliminated from the
data presen ted here as they are nol \mown, but co mparison of the means 01
serum cholinesterase meas ures in the differen t hype rlipidaemia types. and of the
orders of correlations with lipid indice s in the twosex es, shows that differencos in
these relations hips are mino r and cou ld be account ed for by chance . Thus it is
safe to pool the sexes in consideration of the relationship of serum
cholinesterase with serum lipids .
6.1.1.3 Normality of cho linesterase d istribution
Serum cholines lerase activIty was shown to have a normal (Gaussian)
distribution in 451 individuals of the 'usual' phenotype (402 Cs- and 49 C5+) by
Harris er sf . (1963 ) . Altland et al. (1971) found a syme tncat distribution 01
chcnnesterase conce ntration in their 269 blood donor s, of whom 9 had the UA
genotype and 22 were Cs+' However. VOcel et al. (198B) found that tho
histograms of activity were positively skewed in bo th sexes {75 of each j of
TLKkish blood donors . In the present study the consecutive matched patient data
showed norm al distr ibutons of activity and concentra tion in both sexes but lhe
donor results showed a positive skew. Sin ce the independent measures 01
activity and concentration agreed in this it was presuma bly rea! but, assuming
that the patien t data represent the true picture . the dono r distr ibution could easily
be explained by the chance occurrence of mOI ~ wome n than men in the sample.
If this was the case , the mean cholinesterase activit y and concentration are a
little lower th an tl1ey would have been if the sexes were equally represented, but,
from the evidence o f the patients, this should not affect conclusions about the
relationship of cholinesterase to lipids.
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e.1.2 The relationship of serum cholinesterase to serum
lipids
6.1.2.1 Serum cholinesterase in hyperlipidaemia types
Within the hyperlip idaemia classification groups the means of serum
cholinesterase activity ascend in the same orde r (normolipidaemics, type Ha.
type lib, type IV) for the patients and the donors. However, for the patients the
type Ita mean is highly significan tly highe r than that of the normolipidaemics and
not significantly lower than those of type lib and IV whe reas for lhe donors the
mean for type Iia is not s ignifican tly diffe rent from thai o f the no rmolipidaernics
and is highly significantly different from those of t)'PF.!S lib and IV . This diffe rence
is maintained by the ccncennauo n means, and w ithin the two sexes. The means
of activity and concentration for men are higher than those of women in every
group but, with minor diffe rences attributable to smaller num bers, show the same
pattern. (The only other authors 10 spill Iheir data by types and sexes were
Schriewer et al. (1985) but they had very small numbers in some ca tegories.)
All the publications giving mean serum cholinest erase activity for the
hypenloldaemia tyr "lS ag ree that the mean is cons iderably higher lor types lib
and IV than for subjects w ith norm al lipid levels and is in termediate in type Ha.
Where they differ is in whether the mean is higher for type lib or type IV, and In
whether that for type tta is closer to that for normoffpldaemlc s or the other
hyperlipidaemic groups. Our patient data was classifie d with the benefit of
lipoprotein electrophoresis while the donor data was not, but this does not seem
to account for the difference . Cucuianu at al. (1975, 1976, 1978, 1985a, b) found
the same pattern as in our blood donors and !l1ey d id use elect rophoresis.
Schriewer at al. (1985) also found the activity mean fo r lIa closer 10 that for
normolipidaemics but that for type li b greater than that for type IV , and Ihey did
not do electrophoresis . Reuter and Geus (1987a, b) found Iia close r to IV, and lib
higher than IV, but did not give their lipid methods . Jain e t al. (1983) found the
mean for type Ita almost ha lf way between those for normalipidaem ia and type IV
(slightly nearer to normoffptdaemla) and also found the me an higher for li b than
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for IV, but their workwas done in thesame laboratory in which the cholinesterase
activity and lipid measurements presented here were done. II would seem
therefore that these differences would not be resol ved with out larg e numbers of
subjects and are not subs tantia l enough to be important. The mai n conc lusions
thai can be made are that the differences in mea ns of activity between groups
are underlain by differences in concentration and that thou gh men have higher
serum cholinesterase than women the enzyme varies in a similar way with
respectto lipid levels.
6.1.2.2 Correlation of s erum cho linesterase wit h serum
lipids
Serum chol inesterase conc entration and activity corr elaled almost equally
well with serum lipidS in the blood donors. In Il'1epatents , activity correlated less
well with conce ntration than it did in the donors, and less well wi th lipids than did
concentra tion. Prc bably the reason for both of these wa s the same. If Ihe only
reason is that the re had been some decay in activity in vitro then we can say
nothing about whethe r cholines terase might be actively involved in lipid
metabolism fro~fl this. However, one difference between the pattents and blood
donors is that the donors would not have been laking med ications whereas some
of the patients wou ld have been. Some of these would hav e been likely to havo
bean drugs known to cause partia l inhibition of serum ch olineste rase, such as
beta-blockers, whose uses include the treatmen t of hypertension, angina, and
cardiac dysrrhylhmias and seconda ry prevention of myoc ardial infa rction. This is
partlcularly relevant since most of the pat ients eith er had or had had
hyperlipidaemla, withwh ich cardio vascular disease is known to be associated.
Eve n if drugs on ly account for part of the difference between Ihe
correlations of cho linesterase concen tration and activity w ith lipids, this wo uld be
evidence that the associat ion of serum levels of cholinesterase and lipidS is net
due to active involveme nt of the enzyme in !!pld me tabolism . Since the
measurement e rror was greater with concen tration than with acti vity one would
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e xpect the correlations of corce ntrat cn wi th lipids to be poorer than those of
activity with lipids in the donors. The fact thai this is nol so lends support to the
Ide a.
The lower co rrelations of cho linesterase concentration with lipids lor lhe
pa tients than for the dono rs are explainable entirely by the fact thaI the blood
donors do not include any individuals with very high serum lipids. The effect 01
such individuals on the cor relation coefficients is demonstrated very well by the
la rge differe nces in correlations for male and female patients (Table XV, p. 176),
the men showing poorer co rrelations and individuals with muc h higher lipids than
had any woman (Fig. 16, p . 180). The reason that these individuals have such
an effect is thai serum cholin esterase reaches a plateau with higher lipid levels
(F ig. 20a, p. 188).
In their comparison of the correlations of the activities of serum
cho linesterase and yGT with serum lipids, Cucuianu at al. (1976) noted thaI
ser umcholinesterase was known 10 decrease in chronic liver disease. advanced
he art failure and in the acute phase following surgery or myocardial infarction,
and they excluded such patients. Levels of the enzyme are also known to be
affected by other conditions, there being for instance a fall in pregnancy and the
puerperium (smider, 1965). It was not possible to exclude such conditions from
the present data for lackof c linical inf()(fTIation. It is by no means certain however
tha t eKcluding such conditio ns is corr ect or helpful. II serum cholinesterase and
lip id levels are truely related then the y should 90 up or down together in different
conditions.
6.1.2.3 Previous work o n the relatio nship
Having exptcreo arr the caveats we are now In a posit ion 10 examine Ihe
actual nature of the association of serum cholinesterase and lipids. The work
(described in the introduction) with activity assays of Ihe enzyme established that
there are stronger associa tions with triacy/glycerols and VLDL than with
cho lesterol and that that with the e tter is secondary to the others. The
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impression of most authors was thai synthesis or secretion or activity of the
enzyme is related to synthesis or secretion of lriacylglycerols or Vl DL. The
find ing of Kutty at al. (1973) that cholinesterase increased with VLDL in rabbits
treated with E. coli lipopolysaccha ride, and fell as the VLDL was replaced by LDl
supports this. Cucuianu et al. (1975, 1976) suggested that the r1allening of the
increase In cholinesterase with the higher values of triacylglycerol could be
explained by the latter being due 10 decreased removal from the blood rather
than increased synthesis. The failure of cholinesterase to fall significanlly in
treatment of hyperlipidaem ia with clofibrate (Haragus at al., 1973), which seems
10 lower lriacylglycerols mainly by enhancing their removal from the serum, was
cited (Oucu'ano. 1988) as evidence that the enzyme might be ccinduced with
lipoprotein synthesis ramer than induced by serum lipoprotein ccncerurauons.
The finding of v enkatakrishnan (1990) that sorum cholinesterase does not
decline when triacylglycerol concentration is lowered by releasing lipoprotein
lipase with heparin might similarly be taken as support for the contention that the
enzyme is not related to the concentration of triacylglycerol as such, as might the
absence of correlation between serum cho'iresterase and LOL in rabbits with
hyperlipidaemia due to an tm-recepicr defect (Udom el et., 19 89).
6.1.2.3.1 Serum lipids in cho ttnesterase po isoning
The evidence lrom poisoning of cholinesterase slightly militates against
active involvement of the enzyme in lipid synthesis. Kutty a/ a/. (1975) found thaI
serum cholesterol and 'total LOL' fell in a patient po isoned with the
organophosphate parathion, but Ihe lipid levels started to recover before the
cholinesterase. Kutty et af. (1977) found that when the enzyme was inhibited
with neostigmine in rats there was a decrease in incorporation of 3H.;ysine into
LOL, but a slight increase in incorporation into VLDL. Similarly , Ryhanen 81 a/.
(1984) found that when the enzyme was inhibited by dichlorvo s in rabbits the
serum LDL fell dramatically (much more than the cholinesterase activity) butlhe
VLDL was unaffected. These findings could be explained by the drugs inhibiting
lipoprotein lipase which converts VLOL to IOL but, if so, the failure of VLDL to fall
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does not necessarily exclude chol inesterase Irom its synthesis since its level
would be expected 10stay up if it w as no longer being remo ved .
6.1.2.3.2 lipids In thyroid d isorders
Evidence has been cited in the introduction that serum cholinesterase and
triacylgrycerols go up together in nephrotic syndrome and diabetes mellitus.
Cucuianu al al. (1968) noted the occurrence of high cholinesterase with low
choleste rol in hyperthyroidism and low cholinesterase with high cholesterol in
hypothyro idism . They exp lained the former observation by increased mobilization
of lipidS but even faster removal of lipids and the latter (in their 1975 paper) by
decrease d removal 01lipids. The data given in their 1968 paper tell more than the
authors have mentioned in their discussion. They have a plot of serum
cho linesterase activity vs. cholesterol in which normal-bocy-wetqh t subjects,
obese subjects, patients with hyperthy roidism and ones with hypothyroidism are
shown with different symbols. By inspection it is apparent that in all four groups
serum cholinesterase activity increases with increasing cholesterol and that
parallel or nearly parallel regression lines could be drawn through the four groups
or points. Thus the findings of high chollnesterase with low cno'esterc t and low
cho linesterase with high cholesterol in thyroid patients is not paradoxical; there is
a poaluve correlation between the two indices in each of the dysthy roid stales,
but at different levels.
For any given serum cholesterol level, hypothyroid patients have the lowest
serum cholinesterase, then come the normal weight subjects then obese
subjects and then hyperthyroid patients with the highest cholinesterase values.
This might be interpreted as indicating that serum cholinesterase does not play
an active part in lipid metabolism but is synthesized in parallel with it, and thai
synthesis occurs althe lowest rate in hypothyroidism, and in the other groups at
higher rates through to the highest in hyperthyroidism. Looked at the other way,
the results show that for any given serum chollnes.erase level the hyperthyroid
patients have the lowest cholesterol, then come the obese subjects, then the
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normal weight subjects. and then the hy pothyroid patie n ts with th e highesl serum
choles ter ol. If we ass ume tha t the serum cholinesterase leve l is mo re closely
associated with the ra te of sy nthesis of cholesterol then rescue toll us thaI
choles ter ol is removed from th e bloo ds tream more ra pidly in hyper thyroid is m
than in obesity , more rap idly in obesity than in normal w eight subjects . and le as t
rapidly in hypothyroid ism .
Actu ally it is now known that expressio n of the LDl recep tor is reduced in
hypothy roidism (Brunze ll , 1968) and is increased in hyperthyroi d ism {S laels et at.
(1990) so this is a partial answe r . However, the correla tio n 01c ho linest erase with
choles terol seems 10 be a secondary one through the correlation o f both w ith
tr iacylg lycerol concentrat ion. Unfortunat ely Cu cuianu et aI. ap paron tly did n ot
measure serum triacylg lycerols in their thyroid pete nte. It is how ever known th ai
hyperftpldaernla is uncomm on in hype rt hyroid ism and that seru m lriac ylglyce r<"
co ncentr ation is increased in hy p othroi d ism due to redu ct ion o f hpcpro teln lipa se
(Brunze ll , 1988). Putting this to gether wi lh the findings ot high ("nolineslera:;e in
hyperth yroidism and low chOlinesterase in hypothyroidis m an in fe rence tnat cou ld
be drawn is th ai seru m cbottneste ra se is not direc tly relate d 10 the seru m
conce ntration of triacyl glyce rols and therefore is probably related to their rate 01
Syflthesis. Howe ver, this would imp ly th a t triacy lglycerol synthes is is inc reased in
h yperthyroidism and decreased in hypo thyroidism . Ot her possibi' lies are that
se rum cholinesterase sy nthesis ts induced by seru m lriacy lglyce ro l conc entratio n
b lrt is 'downregu laled' in hypothyroidism and 'up regula te d ' inhyperthyroidism. by
an effec t 01thyroid hormone on the gene, like the synthe sis of lipoprot e in fipa se
an d the LDL-re ce ptor, or lhat if ctcttnes to'ase conce ntra lion we re m easure d ,
rather than acti vity, and haematocrit 'vere taken int o acc ount, th e mean
co ncent rations w ould be found to be the , .ne or even re versed.
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6.1.2.3.3 Other c onditio ns lowering serum cholinesterase
Cucuianu at a/. (1985b) included in their data 23 patients with
decompensated portal cirrhosis, 10 with chcleetasle and 12 postoperative
patients. The mean serum cholinesterase activities in tbese groups were
respect ively 33.8%. 34.SOk and 62.4 °10of tha i of normal weight nanT\CIli~i.gaemlc
controls. The mean serum lriacylglycerol was not signif icantly different from
control in any 01these groups but as cholinesterase was nol p loUed against
lriacylglycero\ il ls no t possible 10say whether the two were correlated with in the
groups. The serum cholesterol was significantly lower in the cirrhotic and
postoperative patients and not significantly higher in thechctestatlc patients, and
thel ipoproteins were not measured.
6.1.2.4 Could seru o cholinesterase be co synlheslzed with
ApoB 7
The evidence discussed so far then largely supports the idea met serum
chcuneeterase is cosynthesizad or cosecreted with triacylglycerol or VLDL and Is
not d irectly related to absolute levels of se rum lipids. Th e rank order o f the
correlations found in lhe data presented here ('total LDL' > VLD l >
trlacylgiycerols, Ic..'al cholesterol, LDL·choleslerol and LOLl suggests that the
enzyme could be cosecreted with apoB 100. However , all this would at first seem
to be overturned by the conc lusion of Sorel-Thomas at at. (1989) that'd iEltary
factors that increase LDL concentrations act by reducing clearance of a poa-
containing particles ra ther tha n by increasing production of these lipoprote ins'. If
serum cholinesterase is rot refil led to the absolute levels o f serum llplde, and if
their production does not vary, it is hard to see how the levels of chol inesterase
and lipids could be related at all. Bu t surely there is a relationship. A closer look
is required.
So rc-T bornaa a t ai, (1989) started by citing va rious pieces of evidence for
down-regulation of hepatlc LDl·rece plors by dietary choles terol an d satu rated
fats and suggesled tha t reduced clearance o f LDl precursors could yield a more
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efficien t conversion of apo8 100 particles into LDL through the oellpidanon
cascade . They allowed that in some cases higher l Dl concentrations might
result fro m increase d LDL pro duction as well, though this would not necessarily
be due to Incre ased apoa pro d uction. They then cited their earl ier wo rk of which
t hf')' sai d that res ults fr om live r perfusio n studies had indicated that a lter ations in
di etary choleste rol and fat do not alter hepatic product ion of apoB1UO-conlai ning
p article s .
In the first cited, Johnson et a/. (1983), th ey fed African green m onkeys lor
fo ur mo nths on high·cho llJsterol (lest) or control diets. during which th ose on the
te st die t had higher mean conce ntrations of plasma cholestero l, l DL and a peB
an d ha d higher lDL pa rticle size. Then they removed their livers and perfused
them by recircula tion with an initially llpcprctein-rree meJium for 4 hrs. and
m easure d lhe ac cumulated cholestero l and the size and composition o f the LDL
p articles . They found th at the choles te rol secre tion was greate r from the livers of
the animals fed mo re chcleste rct , and correlated with the c holeste rol
c o ncent ration a nd LDL size in their p lasma. All lipoprotein panicles of LDL or
low er density from the perfusa te from li vers of the test -fed anlmale ha d 5- to 15·
fold mo re choleste ryl este r lhan the conesponclnq subrracuons from th e cont rol-
fed mon keys' liver pe rtcsates. The tri acylgl ycerol and free cholesterol we re
increased lao, but net as much . The authors a lso noted differences be tween the
LDL in the perfusate and that in the plasma and foun d that the LC AT in the
perfusate was inactive. They de duced that the choles teryJesters in the partic les
came from liver secretion rather lhan m odification in the recircu laling perfusa te,
an d tha t very large LDL particles found in plasma but not perfusate we re derive d
trom int ravascular modifica tion of chotesteyl-eeter-erviched particles. Neither the
n umber of parti cles nor rate of secre tion of apeB100 were meas u red. T he
am ount of prote in in th e subtractions was however measured. In the VL DL
p articles it was the same in the fwc gro ups but in the IDL frac tions and l D L it
was grea ter!n am ount - though not in percenta ge - in the test-feri group.
Johnson at al. (19 85) re poned a similar study in whic lI Afr ican green
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monkey s were given 40% of their ca lories as buller or safflower oil. Agai n they
found lhat the rate of accumulation of cholesterol in the liver perfusates
corre lated with the size of the LDL particles in the animals' plasma. bu t for any
given ra te the LDLand VLDL parlicles were smaller from lhe safflower group and
the VLD L contained more choIesteryl es ters and less lriilcylglycerols than those
Irom the butter group. The percentage of protein in all subtractions of lipoprotein
was the same in the twogroups. The amount of protein was the same in VLOL
but in the 7 succeeding subtractions up 10an d including LDL lhe amou nt was
more in the particles from the bulle r gro up in the first 4 and more in tho se from
the safflower group in Ihe heavier :3subrracucns.
Jo hnson et at. (1986) (abstract) fo und thai cynomolgous macaques develop
highor plasma LOL levels and more severe athe rosclerosis than do A.frican green
monkeys fed the same diet. They found that the rate of hepatic aooa secretio n
was only half as much in macaques for a given cholesterol secretion rate .
Looked et lhe other way, their data showed thai the VLDL of m acaques
contained twice as much cholesterol pe r acc a molecute (I.e. per part :cle) than
did the VLOL of African green monkeys . Also, 68% of the eccewas in VLOL in
the macques whereas the figure was only 33% in African green mon keys.
indicating a difference in efficiency of con version of VLDL to LOL or of -emcvel of
LDL
Then Sorc" Thomas at al. (1989) me asured apeS and t nt- receptor mANAs
in African green monkeys that had been fed high· and low-cholesterol diets with
high and low sannafjon of fats for five years. They found no significant effect of
dietary fats on apoB100 mANA abundance in the liver while animals fed the
higher choles terol crets had about 50% less LOL·receptor mANA in the liver.
They also perfused livers from monkeys fed the high.cholesterol die ts and
measured secretion 01apoB100 and cho lesterol. The rate of apoB100 secretion
was line ar and identical in the two groups. There was no correlation between
hepatic apoS secrelion rata and the plasma LOL-choleslerol concentrat ion but
there was a positive correlation b etwee n choleste rol secrelion and plasma LOL-
cholesterol.
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It would seem then that the rate of synthesis of apca . and hence of VLDL
particres, is not affected by diel (at least in African green monkeys) but thai when
dietary fat is higher the apoB10Q·bearing particles are l arg~\ r and con tain more
choleste rol and triacylglycerol. Thus it would seem that it is still possible for
serum cholinesterase secretion 10 be correlated with lriacylglycerol secretion. In
all three papers dicussed the hepatic cholesterol secretion rate wa s said to
correla te with the animals' plasma total cholesterol or lDL·cholestero l. This
makes the authors' claim Ihat 'diet-induced changes in plasma cholesterol
concentrations are primarily due to effects on catabolism of apaS-containing
lipoprotei ns rather than on synthesis and secretion of these lipoproteins from
liver' seem a little silly since they have left out cholesterol secretion. The authors
never gave figures for the correlations but in Sorci-Thomas et al. (1989) Ihe
lndvidual date were given for hepatic cho lesterol secretion rate and plasma l DL-
cholesterol for 17 animals so it is possible to calculate. The correlation coeff icient
is 0.71, so about half of the variation in lDl·cholesterol concentration is due to
rate of hepatic cholesterol secretion. Hepatic triacylglycerol secretion rate and
plasma triacy lglycerol concentration were apparently not measured.
The earlier quotation above, regarding lDL concentrations may be correct.
However, Payne et al. (1991) have measured the serum apoB in 76 overnight-
fasting scoecte for whom lipid profiles had been requested. They have found that
the serum apoB concentration can be predicted to within 4% from r, combined
regression of the serum cholesterol and triacyI9'ycero] concentrations . If serum
cholesterol correlates with cholesterol secretion but apes secrettcn does re t vary
and its ooncentr.euonis solely dependent upon t n t-rececio regulation, it seems
paradoxic al that serum cholesterol and Iriacylglycerol can predict the apaB
concent ration so accurately. II is worth adding here thai Sorel-Thomas of al .
(1989) admit that hepatic LDL-receptor mANA was similar in abundance in
polyunsa luratad and saturated-fat-fed animals , suggesting that the difference in
plasma cholesterol concentration between these groups is not mediated via
effects on the tnt-recemcr. Further work is needed.
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6.1.2.5 The new light shed b\ ' the work presented
We can now return 10 the results of th is study andask what they can tell us
that has not been shown by earlier wo rk. This is the first lime that serum
cholinesterase concentration has been compared with serum lipids and
lipoprotein s. The results show that theraised serum cholinesterase activity found
in hyperflotdaemtas is indeed due to increased ccncent.etlcn of the enzyme
rather than to increased specific activity, su ch an mighthevs been caused by an
allosteric interaction with one of the lipids. Also. at least in these subjects, there
is no subpoputaticn with a high-specific-activity variant. It has also been shown
that, atieast in these patient samples, concentration is a more reliable measure -
for whatever reason - for determining the relationship of serum ccounesterase to
the lipids. More important, perhaps. this appears to be the first time that anyone
has taken notice of the actual shapes of the plots of cholinesterase against lipids.
6.1.2.6 The meaning of the shape of cholinesterase.llpid
plots
6.1.2.6.1 Preliminaryremarks
Before considering the meaning of th ese shapes, it is worth emphastalnq
two points. One is that in comparing the serum concentrations of two
components one must remember that both can vary in the rate of entry and the
rate of le aving the circulation. The other is that serum cholinesterase is in the
serum. or mere properly when considering what might be happening in vivo, the
plasma. This point is made to deal with the suggestions that serum
cholinesterase activity might correlate with lipid synthesis. Since the lipids and
lipoproteins are synthesized in the liver. and 'serum' cholinesterase is in the
plasma. measuring the enzyme in the blood would then only be useful as a
predictor of the butyrylcholinesterase activity in the liver. Waterlow (1950), KUlly
ot al. (1981b, 1984) and Venkatakrishnan (1990) have shown that serum and
liver cholinesterase activities tend to go up together, but Kulty et al. (1984)
showed that serum cholinesterase activity correlated better with s erum
tr\acylglycerol concentration than with liver cholinesterase activity in Zucker fat
rats .
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6.1.2.6.2 The correlation coefficient is an inadequate
measure
Ocrr elattcn coefficients betwee n se rum cho linesterase and the sorum lipid
in1ices we re ca lculated mainly because ot her workers ha d done this before, bu t
what the plots of cholineste rase with those indice s that give tho best coneteuona
show is that thi s statistica l test is not rea lly appropriate because the relationship
is nollinear. The distribution of points is tr iangular . Because of this if is possible
that the lipid index which is the most closely related 10 serum cholines terase
(assuming thai there is a substantive relationship) is not the one thai gives the
highest correlation coefficient. It is poss ible tnat the true relationship is wilh
lriacylglycerols rather than 'total LDl' ; compare the outlines in Fi9S. 14b (p. 177)
and 15a (p. 179). This would make much more sense in terms of the resu lts of
Sorel-Thomas et al. (1989) discussed above .
6.1.2.6.3 Logarithms and the abstracted chollne sterase-lipld
curve
If serum cholinesterase was reall y related to the logarllhm o f the
lriacylglycerol concentration this would say something about the kinetics of the
relationship and it should still be true jf o nly part of the range of varlauon was
studied. The fact that the logarithm gave a poorer correlation in the blood donors
is somew hat against this. The shape of the distribution shows tha t the
relationship of cho linesterase to tnacylqlycercl or 'total lOL' is not a slraig ht line
which curves over and reaches a platea u with Ihe higher lipid values; that
description is only an abstraction which may not represent the true na ture of
affairs. The plots show that both the lower and upper borders are approximately
straight.
6.1.2.6.4 The gap between Cucuianu's findings and the new
results
Why is it then that at low serum concentrations of triacylglycerol or 'totat
LOl' a wide range of cbcflneeterasa concentratio ns is found but that at high lipid
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concentrations only high cho lines terase is found? The hypothesis of Cucu ianu at
al. (1975) was Ihat elevation of serum cholinesterase activity 'could be
connected to mec hanisms lead ing to an increased secre tion rate of lipoproteins '
and tha llhe graph 01mean chol inesterase against mea n Iriacylglycerollevels out
because some of the highest triacylglycerol conce ntratio ns are due to decreased
removal rather than increased prod uction . On li s own, this dOes not explain why
some individuals with low serum lriacylglycerol or ' total LDL' have chol ines terase
conce ntrations as high as those with high conce ntrations of tr iacy lglycerol. It a lso
predicts that there should be some individuals with high trig lyceride who do not
have high serum cholinesterase. No such individuals occ ur in lhe data presen ted
here so il is worth inspecting their composition.
6.1.2.6.5 Couid the data Include hyperllpidaemla due to
decreased clearance alone?
Amongst these data there are two individuals w-cse serum lipoprotein
electrophoresis suggested thatlhey had type III hypertipoproteinaemia. This is a
condition (also called remnant removal disease or dysbetalipoproteinaemia) in
which there ~ decreased clearance of Vl Dl remnants due to defective binding of
apeE to the LDl receptor, About 1 in 100 people have two alleles producing
abnormal apeE. Most of these do not have hyperlipidaemla and tend to have tow
cholesterol and LDl levels but about 1 in 100 of them have hyperlipldaemia,
apparenUybecause of an additional cause of hypertriacylgtycerolaemia. The two
cases in these data did not have very high lipid concentrations. Their
cholinesterase. triacylglycerol and 'toter LDL' concentrations were respectively
36.2 and 34.2 mg/L, 2.02 and 3.23 mmol/L. and 4.4 and 6.9 gIL and by
inspection of Figs. 15a (p. 179) and 14b (p. 177) it can be seen that they both tie
quite close to the top left corners of the distributions, Le. the serum
cholinesterase concentrations are quite high even though the triacylglycerol and
'toter LDL' concentrations are not very high.
In the plot of chcnnesteraee concentration against lrlacylglycerot the two
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most extreme right points represent the two pauenrs with type V
hypertipoprolelnaemia and all the other individu als in the lOP half of the fange
have type IV (the highest lr iacy1g1ycerol concentration amongst the typa lib
pat ients be ing 6.97 gil). In the plot of chol ineste rase vs 'total LDL' the lOP right
ccere e of the distribu tion includes the cases of type V and cases of type IV, but
also some with type lib hypertipoproleinaemia. the highest 'Iolal LOL'
concentration amongst the tatter in these data being 10.2 gil. In type lib
cholesterol is princ ipa lly ra ised but lriacytglyCE1'Ols are also elevated; lOL and
VLOL are raised. In types IV and V triacylglyc6IoIs are principally raised but
cholestero l lends 10 be rais cJ too in type IV and is always raised in type V . In
type IV, VLDl is raised and in type V, chylomi crons ere found in the blood in the
fast ing slate as well as raised VLDL. These types are only phenotypes and all
have more than one cause ,
Inherited causes of hy pertriacylglyce rolaemia include ' familial
hypert riglyce rid'aemia ', familial comb ined hype rlip idaemia and disorders in whic h
lipoprotein lipase funct ion is defect ive. In familia l hyper triglyceridaem ia, there is
increased tr iacylg lycerol synthesis and removal seems to be normal. Choles terol
syn thesis may also be Increased. VLD L conc entration is increa sed but LDL
levels are norma l. It can appear as type IV or type V. The incidenc e of this
co nd ition is thougnt 10 be abou t 1/2 00 and it wo uld be more co mmon amongs t
peop le selec ted 10 have se rum lipid profiles . Fam ilial com bined hyperlipidaemia
appea rs to be due to incre ased syn thes is o f apeS and can man iles t as Iype Ua
(ra ised cholesterol only), li b or IV, even in the same individual at differen t times.
(The reference used for the hyperl ipidae mia types (Brum:ell , 1988) was wrnte n
before the paper of Sore l-Th omas at al. (1989) but their work cou ld not con trad ict
(his anyway) . The incidence is thought 10 be abo ut 1/100. Defective upcprctein
lipa se function cau ses hyperll poprotei naemia Iype t (cnytcmcrc naernia only) or
type V, II can be due to a deficiency of the enzyme (which hyd rolyses
triacy lglycerofs in VLDL and chylomicrons) in some or all tissues or a def iciency
of apoCli (which activates il) or a familial Inhib itor. This ca use 01
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hypertriacylglycerolaemia then is due 10 defective removal, but it is very rare.
There have been other reports of familial type V of unknown aetio logy and cases
of type IV noted to have defects in VlDL removal not characterised by one of the
above defects in lipop rotein lipase functio n.
Acquired hypertrlacylg lycerolaemia occurs in diabetes mellitus (due to
increased triacylglyceror synthesis), uraemia (which appears to diminish
l'poprctein-upase removal of triacyJglycerots) , and mini mally in obes ity, oestrogen
therapy and alcoholism (which all seem to hepenc VLDl secretion). Also,
diuretics and bela -blockers tend 10 increase LDL (mechanism not given) and
there are other, rare, causes of acquired hypertriacylg lycerolaemia.
Type V hyperlipopro teinaemia is usually due to the interaction of two
common forms of hypertriacylglycerotaemia, usually one genetic and one
acquired. Untreated symtomatic diabetes is frequently a cause in the presence of
familial hypertriglyceridaemia, familial combined hyperlipidaemia, or less
commonly remnant removal disease. Oestrogens, diure tics, beta-blockers,
alcohol, and glucocorticoids often markedly exaggerate pre-existing
hyperlipldaemia due to these inborn errors of metabolism. Hypothyroidism and
uraemia occasionally contribute. Most cases of type V then are due to increased
production of triacylglycerols. However, at high synthes is rates in type V and type
IV the removal mechanism may become overloaded.
Acquired causes of type lib hyperlipoproteinaemia include hypothyro idism,
nephrotic syndrome and glucocorticoid excess either due to Cushing's syndrome
or steroid therapy. In hypothyroidism, as already mentioned, LDL·receptor
expression is reduced - resulting in accumulation of chylomicron and VLDL
remnants and lO L - and the lipoprotein-lipase level is low. In nephrotic syndrome
there is increased hepatic lipid synthesis and defective catabolis m of
lriacylglycerol·rich lipoproteins, the latter possibly due to urinary loss of cofactors
for lipoprotein-lipase. In glucocorticoid excess there are increased VLDL and/or
LDL levels (mechanism not staled).
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A causeof hyperlipidaemJa not mentioned above is LDL-receptor def iciency
which of course increases plasma l DL. It occurs in the heterozygous form with a
frequency of about 1 in 500 and accounts for at least 1 in 5 cases of high serum
cholesterol. Cases of this defect may well occur in the data therefore, but they
usually have type I ia hyperlipoprole inaemia (with normal lriacylglycerol revels)
and type li s does not occur amongst the people with very high 'totat LDL' in
Ihese data.
In cases in which high serum Iriacylglycerol or ' toter LDL' concentrations are
due to defective removal without increased synthesis the theory of Cucutanu at
st. would predict that they would have serum cholinesterase concentrations
resembling those of people without raised serum lipids, I.e. that they could have
a conce ntration anywhere In the range , not just at the high end. From the above,
most oases seem to be due 10 increased synthesis with only untreated
hyr ..Ihyroidism, uraemia , and rare gene tic defec ts causing high levels purely by
decreased catabolis m, while in nephrotic syndrome and in some cases of type IV
and V hyperJipoproteinaemia removal may be reduced in conjunction with high
synthesis, in which case serum chotinesterase would be expected to be high
anyway . It is pcealble therefore thai in the data presented here there are no
cases of high serum triacylglycerol or 'tota l LDL' due to decreased removal alone
and that the theory of Cucuia nu et al. (1975) is not contradicted. There is
howeve r another possible explanation for the shape of the distributions.
6.1.2.6.6 An alternative hypothesis
It is clear that Individuals with normal serum lipid levels have a wide range
of serum cholineste rase concent rations. The observed shape of the plot against
triacylglycerol or 'total LDL' would occur if serum conce ntrations 01these entities
induced increased synthesis of cholinesterase from its normolipidaemic level but
thai there is in most individual s approximately the same maximum possible
serum concentratio n ei ther due to a maximum rate of synthesis or to induction 01
serum cholinesterase catabolism. The abstracted plot of mean cholineste rase
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against mean Iriacylglycero l or 'tota l LDL' conce ntration, as in Fig. 20a (p. 188),
would then be curved purely because though the minimum cholinesterase
increases with with increasing IriacyJglycerolaemia the maximum remains the
same . There is then no need to invoke a different rt echanlsm of hyperlipldaemia
to account for the curvature .
6.1.2.6.7 Counters to the previous arguments
If serum cholinesterase synthesis is induced by the serum concentration of
tnacylqlycero! or apoB·beariny lipoprotein rather than being linked to their
synthesis or secretion, we have to counter the evidence for lhe latter . First there
is the evidence thai serum cholinesterase activity did not fa ll when Iriacylglyce rol
was lowered with clofibrate . In the 20 patients treated by Haragus Bt a/. (1973)
the mean serum triacylglycero l fell by 31.3%. The mean serum cholineste rase
activity fell by 7.2% but this was not statistically significant. Because of the shape
ot the distribution and abstracte d plot of means , we do not expect the mean
chofmeeterase to change very much for quite a large fall in triacylglycerol in the
top part of the range. However. the means of serum triacy lglycerol before and
after treatment of the patients of Haragus at a/. were 198 and 136 mg/100 ml
(2.24 to 1.54 mmolJL in S.1.units). These values are both quite low. To find out
wha t change in cholinesterase might be expected it is the refore necessary to
make some calculations from the dat a used in this thesis.
It is wor th noting here Ihal Ihe relative variation in serum cholinesterase is
much less Ihan thet of triacylglycero l, the range of l riacy lglycerol in the 282
patien ts being 0.45 to 15.48 mmolJL wher~as that of serum cholinesterase
activity was 1778 to 5806 U/L. excl uding Ihe single activity result (6542 U/L) that
stood well above the rest. In the triacylglycerol distribution the results are even
more clustered at the lower end of the range than are the 'total LOL' result s
(compare Figs. 14b (p. 177) and 15a (p. 179)). The method of div iding the range
into fifths proves unsatisfactory for predic tion of changes in cholinesterase
between such low triacylglyce rol concentrati ons, the mean Iriacylglycero l in the
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first fifth of the range (N .. 218) being 1.73 mmol/L and thai in the second flllh of
the range (N .. 48) 4.50 mmolfL. Taking 'qumfjee' instead with alterna tely 56 and
57 indiv iduals in each, the means of triacyrgtycerol ccncen traucn and serum
chol ines terase activity in the seco nd qulntlle (N .. 57) were 1.46 mmol/L and
3727 Ufl, for the third quintile (N .. 56) 1.98 mmol/L and 3859 UfL, and for the
fourth qctntlte (N .. 57) 2.88 mmo l/L and 3921 U/L. Interpolating between these
points, the predicted fall in serum cholinesterase activity between triacylglycerof
conce ntrations 012.24 and 1.54 mmol/L would be from 3876 .9 10 3742 .7 U/L or
jus t 3.46%. This Is only abou t ha lf the drop that Haragus at al. obta ined so this
shows Ihat II would not be righ t to interpret their figu res as showing that
cholinesterase does not respond to serum triacylglycerol coocentrauon and mus t
rather be related to rate of synthesis.
The seco nd piece of evidence mentioned was that Venkatakrlshnar. (1990)
obtained a drop of 85% in serum triacylglycero l concent ration with in 30 minutes
after intravenous injectio n of hepari n into rats but found no lall in serum
cholineste rase activity . The answer 10 this is that the in vivo half-life 01 serum
cholineste rase is much too long to respond so rapidly . Estimates 01 the hall- lile of
human serum cholines terase have lain between 2 and 16 days (W hillaker, 1986).
From this it is clear that whether se rum cholineste rase correlates wilh the rate 01
synthes is or the serum conce ntratio n of triacylglyce rols. it could only correlate
well with the mean (of Iriacylglycerol synthesis or concen tration) over al least
sever al days .
The finding of Udo m et al. (1989) that serum cholinesterase did not
cor relate with LD L concentration in rabbits with LDL·receptor deficiency also
does not really stand against the hypo thesis Ihat the enzyme might be induced
by serum Iriacylglycero l concen tration since the latter was not measured and is
not usua lly raise d In that condition.
One ether observation putlorward by Cucu ianu at al. (1975) was that a few
patients with excess ive hype rtriacylglycerolaemia had normal serum
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cholinesterase activity. Inspection of the records of this laboratory shows that
here 100 not all individuals with very high Iriacylglycerot levels have had high
serum cholinesterase activ ities. Howe ver. the work presented here has shown
that activity measurements are nol as reliable as those of concent ration. If
activ ity is used then samples sent by post to the laboratory should be excluded,
as should samples from individuals laking drugs which inhibit cholines terase
activity. Samples should be frozen or activity should be measu red when they are
fresh, and when the activity is expected to be high • because of high
Iriacylglycerol concenlralion • activity measurement should be repeate d al 1 in 2
dilution.
6.1.2.6.9 A compromise hypothesis
Between the suggest ions that, on the one hand, serum cholinesterase
synthesis might have a stimulus in common with VLDL or triacylglycerol
synthesis, o r that the enzyme might even be connected wil h their synthesis in
some way, and on the other hand the suggestion that serum cholinesterase
synthesis is induced by serum triacylgtycerol concentratio n, there is a middle
way. It could be thaI the synthes is of the enzyme is induced by the secretion of
VLDL lruo the plasma or by rising plasma concent ration of VLDL or
triacylgtycerol. If so, a high serum cholinesterase concentration could indicate a
high rate of IriacylglyceroJ synthes is even in an individual in whom the
triacylglycerol removal system was malntaininq the serum level within the normal
range.
6.1.2.7 Assoc iation of chol inesterase with the LDL particle
Since serum cholinesterase concentrat ions at lhe upper end of the normal
range have been observed in association with low-normal LDL concent rations
Ihe data cannot support the hypothesis of Kully at al. (1973) and subsequent
papers that the enzyme prolongs the half-life of LDL. However, Ihis does not
exclude the possibi lity that the enzyme could be chemically associated with LDL
in the way that they propsed.
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6.1.3 The possible function o f serum choli nesterase
The possibility that the synthesis of serum cholinesterase might be
regulate d by the arrival of triacy lglycerols or VLDL in Ihe plasma, is an opening to
a discuss ion of the possible functio n of the enzym e in the blood. II seems highly
likel y that in Ihe nervous sys tem and muscles butyrylcholinesterase byorolyses
acetylcholine at concentrations Ihat would inhibit acetylcholinesterase (see
introduction). The enzy me hydrolys es bulyrytcholine laster than acety lcho line.
Tilt; argumen t Ihat neither acetylcholine nor butyrycholine occur in the plasma
and that there is therefore no app arent functio n for the enzyme in the blood may
be a rather blin kered one . For a s tart, the occu rrence of the enzyme in the blood
in many species makes it unlike ly that it does not have a function in the blood.
Seco ndly, other plasma esterae ee are found in increased conce ntrations in
hyperlipidaemia. Beynen at af. (1987 a) showe d that a high -cho lesterol, high -
chelate dlet caus ed a sign ificant increase in plasma total esters -se activi ties in 6
out of 7 strains of mice and Beyne n at af. (1987b) showe d tho sam e in 4 oul of 4
strains of rat. Patel er al. (1990) have shown that in streptozolocin -diabetic rats
there is not on ly an increase in serum cholestero l, triacylglycerols and
cho linest erase but in carboxyleslerase and paraoxonase too.
In human serum the presence of a carboxylesterase was published only as
recently as 1978 by Som orin and s kcrece. In its purified stale this enzyme (EC
3. 1.1.1) hydrolyses sho rt-chain fa tty -acid esters and scarcely hydrolyses long -
chain fatty-a cid es ters. It therefo re had at first no apparent func tion bec ause
short-ch ain fatty-a cid este rs are not normally found in human se rum. Howeve r,
Shirai at al. (1988) investigated the effec ts of phospholipids on the substrate
aff inity of the enzyme. They showe d that card iolip in increased triole in hyd rolysis
by the enzyme and reciprocally decrea eed its hydro lysis of tributyrin.
Phosp hatidylserine and phosphatidylinosito l also enha nced the
carbc xytes terese -catalyeed hydrolysis of trio lein but not as much as did
cardiolipin. PhosphatidylethanoJamine and sphingomyelin did not cause any
enhancement. The autho rs poin ted out that cardioli pin has three negative
at
charges in its polar head where as phosphalid ylserine and phosphalidylinosilo l
have one and phosphatidyle lhanolamine and sphyngomyelin have none. They
proposed thaI the enzyme might have in addition to its catalytic ene a substrate-
recognition site and mat this site might have three positive charges. They
suggested that by interacting with this site. cardiolipin would neutralize the
charge and give the enzyme greater affinity for a hydrophobic este r compound.
(One slight discrepancy was that phosphatidylcholine also increased the
hydrolysis of tributyrin and it has no charge. However, il was not C: 'lite as
effective as phosphatidylinosilol and markedly less effective than
phosphatidylserine, and lysophosph atidylchOline did not enhance triolein
hydrolysis.)
Shirai and Jackson (1982) showed thaI hydrolysis by bovine milk
lipoprotein- lipase of the water-soluble substrate p-nitrophenyl butyrate (PNPB)
W~-tS enhanced by phospholipids , particularly dlpalmiloy l phosphalidylcholine.
This enhancement was much greate r In the gol state, i .e. with phosp holipid
vesic les. In this case they favo ured tho hypothesis that the binding of the enzyme
to the lipid Interface , possibly through a recognit ion-site, caused a conformati onal
change which increas ed the affinity for the water-soluble substrate. Shirai at al.
(1982) then showed that apoCIl enhances triolein hydrolysis by the enzyme and
reciprocally decreases the hydrolysis of PNPB. At the time thay thought Ihat the
apol lpoprotein acted by causing a co nformational change in the enzym e but in
discussion of their work on human serum carboxyles terase Shirai at a1. (1988)
they proposed that here too the mechanism was a change In hydro phobic ity.
II seems possible that serum cholinesterase could take pari in lipid
metabolism in the blood by means of a change in its substrate affinity by a
cofactor . Three groups of workers independently produced evidence Ihal
acety lcholinesterase has an anionic position In the act ive centre (see Myers,
1952). Nacnmanscn and Wilson (195 1) reviewing their own and other work on
the enzyme discussed evidence for the active centre being com posed of an
anionic sile, having a negative charge and holding the positively-charged
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quarternary-ammonium choline part of acetylcholine, and an 'esterettc' (sic.) site
(otherwise known as the esterasic site) accommodating the acetyl part. They
observed that compounds containing two cationic groups at a given separation
were far more effective inhibitols than the monoquarternaryions. suggesting the
existenceof two anionic sites, not necessarily both substrate-activating sues.
Kalow and Davies (1958) investigated the effects of inhibitors on tho usual
and atypical variants of serum cholinesterase and found them 10 fall into three
groups. The majority inhibited the usual variant more thanthe atypical one by the
same equation. The second group was of bts-quarternery ammonium
compounds which caused a much graaler difference in inhibilion between tho
two variants but in the same direction. The authors suggested that this could be
because these compoundShad a two-point attachment to the usual esterase but
only a one-point attachment to the atypical variant. Their results indicated that
the inhibition of the usual variant was partially non-competitive, suggesting that
one 01the negative charges might not be in Ihe active centre They also found
that every fourth inhibitor molecule appeared to block two active centres. By
contrast, the Inhibition of the atypical variant was completely competitive and the
blocking ratio of inhibitor to active centre was 1:1, suggesting that only one
quarternary nitrogen was attached to the enzyme and that the point of
attachment was elweys the anionic slte 01 the active centre. Thus the negative
charge thaI was missing in the atypical variant was apparently not in the acuve
centre but i~ a position that could affect it and from which a bridge could be made
to another subunit 01 the enzyme. The third group of inhibitors,
organophosphates, inhibited the two variants eqvally. Since these were thought
to react with the esterase site (Nachmanson and Wilson, 1951) they suggested
that the esteraslc sites were the same in the two variants. This was proved to be
correct when McGuire at al. (1989) showed that the only consistent difference
between the DNA sequences coding for these two variants was a single base-
change which resulted in the substitution of a neulral amino-acid (glycine) for an
acidic one (aspartic acidl at position 70 and hence thai the esterase sites were
the same. The active site serine is amino-acid 198 (l ockridge et el. (1987).
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Harris and Whittaker (1961) were surprised to discover that sodium fluoride
could also diffe rentiale between the usual and atypical variants and in 1963 that
at much higher concentrations sodium chloride could too. However, with sodium
fluoride the usual enzyme is inhibi ted more Iha n the atyp ical, as is the case with
dibucaine, whereas sodium chloride inhibits the atypica l variant more . It was
also found (Harris and Whittaker, 1961,1962) that there were some individuals
who cou ld not be classified in the same way by dibucaine and fluor ide, reveating
new phenotypes which were shown as probably allelic (Whittaker, 1967) and that
there were some who were of the usual phenotype by dibucaine and fluOl'ide
inhibition but seen to be of an intermediate phenotype when classified by chlorida
inhibition (Whittaker, 1968c, 196Bd). Two of the latter were known to be sensitive
10 succinylcholine. II would thu.. appear that mere are at least two positive
charges and at least two negative charges on the serum cholinesterase
monomer in positions whk;~ can :>..ffect substrate affinity.
At this point the activation of serum cholinesterase by alcohols should be
mentioned. Todrick et al. (1961) showed that alcohols activated chotlneeterases
up to an optimum. and that beyond that concentration the activation continued to
decline so that at higher concentrations inhibition occurred. They worked with
acetylcholinesterase from rat brain and human erythrocytes, and serum
cholinesterase from the horse, and with acetyr-, p-methyt- and benzoytchotine as
substrates. The finding 01 particular relevance to substrate-specificity was that
the hydrolysis of acetylcholine by the horse serum cholinesterase was inhibited
at all alcohol concentrations. Thus there was a range of alcohol concentration
over which the hydrolysis of benzoylcncune was increased but the hydrolysis of
acetylcholine decreased. This was confirmed with human serum cholinesterase
and Ihe same substrates by Vincent et al. (1982).
Todrick ar el. (1961) also showed tnat me optlmum activaling concent ration
of alcohols decreases as chain length increases. Main er al. (1961) showed that
the hydrolysis of o-nltrcphenyt butyrate (ONPB) by human serum cholinesterase
W':lS increased by butan-t- ol and Main (1961) showed thaI the hydrolysis of
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PNPB. for which the enzyme has less affinity, was inhibited by b ulan-t -el. The
latter also found that activation of ONPB hydrolysis increased with increasing
alcohol chain length and that acetone and other isomers of butano l woul d also
activate the hydrolys is though no t as much as bvtan -t-ot.
Whittaker (1968a) inv9sligat.ed the effects of alcohols on lhe usual and
atypical variants of human serum crclinesterase with benzoylcholine as
substrate She found that alcoho ls activated the atypical variant much less than
the usu al one and inact ivated II at lower concen trations . With increasing chain
length the activation was greater . opt imum conce ntration of alcoho l lower and the
concentration giving the greatest difference in percentage ecuvatton of the
variants lower. Whill aker also tried varying pH and interpreted her results as
showing that changes In activity were independent of pH in the range 5.9-8.45
excect thai no activation of the atypical variant was observed at pH values above
6.6 with butanol. Actually the results suggest that for each alcohol there is a pH
optimum both for maximum percentage activation and lor maximum optimum
alcohol concentration. This pH optimum is higher lor tlla atypical than for tho
usual variant and it appears to go down with increasing Chain length 01 alcohol
for both variants, but more data are required. She did not try varying substrate
concentration.
Todrick et al. (1961) did vary substrate concentration. Their hypothesis was
that alcohols competitively inhibit the cbonresterasee and that apparent
activation is due to reduction of substrate inhibition. As there is no substrate
inl,ibition of serum cholinesterase by acetylcholine, inhibition ccccrs at coco.
From their results they concluded that this is the case. There does however
appear to be a contradiction. They did demonstrate ccmpetlttve inhibilion at tower
alcohol concentrations and an irreversible fnacuveuon at higher concentrations
undoubtedly due to oenaturancn. However they have a graph of activity against
pS (reciprocal of the logarithm of substrate concentration) tor horse serum
cholinesterase with benzoyleholine as substrate and with and without a.19M n·
butanol. It their hypothesis were correct the maximum activity should nOI be
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increased by the presence of alcohol but the optimum pS should be lower (l.e.
optimum substrate concentration higher) so that at higher substrate
concentrations there is more activity in the presence of alcohol but at lower
substrate concentrations there is more activity without alcohol. Actually the
optimum pS is unchange d and the maximum activity is greater with butanol. This
is the exac t opposite of what the hypothesis predicts and the authors did net
address this. In the hydrclyale of acetylcholine by acetylcholinesterase the curve
was shifted 10 the left by butanol but the peak activity was still much higher with
the alcohol.
Main (1961) was apparently unaware of the conclus ion of Todrick at al. His
investiga tions led him to conc lude that alcoho ls affect the activity by cilang ing
some aspect of the environment on which k3 (the rate constan t for the change of
the enzyme -substrate complex to enzyme + products) is dependent . It had been
sugges ted to him that this acnvaucn could coexist with competitive inhibi tion but
he concluded that this was not occurr ing. Whittaker (1968a) did not conside r the
explanat ion of the phenomenon but made the practical cbservatlcn that the
differential actlvanon of the serum cholines terase variants by alcohols could be
used as another method of ditinguishing betwee n them. She went on (Whittaker,
1968b) 10 show that there were some individuals with whom enzyme actlvetlon
was discrepant with the phenotype !:uggested by dlbuc...ne and fluor ide
inhibition. revea ling yet more new phe notypes .
It has been shown that the atypical variant differs from the usual one by
having one less charge apparently outs ide the active centre but affecting
subst rate affinity . If this charge reduction increases the affinity of the enzyme for
more hydrophob ic substrates (as in the case of serum carboxyles terase) then
one might expec t that the atypical variant of serum cholineste rase would have
greater affinity for longe r-cha in chol ine esters than does the usual variant. As it
happens, the action of these two variants upon a series of cho line este rs was
investigated by Davies at al. (1960) and they cc ncf..ded Ihat this did appear to be
the case, though they did no t offer an explanatio n. Their actual finding was tha t
216
relative 10 the respective maximum velocities of hydrolysis of butyrylcho line by
each variant , pentarcyt-, hexanoyl· and heptanoylcholine were hydrolysed faster
by the atypica l variant than by the usual . thOugh only pentanoylcho line was
hydrolysed taster than butyrylchol ine.
u may be remembered thai the Cs variant of the enzyme appears 10 be a
combination between serum chol inesterase and ano ther unident ified prote in and
that this variant hr e higher activity than the usual vari ant. This. however, appears
10 be becaus e at Incr eased concent ration rather than increase d spec ific activ ity.
Thus we have examples that the activity and substrate-specificity of serum
cholineste rase can be altered by change of surface charge and by alcohols, if net
by association with another protein . It does not seem beyond the bounds 01
possibility therefore that there could be a cofactor wh ich ena bles Ihe enzyme to
lake part in serum lipid metabolism to account for the induction of the enzyme in
hyperltpldaemta. The recently -noted sequen ce similari ty with Geotrichum
candidum lipase (Slabas et af.• 1990) perha ps lends some cre dence 10 this. A
sequence of seven amino-acids surround ing the serine of the acnve site of serum
cholinesterase is Idenncat, The disulph ide bonds on ei ther side of this are
preserved. As in the chol inesterases there is an aspart ic acid residue
immediately before the seco nd cysteine of the first pair, though t possibly to play
a part in thei r active site (Chatonnet and Lockridge, 1989) and there is another
aspartic aci d in almos l lhe same position as the one that is absenl in the atypical
variant, just beyond the first cys teine. However, in G60trichum candidum lipase ,
in the loop between the first two cysteines there are 17 extra amino-acids .
Perhaps a co tactor might fill the rOle of Ihese extra residues . The carboxy -
termina l end is much less similar 10 the cholln esterase s. As in rabbit microsoma l
esterase and Orosophila esterase-a, the third disulphide bond is absent but two
histidine res idues are present in similar positions to those in all the other
enzymes.
Geotrichum candidum lipase hydrolyses all ester bonds in lriacy lglycerols
and displa ys a high affinity for triolein (according to Shimada at af. (1989) , the
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seque ncers, quoting an earlier reference) . Lipoprotein triacylgJycerots are thoughl
mainly to be hydrolysed at positi ons 1 and 3 of the g lycerol mo iety by lipoprotein
fipases on the capilla ry walls before diffusion of the free fatly acids into the ce lls
while the resu ltant 2-monoucy lglycerots either diffuse in also or are hydrolysed by
serum monoacylglycerol hydro lase. This would nol seem to reave a niche for
another serum lipase . If however thera is a physiologi cal role lor the recently-
demons trated activity 01 serum carboxyleste rase, then there could be further
niches . Shira i at af. (1988) found that though ca rdiolipin increased the hydrolysis
of Iriolein by carboxyJesterase, it did not affect the hydrolysis of diolein and
decresed the hydrolysis of mcnc-oteln. There is also the possibility tha t
cholinesterase might take part in some other aspect o f Vl Dl metabolism.
6.2 CONCLUSIONS
1. Measurement of the buty rvlcholmesterase concen tration in human serum
samples has pro ved more reliable than measurement of the activi ty of the
enzyme in examination of the relationship of the enzyme to serum lipids an d
lipoprote ins despit e the fact that the repeatabi lity of the assays was better
for activity. This is because (a) activity tends to decay with age of th e
sample while co ncentration coenaes liltle, (b) the activity assay becomes
unreliable at high levels and probably also (0) because various drugs
competitively inhibit activity .
2. Mean serum cho linesterase concentration , like activity, was lower in wome n
than in men. Simpson (1966) showed that mean ac tivities were the same if
cor rection was m ade for haematoc rit and we ight. This could not be done fo r
these data as these parameter s we re not known, but the chol inesterase wa s
found to be related to serum lipids in the same way in the two sexes .
3. The serum lipid ind ices that correlate best with choli nesterase concentration
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are fi rst total heparln-precipitebte low density lipoprotein concentration
(VLD L + LOL), then V LDL alone, then tr iacylglycerol co ncentration .
4. The plOIS of serum concentration of cholinesterase against these lipid
indice s are no t linear but have a wetl-oeflned triangular shape,
With very few exceptions the maximum cholinesterase concent ration is
approximately the same at all values of the lipid indices. suggesting a
maximum rate of syn thesis or the ope rati on of a catabolic mechanism which
limits the maximum serumconcentrationachievable.
The minimum Cholines terase concentration increases linearly wi th increases
in the lipid indices until il meets the maximum. No exceptions wort'!
encountered. In Ihe plots of cholinesterase activity against the lipid indices
there were some exceptions (falling below the line), probably due to the
reasons given in '1' above.
The minimum and maximum lines mel at approximately themaximaof 'total
lDl' a nd trlacy lglycerol found In these data (14.0 gIL and 15.48 mmo l/L
respectively) or slightly beyond them. At even higher concentrationsof 'total
LDl' or triacylglycerols thecholinesterase concentration wouldbe expected
to be at themaximum.
Thus at low-nornal concentrations of the lipid indices there is a wide range
of serum cholinesterase concentrations in diffe rent individuals but, as the
lipid indices increase . this range Is progressively reduced from the rower
endwhile the upper end remainsconstant.
5. Because of this shape, the graphs of mean serum cholinesterase
concentration against mean 'to tal lD L', VLDL or lriacylglycerol ascend in a
convex:shape to reach a plateau .
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6. The hypothesis of Oucuianu et al. (1975) to explain the shape of this curve
was that serum cholinesterase activity correlates with lriacylglycerol
eynthese and that the line is not stra ight because in some cases very high
Iriacylglycerol concentrations are caused or enhanced by decreased
catabolism rather than Inc reased synthesis. This explana tion ignored the
fact Ihat the maximu m cholinesterase concentratio n is the same whatever
the triacylglycerol conce ntrat ion. The distribution could be explained by the
induction of increased serum cholinesterase synthesis or secretion by
increasing se rum tr iacylglycerol concennafton . irrespective of its cause - up
to a maximum serum conce ntration.
7. The hypothesis of Cucu ianu atal. would be proved correc t by the finding of
cho linesterase concen tratio ns below the expecte d minimum for their
triacylglycerol concentration in some individuals wit h decreased
lriacylglyc3 rol catabo lism w ithout increased triacylglycerol sy nthesis and no
defect of cho linesterase synmees . The findln!:l by Cu culenu et a/. of normal
cholinesterase activ ity in some cases of high triglyceride triacylglycerol is
not sufficien t because they did not measure the concentration of the
enzyme.
The alternative hypo thesis would be favoured by the finding that known
cases of impaired triacylglycerol ca tabolism did not have cholinesterase
concentratio ns below their expected minima. The da ta prese nted here may
not contain any cas es in which triacylglycero l removal is imp aired without
increased syn thesis but eve n if there are some, this would not prove the
attemauvehy pothesis becau se their cholinesterase concent ra tions cou ld be
in the upper end of th e range by chance. Increasing nu mbers of such cases
without the finding of any with low cholinesterase concent rations would
progressively decrease the p robability of the hypothes is of Cucuianu ,r al.
6, The improvement in correlation with chollnesternse by taking logarithms of
tr iacylglyc erol co ncentrations operates only because of Ihe shape 01 the
cholineste rase-triacylglycerol distribution. The improvement is greater if the
ceta con tain enhanced numbers of indivi duals wilh hi gh triacylglycero l
concentra tions and it does not happen if the data do not contain suc h
individuals . The laller finding is against lhe un derlying relationship of
cholinesterase concentration being to the logarithm rathe r than to the lipi d
concentra tion directly.
9, Th e triangular sha pe of the plots of cholinesterase against 'total LD L', VLD L
an d triacy lglycero ls indicates that calculation of corre lation coefficients Is no t
the appro priate s tatistical method 10de scribe the relat ionships . It may
therefore be that the Index giving thegreatest cor relation coefficient {to ta l
LOL') is not the one with the primary relat ionship to serum cholinesterase .
At tnevery lowest concentrations 01'total LOL' and VLDL the cholinesterase
concentration tends to be Jo,Y so the left border otme distribution is no t
par allel to the cho linesterase axis butasce nds to the maximumm uch more
steeply tha n does the low er border . With tri acylglycerol the same tendency
occurs but the lef t border is much Sleepe r. This causes theshape to be
fu rther fro m linea rity. Th e primary reteuonshc may be between serum
cholinesterase and serum triacylglycerols, even tho ugh it does no t give the
hig hest corre lation coeffici ent.
10, If the hypo thesis thai serum cholinesterase synthesis is related to VLDL or
tri acylglyce rol syn thesis ra ther than to their serum concen trations is corec t
the n the pr imary relations hip of cholines terase cannot be to apoB (the
common factor of VLDL and l OLl if the findings of Sore-Thomas at al.
(1989) are correct that apoB synthesis is nor incre ased in byperaptoaemta.
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so is presumably 10 triacylg lycerol synthesis . If the primary relations hip of
cholinesterase synthes is is to serum lipid co ncentra tion the n it mig ht be
related either 10 the concentration of friacylglycero ls or apaS-bearing
lipop roteins. T he data cannot distinguish these possib ili ties.
11. The maximum found in serum cholinesterase concen tration contrasts with
serum y·gluta myt transferase, the mean activity of w hich was shown 10
incre ase con ti nuously with inc reasing serum Iria cylglycerol co nc entration by
Cucuianuot al. (1976 ) .
12 . Radial immunodiffusion has shown repeatable individual va riation in the
patte rns of bUlyrytch o linesle rasb-sla ining fm m unopre cipitin rings. Family
studies would be required10determine whether thesea re inhe rited.
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